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IV.  Abstract 
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The release of the oocyte from the ovary (ovulation) and terminal differentiation of 
cells of the preovulatory follicle (luteinization) are initiated by the surge of pituitary 
luteinizing hormone (LH) and are essential for proper reproductive function.  As a 
result, major research efforts have been dedicated to deciphering the signaling 
pathways and transcriptional networks that are activated in granulosa cells following 
the LH surge.  Remarkably however, few studies have examined the role post-
transcriptional gene regulation plays in mediating LH action within preovulatory 
granulosa cells.  Because cell and tissue function are reliant on the proper splicing, 
localization, and translation of mRNA to protein (i.e., post-transcriptional gene 
regulation) understanding this regulatory mechanism is essential for understanding 
ovarian (granulosa cell) function.  MicroRNA (miRNA) mediate changes in post-
transcriptional gene expression and have been tightly linked to a number of cell 
developmental and differentiation events.  We identified miRNA-21 (miR-21) as an 
LH-induced miRNA in murine granulosa cells.  The goal of this dissertation was to 
determine the function of miR-21 in granulosa cells of the periovulatory follicle.  We 
found that in vitro knockdown of miR-21 in granulosa cells using antisense locked 
nucleic acid oligonucleotides (LNA) increased apoptotic death and decreased global 
translation, and these cellular events could be separated pharmacologically.  
Exogenous miR-21 increased global translation and our current evidence implicates 
changes in the activity of the Akt/mTOR pathways upstream of the critically 
important elongation factor-2 as the cause for this increase in protein synthesis.  In 
vivo knockdown of miR-21 blocked ovulation and increased granulosa cell apoptosis.  
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Therefore, miR-21 functions in periovulatory granulosa cells to inhibit apoptosis and 
to promote global translation, thus likely promoting the formation of a functional 









1.  The Periovulatory Follicle 
To initiate ovulation and luteinization, luteinizing hormone (LH) acts on the 
dominant preovulatory follicle to form the periovulatory follicle. Periovulatory 
follicles are defined as those follicles that respond to the ovulatory surge of LH and 
proceed to ovulation.  Cells of the periovulatory follicle mediate the processes of 
ovulation, oocyte maturation, and luteinization, and the follicle undergoes drastic 
molecular, phenotypic, and functional changes to allow for these to proceed. In the 
mouse, these changes are rapid, synchronized, and strictly regulated as 13-15 h after 
the LH surge ovulation occurs, followed by involution of the periovulatory follicle to 
form the corpus luteum (Runner MN, 1953) .  Molecular changes within the 
periovulatory follicle occur within 1 h after LH, and phenotypic changes are evident 
5-7 h after LH (Chaffin and Stouffer, 2002; Oonk et al., 1989).   
 
Origin and Structure 
The periovulatory follicle marks the last transition in the lifespan of the 
follicle as it converts to a new ephemeral gland, the corpus luteum.  To appreciate the 
complexity of the periovulatory follicle, one needs to understand its origin and 
structure.  The female contains a quiescent pool of immature primordial follicles that 
will either develop into a periovulatory follicle and ovulate or will degenerate through 
a process called atresia.  Primordial follicles are comprised simply of an oocyte, 
arrested in the diplotene stage of meiotic prophase, surrounded by a single continuous 
or discountinuous layer of squamous stromal cells (Hirshfield, 1991; Zamboni, 1974).  
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Gradually and continuously, some of the primordial follicles are “activated” due to 
the actions of, among others, GDF-9, Kit ligand, and nerve growth factor beta 
(NGFB) to begin the development process (Dissen et al., 2001; Dong et al., 1996; 
Reynaud et al., 2000).  The primary follicle is distinguished from the primordial 
follicle by a larger oocyte surrounded by cuboidal stromal cells, which are now 
referred to as granulosa cells.  A basal lamina surrounds the granulosa cells, which 
separates them from the blood supply and promotes granulosa cell proliferation, 
polarity, and differentiation (Amsterdam et al., 1989; Luck and Zhao, 1993; Rodgers 
et al., 2001).  The preantral follicle forms as granulosa cells proliferate into layers 
concentric with the inner most layers (Zamboni, 1974).  In addition, the oocyte 
secretes glycoproteins (ZP1, ZP2, and ZP3) to assemble the zona pellucida, which is 
important for oocyte growth and, later, for fertilization (Bleil and Wassarman, 1980; 
Rankin et al., 2001; Wassarman, 2005).  Those granulosa cells immediately adjacent 
to the oocyte are now referred to as corona radiate cells, and these cells directly 
interact with the oocyte through trans-zonal cytoplasmic projections that form 
communicative and adhesive junctions with the oolema (Anderson and Albertini, 
1976; Eppig, 1982). Through these junctions maternal signals are transmitted to the 
oocyte, which in turn signals back to the somatic cells to direct them to perform 
functions necessary for oocyte development, thus forming a regulatory loop.  
Surrounding the corona radiata another layer of nurse cells, the cumulus cells, form 
junctions and communicate with the corona radiata.  This combination of the oocyte, 
corona radiata, and cumulus cells is called the cumulus-ocoyte-complex (COC), and 
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the entire COC will be ovulated.  As the follicle grows the number of granulosa cell 
layers increases, and development during this period is gonadotropin independent 
(Peters et al., 1975).  Release of follicle stimulating hormone (FSH) from the pituitary 
causes the formation of a fluid-filled antrum within the follicle and the disassociation 
of the COC from the mural granulosa cells to form the antral follicle (Baccarini, 
1971).  FSH is required to stimulate/maintain antral follicle development (McGee and 
Hsueh, 2000), and the importance of FSH during this final transition is evident in that 
FSH null mice are devoid of any follicles past the preantral stage (Kumar et al., 
1997).  In response to FSH, granulosa cell proliferation increases and these cells 
secrete paracrine factors that promote fibroblast-like precursor cells surrounding the 
basal lamina to differentiate into theca cells (Magarelli et al., 1996; Zachow et al., 
1997).  Theca cells produce large amounts of androgens, and therefore differentiation 
involves an upregulation in genes involved in androgen biosynthesis, such as 
cholesterol side-chain cleavage cytochrome P450, 3β-hydroxysteroid dehydrogenase, 
and 17α-hydroxylase.  Thecal androgens are aromatized into estrogens by mural 
granulosa cells (Erickson et al., 1991; Erickson et al., 1985).  Therefore, following 
FSH stimulation the follicle produces large and increasing amounts of estrogen, and 
the increasing levels of estrogen feedback on the hypothalamus and pituitary to 
stimulate the LH surge (Kamel et al., 1987; Legan et al., 1975).  FSH also acts on 
mural granulosa cells to increase LH receptor expression, so the granulosa cells can 
respond to the LH surge (Adashi, 1994; Zeleznik et al., 1974).  In addition, FSH 
increases levels of vascular endothelial growth factor (VEGF) in the preovulatory 
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follicle, thus increasing blood vessel number and permeability so that LH can pervade 
the follicle and act on granulosa cells (Mattioli et al., 2001).  LH binds to the newly 
acquired LH receptor on the granulosa cells to cause formation of the periovulatory 
follicle.  LH receptors are expressed primarily by theca and mural granulosa cells, 
and not on cells of the COC, so the LH-induced mural granulosa cells must relay the 
LH signal to the COC to stimulate oocyte maturation, cumulus expansion, and 
ovulation (Eppig et al., 1997; Peng et al., 1991).  In addition, granulosa cells of the 
periovulatory follicle mediate the breakdown of the surrounding basal lamina, theca 
cell layers, the dense, collagenous structurally supportive tunica albuginea, and the 
outer surface epithelium, to allow release of the entire COC from the follicle.  
Following ovulation, the follicle collapses and the blood supply invades the formerly 
avascular granulosa layer to form the corpus luteum.  In rodents, the corpus luteum 
survives about two days if there is no mating stimulus (which will increase prolactin 
levels and maintain the corpus luteum), and, under the influence of prostaglandin 
F2α, undergoes luteolysis to form the corpus albicans (Bachelot and Binart, 2005; 
Horton and Poyser, 1976). 
 
Events Stimulated by LH in the Periovulatory Follicle 
Luteinizing hormone (LH) is released by the pituitary as a result of increasing 
levels of estradiol from the FSH-induced growing follicle.  Luteinizing hormone 
binds to G-protein-coupled LH receptors, acquired due to the FSH stimulus, on 
granulosa cells of the dominant follicle to increase cyclic AMP (cAMP), cyclic GMP 
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(cGMP), and intracellular calcium levels (Davis, 1994; Marsh et al., 1966; Richards 
and Rolfes, 1980).  These second messengers activate a number of cell signaling 
cascades, including the PKA pathway and the MAPK/ERK pathway (Babu et al., 
2000; Bachelot and Binart, 2005; Cameron et al., 1996; Fan et al., 2009), inducing 
molecular changes that lead to the follicular and cellular events necessary for 
ovulation and luteinization (Duggavathi and Murphy, 2009).   Although tightly co-
regulated, LH surge induced events, such as ovulation and luteinization, can be 
considered as two separate events in that one is not required for the other to occur 
(Smith et al., 1994).    
Although LH only binds to receptors on mural granulosa and theca cells, it 
causes profound changes in all cells of the follicle.  The LH surge initiates cumulus 
expansion, re-entry of the oocyte into the cell cycle, and oocyte cytoplasmic 
maturation, all of which are necessary for successful fertilization and embryonic 
development.  In addition, the LH surge initiates the breakdown of the follicle wall, 
thus allowing the release of the COC from the follicle through ovulation.  Finally, the 
LH surge initiates the process of luteinization, in which the periovulatory follicle 
transforms into a highly vascularized transient endocrine organ.  This organ, the 
corpus luteum, produces the high amounts of progesterone that are necessary to 
maintain pregnancy.  Because this is such a critical time in female reproduction, these 




Ovulation: Follicular Rupture 
During ovulation, the periovulatory follicular wall must be breached at a 
specific location, the stigma, to allow the release of the COC into the oviduct 
(Thomson, 1919).  The collagenous connective tissue of the theca externa and tunica 
albuginea provides strength to the follicular wall, and thus breakdown of these fibers 
is among the most important structural change of follicular rupture (Tsafriri, 1995).  
In addition, the basal membrane that separates the granulosa cells from the highly 
vascularized theca interna cells must be degraded (Tsafriri, 1995).  In 1916, S. 
Schochet proposed that follicular fluid contains a “digestive enzyme” that could 
breakdown the follicle wall to allow for ovulation.  This idea was met with a fair 
amount of skeptism by his colleagues, who continued to consider intrafollicular 
pressure the cause for ovulation as late as the 1970s, until it was finally established 
that antral pressure does not increase prior to ovulation (Parr, 1975).  Moreover, later 
studies confirmed Schochet’s hypothesis and LH-induced proteolytic mediators were 
identified in granulosa cells that activate proteolytic cascades to breakdown the 
follicle wall.  These proteolytic mediators, prostaglandins, were first suggested to be 
important for follicle wall breakdown when it was shown that prostaglandin 
antiserum or prostaglandin synthase inhibitors, such as aspirin and indomethacin, 
could block ovulation (Bjersing and Cajander, 1975; Orczyk and Behrman, 1972).  
Levels of both prostaglandin synthase (Ptgs2) and prostaglandins increase after LH 
(Huslig et al., 1987; LeMaire et al., 1973).  The importance of prostaglandins was 
further confirmed in Ptgs2 deficient mice, in which breakdown of the extracellular 
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matrix around the stigma is impaired (Davis et al., 1999).  Prostaglandins initiate the 
breakdown of the follicle wall by activating plasminogen activators, which convert 
plasminogen in the follicular fluid to the active protease plasmin (Beers, 1975; Curry 
and Smith, 2006; Markosyan and Duffy, 2009).  Plasmin activates the matrix 
metalloproteases (collagenase, stromelysin, and gelatinase), which proteolytically 
digest and weaken the follicle wall to allow for rupture (Reich et al., 1986; Woessner 
et al., 1989).   
 
Cumulus Expansion  
Cumulus cells secrete a “jelly-like matrix” composed of the 
mucopolysaccharide hyaluronic acid (HA) in a process called cumulus expansion 
following the LH surge (Austin, 1961; Eppig, 1980; Salustri et al., 1992).  Cumulus 
expansion has been implicated in follicle cell survival, ovulation, and fertilization.  
Within the follicle, HA has been indicated to be important for cell growth and 
survival of both cumulus and mural granulosa cells as well as for oocyte quality 
(Kaneko et al., 2000; Ohta et al., 1999).  This appears to be mediated by the binding 
of HA to CD44 receptor on granulosa cells and the oocyte, which activates the 
epidermal growth factor receptor 2 (ErbB2) receptor to initiate the phosphoinositide  
3-kinase (PI3k)-dependent pathway, thus promoting cell growth and survival and 
preventing apoptosis (Kaneko et al., 2000; Schoenfelder and Einspanier, 2003; Yokoo 
et al., 2002).  Expansion is also necessary for ovulation, perhaps by forming a 
protective and flexible meshlike structure that allows the COC to safely deform as it 
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passes through the follicle stigma (Russell and Salustri, 2006).  Indeed, the loss of 
genes necessary for expansion result in reduced ovulation rates and a high incidence 
of oocytes trapped in luteinized follicles (Fulop et al., 2003; Varani et al., 2002).  The 
sticky matrix of the COC may also facilitate COC pickup by the oviductal epithelial 
cells and its subsequent transport through the oviduct (Talbot et al., 2003).  Within 
the oviduct, follicular molecules, such as progesterone or heparin, stuck to the 
expanded COC may act as a chemoattractant for sperm (Eisenbach and Tur-Kaspa, 
1999).  Additionally, the HA matrix may play a role in sperm capacitation (Van Soom 
et al., 2002), polyspermy prevention (Hong et al., 2004), or sperm acrosome 
activation (Tesarik et al., 1988), and an increase in expansion is associated with an 
increase in fertilizability (Chen et al., 1993).  
Since cumulus cells and the oocyte do not express LH receptor, the molecular 
events that initiate cumulus expansion in response to LH are hypothesized to be 
mediated through the mural granulosa cells (Eppig et al., 1997; Peng et al., 1991).  
Granulosa cells use paracrine signals to transmit the LH signal to the COC.  
Epidermal growth factor (EGF)-like ligands, such as amphiregulin, epiregulin, and 
betacellulin, are expressed by granulosa cells in response to LH (Liu et al., 2009; Park 
et al., 2004).  Their membrane-bound precursors are cleaved by ADAM (a disintegrin 
and metalloprotease) proteases, which are also upregulated in response to LH, and the 
mature ligands are released into the antrum of the periovulatory follicle (Conti et al., 
2006; Sriraman et al., 2008a).  These EGF ligands bind to ErbB receptor tyrosine 
kinases on cumulus cells to increase the expression of proteins necessary for cumulus 
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expansion, such as hyaluronidase synthase, Ptgs2, and tumor necrosis factor alpha 
induced protein 6 (Tnfaip6; Liu et al., 2009; Ochsner et al., 2003; Park et al., 2004; 
Yamashita et al., 2007).  In addition, the inflammatory cytokine interleukin 6 has also 
recently been described as another, independent paracrine mediator of cumulus 
expansion that activates genes necessary for cumulus expansion (Liu et al., 2009).   
However, despite the importance of mural granulosa cells, the oocyte also seems to 
play a role in regulating cumulus expansion as removal of the oocyte from the COC 
complex prevents gonadotropin-induced cumulus expansion (Buccione et al., 1990).  
Ovarian secreted growth factors, such as GDF-9 and BMP15, have been implicated as 
oocyte paracrine signals that are necessary for cumulus expansion (Dragovic et al., 
2005; Gueripel et al., 2006).   
 
Oocyte Maturation 
Occurring simultaneously with cumulus expansion is maturation of the 
oocyte, which includes both nuclear and cytoplasmic maturation.  During 
embryogenesis, oocytes enter meiosis and arrest at the dictyate stage of prophase I 
(Eppig, 2003).  Oocytes remain in prophase I through folliculogenesis, until the LH 
surge signals oocytes of antral follicles to undergo nuclear maturation (Eppig, 2003; 
Van De Kerckhove, 1959).  During nuclear maturation the nuclear membrane 
(germinal vesicle) breaks down, the chromosomes condense, and the oocyte 
transitions out of prophase I to finish meiosis I (“meiotic resumption”), resulting in an 
extrusion of a polar body (Austin, 1961; Calarco et al., 1972).   
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Prior to formation of the antral follicle, the oocyte does not have the ability to 
undergo meiotic resumption, suggesting that inherent factors keep it arrested until this 
point (Eppig, 2003; Mehlmann, 2005).  After antrum formation, however, the oocyte 
will spontaneously resume meiosis if removed from the follicle, suggesting that 
follicular factors must be responsible for its arrest (Mehlmann, 2005; Pincus and 
Enzmann, 1934; Racowsky and Baldwin, 1989).  Indeed, loss of gap junctions 
between the oocyte and the corona radiata prevents the initiation of meiotic 
maturation (Carabatsos et al., 2000).  Cyclic AMP is necessary for meiotic arrest, and 
elevated cAMP levels prevent meiotic resumption (Cho et al., 1974; Conti et al., 
2002).  Historically, cAMP from cumulus cells was thought to transit through gap 
junctions to the oocyte to maintain meiotic arrest (Anderson and Albertini, 1976; 
Piontkewitz, 1993, Webb et al., 2002).  However, recent reports have indicated that 
cAMP does not originate from cumulus cells, but elevated cAMP levels are due to the 
activation of an oocyte-expressed orphan receptor, G-protein coupled receptor 3 
(Gpr3; Mehlmann et al., 2004).  Maintainence of oocyte cAMP levels by Gpr3 
activation of adenylyl cyclase thus prevents meiotic resumption. Inhibition of Gpr3 
using an inhibitory antibody causes meiosis to resume (Mehlmann et al., 2002; 
Mehlmann et al., 2004; Pirino et al., 2009).   Elevated levels of cAMP activates 
protein kinase A (PKA), which phosphorylates the cell cycle mediators Cdk1 and 
cyclin B1 to prevent their activity and thus prevent meiotic resumption (Pirino et al., 
2009).  In addition, PKA also phosphorylates the phosphatase Cdc25b to prevent its 
activity (Pirino et al., 2009).  Luteinizing hormone causes a loss of interaction 
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between the oocyte and the somatic cells, thus decreasing the cell signaling that 
activates PKA (Eppig, 1982).  As PKA levels fall, Cdc25b becomes active and can 
dephosphorylate and thus activate mediators of the cell cycle to promote germinal 
vesicle breakdown, the condensation of chromosomes, and the formation of the first 
metaphase spindle (Pirino et al., 2009; Verde et al., 1990).  Cdc25b knockout mice 
are sterile due to inability of the oocytes to resume meiosis (Lincoln et al., 2002).  
   Concomitant with nuclear maturation, the oocyte cytoplasm also matures 
with the acquisition of factors necessary for fertilization and subsequent early 
embryonic development are produced and organized (cytoplasmic maturation).  One 
of the most morphologically obvious changes is the production and accumulation of 
cortical granules under the oocyte plasma membrane (Sathananthan et al., 1985).  
Cortical granules are synthesized from the Golgi complex, and contain at least five 
different proteins (Gross et al., 2000; Sathananthan et al., 1985).  Some of these 
proteins, such as N-acetylglucosaminidase, modify the zona pellucida after 
fertilization to prevent polyspermy (Miller et al., 1993).  Other proteins, such as p62 
and p56, remain in the egg and are important for cell division in embryogenesis 
(Hoodbhoy et al., 2000; Hoodbhoy et al., 2001).  
Cytoplasmic maturation also results in the accumulation of other molecules 
within the oocyte.  It is well established that fertilization results in an increase in 
intracellular calcium levels within the egg to cause cortical granule exocytosis and the 
resumption of meiosis II (Kline and Kline, 1992; Miyazaki et al., 1993; Taylor et al., 
1993).  However, the immature oocyte does not contain enough stored calcium to 
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initiate these processes (Mehlmann and Kline, 1994).  Therefore, following the LH 
surge, the oocyte increases its calcium stores, in part by increasing its amount of 
endoplasmic reticulum, and gains an increase in sensitivity of IP3-induced calcium 
release, thus preparing the oocyte so it can undergo the calcium oscillations needed 
during fertilization (Mehlmann and Kline, 1994; Mehlmann et al., 1995).  In addition, 
prior to fertilization, the sperm chromatin is tightly condensed, but entry into the egg 
causes rapid decondensation so that the chromatin is released (Borenfreund et al., 
1961; Perreault et al., 1988).  Levels of glutathione, which has the ability to reduce 
protamine disulfide bonds, increase in the oocyte cytoplasm following the LH surge, 
and this increase is necessary for sperm decondensation (Perreault et al., 1988; 
Sutovsky and Schatten, 1997).   
 
Luteinization 
In 1940, luteinizing hormone was isolated from the anterior lobe of the 
pituitary gland, and was named such because it causes formation of CL in the ovary 
(Shedlovsky et al., 1940). The CL was first described by Renier de Graaf in 1672 in 
“De Mulierum Organis Generationi Inservientibus Tractatus Novus”, and in this 
paper he proposed that CL are transient structures that develop from antral follicles 
and, furthermore, the number of CL corresponds to the number of embryos (translated 
by Jocylyn and Setchel, 1972).  The idea that the CL might function as an endocrine 
organ was not proposed until two hundred years later by the French scientist A. 
Prenant (1898), and soon thereafter was confirmed when L. Frankel (1903) 
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demonstrated that removal of the ovaries in pregnant rabbits during the first week of 
gestation results in loss of pregnancy.  In the 1930s, this CL-released “progestational 
substance” was identified as the steroid progesterone (Allen and Wintersteiner, 1934).  
Progesterone is necessary for implantation, uterine quiescence, lactation, (Corner, 
1929; Robson, 1936), and feedback to the hypothalamus and pituitary to prevent a 
subsequent LH surge and ovulation in case pregnancy should occur (Parkes, 1929).  
Several histological and electron microscopy studies have examined the 
morphological changes that occur during luteinization.  At the tissue level, the 
basement membrane breaks down and there is an involution of granulosa and theca 
cells into the center of the antrum (Van Blerkom and Motta, 1978).  In addition, there 
is rapid and dramatic angiogenesis so that the CL has an abundant blood supply in 
which to release progesterone into circulation (Cavender and Murdoch, 1988; 
Shimoda, 1993).  Cords of granulosa cells surround the capillary vessels, forming 
interconnected spaces that allow for immediate release of progesterone into the blood 
(Van Blerkom and Motta, 1978).  At the cellular level, granulosa cells transform into 
progesterone-producing luteal cells.  There is a massive increase in organelles 
involved in steroid synthesis, including an increase in mitochondrial and smooth 
endoplasmic reticulum membranes and an increase in size of the Golgi apparatus 
(Cavazos et al., 1969; Crisp et al., 1970; Enders, 1973; Fawcett et al., 1969; 
McClellan et al., 1975; Priedkalns et al., 1968).  This, along with an increase in large 
lipid droplets containing cholesterol esters, results in considerable granulosa cell 
hypertrophy.  Within hours, the ~10um granulosa cell grows to an ~40um luteal cell 
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and increases in volume by 8-fold, transforming to the largest steroidogenic cell in the 
body (FIG V-1; Fawcett et al., 1969; Murphy, 2000).  Furthermore, with the large 
increase in cellular membranes, the follicle can now increase serum progesterone 
concentration to the ng/mL range, compared to the pg/mL of estrogen it was making 
prior to the LH surge.  It is important to note that an increase in cell size, not cell 
number, is responsible for this increase in steroidogenic ability, as the granulosa cell 
is terminally differentiated and has exited from the cell cycle (Rao et al., 1978; 
Robker and Richards, 1998a). 
While early studies on luteinization focused on changes in morphology and 
general function of granulosa cells, later studies have focused on molecular changes 
that are occurring to mediate this transformation.  A number of transcription factors 
have been identified as vital to the luteinization process, such as C/EBPβ and Egr1.  
Follicles of C/EBPβ null mice, while able to ovulate, are unable to undergo 
luteinization (Sterneck et al., 1997), and Egr1 null mice have defects in both 
ovulation and luteinization (Topilko et al., 1998), suggesting that these two 
transcription factors regulate luteinization.  These transcription factors, and others, 
regulate a variety of genes that mediate the functional shift from an estrogen-
producing cell to a progesterone-producing cell.  The expression of genes involved in 
progesterone synthesis are upregulated, such as steroid acute regulatory protein 
(StAR; Kiriakidou et al., 1996), P450scc (Goldring et al., 1987) and 3βhsd (Couet et 
al., 1990), while genes involved in estrogen synthesis, such as P450 17alpha 
hydroxylase (Cyp17; Hedin et al., 1987) and,  in most species, P450 aromatase  
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Figure V-1.  The transition of a granulosa cell to a luteal cell involves a rapid and 
dramatic increase in mitochondria and smooth and rough endoplasmic reticulum, 
resulting in a pronounced hypertrophic response. Cells also accumulate lipid droplets 





(Hickey et al., 1988), are downregulated.  
The LH-induced cessation of the cell cycle is due to a loss of proteins that 
promote the cell cycle, including cyclins and Cdk2, and an increase in proteins that 
inhibit the cell cycle, including the Cdk inhibitors p21cip1 and p27kip1 (Hampl et al., 
2000; Richards et al., 1998; Robker and Richards, 1998a).  Furthermore, until onset 
of luteal regression, luteal cells are resistant to apoptosis (Matsubara et al., 2000).  
This apoptotic-resistance is due to the activiation of survival factors in granulosa cells 
by LH (Hu et al., 2004).  While granulosa cells isolated prior to LH succumb to Fas-
ligand induced apooptosis, granulosa cells isolated after LH are resistant to Fas-ligand 
induced apoptosis (Quirk et al., 2004).  Treatment of cultured granulosa cells with the 
progesterone receptor antagonist RU486 inhibited this LH-induced resistance to 
apoptosis in some cells (Quirk et al., 2004).  Therefore, the apoptotic resistance 
appears to be in part mediated by progesterone receptor (Quirk et al., 2004).  In 
cultured porcine granulosa cells, LH suppressed the pro-apoptotic p53 and prevents 
cleavage/activation of caspase-3, and increased levels of the anti-apoptotic Bcl2 
(Dineva et al., 2007). In vivo, the expression of the anti-apoptotic Bcl-2 family 
protein myeloid cell leukemia-1 (Mcl-1) and the anti-apoptotic P11, which inhibits 
activity of the pro-apoptotic Bad, were shown to increase following hCG in the rat, 
and therefore may play a role in the survival action of LH on granulosa cells (Chun et 
al., 2001; Leo et al., 1999).  While these studies begin to examine the molecular 
events mediating LH-induced resistance to apoptosis, there are still many unanswered 
questions as to the molecular signals that mediate this resistance.   
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Controlled Ovarian Stimulation 
 Because of the cyclic nature of the ovary, and the recruitment and ovulation of 
just a few follicles at a time, it is difficult to isolate a large number of comparable 
granulosa cells from the ovary to examine and study.  Therefore, researchers have 
adopted a “superovulation” technique in which immature animals are injected with 
exogenous hormones to synchronize and stimulate the growth of multiple follicles so 
that a large number of granulosa cells can be collected (Runner and Gates, 1954).    
While the technique also works on adult animals, and is in fact used on humans (and 
animals) during in vitro fertilization protocols, for laboratory studies immature 
animals are most often used because a larger number of cells can be obtained (Zarrow 
and Wilson, 1961).   
 Both FSH and LH have short half lives (3-4 hours for FSH, and 20 minutes 
for LH; (Speroff, 2004) and have to be continuously infused into an animal during 
ovarian stimulation (Armstrong and Opavsky, 1988; Hamilton and Armstrong, 1991).  
Therefore, the identification of hormones that bind to FSH and LH receptors, but 
have longer half-lives, provided a means for inducing superovulation with just a 
single injection.  These hormones, equine chorionic gonadotropin (eCG, also called 
pregnant mare serum gonadotropin (PMSG)) and human chorionic gonadotropin 
(hCG) are produced by the placenta (mare or human, respectively) and have similar 
structure and biological activity to FSH and LH, respectively (Cole, 1930; Lamond, 
1960).  Like FSH, eCG stimulates follicle development, and, like LH, hCG stimulates 
ovulation and luteinization (Lamond, 1960).  However, eCG and hCG have much 
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longer half-lives (6 days and 24h) than FSH and LH due to heavy glycosylation, and 
thus can be given as a single injection (Ladman, 1964; Speroff, 2004; Wang et al., 
1995).  Therefore, a superovulation protocol has been established that gives a dose of 
eCG to stimulate follicle development, followed by a dose of hCG to stimulate 
ovulation and luteinization (Runner and Gates, 1954).  This superovulation protocol 
has been utilized in this work to obtain a large number of similar granulosa cells for 
study. 
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2.  Post-Transcriptional Gene Regulation 
In 1969, a paper published in Science by Gordon M. Tomkins et al. suggested 
that a “post-transcriptional mechanism” acts on messenger RNA (mRNA) to either 
repress or enhance translation (Tomkins et al., 1969).  While they conceded that 
transcriptional regulation plays a large role in gene regulation, they state that control 
of the synthesis of mRNA, or “post-transcriptional gene regulation”, is just as 
important in determining the final proteome of the cell.  Since then, several studies 
have shown a lack of correlation between the steady state messenger RNA (mRNA) 
levels and the levels of the proteins encoded by these mRNA (correlation of 0.4, Gygi 
et al., 1999; correlation of 0.6, Ideker et al., 2001).  This suggests that post-
transcriptional gene regulation plays a major role in the establishment of a final 
proteome.  Post-transcriptional gene regulation includes the regulation of the 
transport, turnover, and translation of mRNA, and infers several advantages on the 
cell.  It allows the cell to respond rapidly to a signal, but still allows swift reversibility 
(Sonenberg, 2000).  It allows for spatial control of a particular protein through mRNA 
localization and storage (Anderson and Kedersha, 2006; Colegrove-Otero et al., 2005; 
Hillebrand et al., 2007), and allows for cells lacking transcriptional control, such as 
transcriptionally quiescent oocytes or enucleated platelets a mechanism to regulate 
gene expression (Keene and Tenenbaum, 2002).  Perhaps most interestingly, it may 
allow the coordinated expression of protein families, in a sense acting as a post-
transcriptional operon (Keene and Tenenbaum, 2002).   
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Post-transcriptional gene regulation can be either global or specific.  Global 
control can rapidly increase or repress the translation of the majority of mRNA.  For 
example, stress causes the translation of all mRNA, except for those involved in cell 
survival, to decrease (Wek et al., 2006).  These global effects on translation are due to 
regulation of the availability or activity of translational components, such as initiation 
factors, elongation factors, ribosomes, or tRNA (Rajasekhar and Holland, 2004; 
Sonenberg and Hinnebusch, 2007).  Specific control of translation, on the other hand, 
depends on the presence of cis-acting regulatory elements in the 5’ or 3’ untranslated 
regions (UTRs) of mRNA.  Trans-acting factors, including RNA-binding proteins and 
microRNA (miRNA)/RISC, act on these regulatory elements and can affect the 
translation, stability, or localization of often functionally related mRNA.    
 
Post-Transcriptional Gene Regulation in the Ovary 
The role of post-transcriptional gene regulation in the ovary remains virtually 
unexplored.  Expectedly, it has been most studied in the transcriptionally quiescent 
oocyte.  In 1964, Gross and Moyer showed that treatment of sea urchin eggs with 
actinomycin D did not affect their ability to rapidly synthesize proteins following 
fertilization (Gross et al., 1964).  In addition, they showed that sea urchin eggs do not 
incorporate isotopically labeled uridine into RNA.  Therefore, the oocyte is 
transcriptionally quiescent during maturation, fertilization and early embryogensis 
(up to the 2-cell stage in mouse, between the 4-and 8-cell stage in human), and thus 
must rely on stored mRNA during early embryonic development (Gandolfi and 
 37 
Gandolfi, 2001; Gross et al., 1964; Memili et al., 1998).  During folliculogenesis, the 
oocyte synthesizes and stores mRNA and proteins that will be used during this time 
period, and thus this stored pool must be kept stored and stabilized until needed 
(Gandolfi and Gandolfi, 2001).  RNA-binding proteins have been demonstrated to be 
important for storing mRNA during this time period.  For example, MSY2 is a germ-
cell specific RNA-binding protein that accounts for 2% of the protein in the oocyte 
(Yu et al., 2002).  It binds non-specifically to oocyte mRNA, acting as an mRNA 
stabilizer and translational repressor until an undefined signal causes MSY2 to release 
its transcripts so they can be translated into protein (Yu et al., 2002).  
Within the somatic cells of the ovary, including granulosa cells, the role of 
post-transcriptional gene regulation has not been extensively examined.  In fact, only 
several transcripts have been identified as post-transcriptionally regulated.  Connexin 
43, a major component of granulosa cell and oocyte gap junctions, is translationally 
repressed after the LH surge, although the specific RNA-binding protein that is 
responsible for the repression has not been identified (Kalma et al., 2004).  The 
degradation of the LH receptor transcript is increased after the LH surge, and this is 
mediated by mevalonate kinase, which acts both as an RNA binding protein and an 
enzyme in cholesterol biosynthesis (Wang and Menon, 2005).  In cultured bovine 
granulosa cells treated with FSH, the aromatase transcript has been shown to be post-
transcriptionally regulated as its transcript has a longer half-life after cAMP 
stimulation (Sahmi et al., 2006; Sahmi et al., 2004). Finally, two miRNA, miR-17-5p 
 38 
and let-7p, were recently shown to post-transcriptionally regulate TIMP1 expression 
during corpus luteum angiogenesis (Otsuka et al., 2008). 
  Recently, the role of microRNA as post-transcriptional mediators has been 
shown to be necessary for normal female reproductive function, as the loss of miRNA 
in the granulosa cells and reproductive tract leads to impaired fertility (Hong et al., 
2008).  Therefore, recent focus has shifted to identifying individual miRNA that are 
important for female reproduction.   
 
3.  MicroRNA  
Lin-4 was identified in C. elegans mutants in 1981 as a mediator of 
Caenorhabditis elegans development (Chalfie et al., 1981).  Unexpectedly, twelve 
years later, cloning of lin-4 indicated that it was not a protein-coding gene, but 
encoded for a small, 21-nucleotide RNA molecule (Lee et al., 1993).  Furthermore, 
binding of lin-4 to the 3’UTR of a protein-coding mRNA, lin-14, repressed its 
translation (Lee et al., 1993).  In 2000 another small RNA was identified in C. 
elegans (let-7(Reinhart et al., 2000)), followed by confirmation of the existence of 
small RNA in many diverse species, including humans (Pasquinelli et al., 2000).  In 
2001 the term “microRNA” was introduced as nomenclature for these small, 
regulatory RNA (Lagos-Quintana et al., 2001).  Since then, thousands of miRNA 
have been identified in a multitude of organisms (microRNA.sanger.ac.uk/) and 
miRNA have led to an explosion in our knowledge of the role post-transcriptional 
gene regulation plays in organ function.  It is predicted that 1-5% of genes encode for 
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miRNA, and they regulate the expression of as many as 30% of mRNA (Berezikov et 
al., 2005; Lewis et al., 2005). However, the functional importance of individual 
miRNA and the identity of their specific mRNA targets are just now beginning to be 
elucidated in rodents and human cell lines.  It remains to be determined if the function 
of miRNA is conserved across species in the same manner as protein-encoding genes.   
 
MicroRNA Biogenesis  
MicroRNA genes reside between protein-coding genes (i.e., intergenic) and 
within introns of genes, and in a few cases reside within exons or comprise the entire 
intron (i.e., mirtrons; Berezikov et al., 2007; Saini et al., 2007).  As a result miRNA 
can be transcribed either independently (intergenic and intronic) or in succession with 
an mRNA if they reside within an intron or exon (Corcoran et al., 2009).  The initial 
long primary RNA transcript (pri-miRNA) is capped (methyl-7-GpppG) and 
polyadenylated, and thus the transcription of most miRNA genes is mediated by 
polymerase II, although a few are transcribed by polymerase III (Borchert et al., 
2006; Cai et al., 2004; Kim, 2005; Lee et al., 2004b).   
Within the pri-miRNA a secondary structure forms comprising an ~80-110nt 
stem loop.  A protein complex called the microprocessor, composed of DGCR8 
(DiGeorge syndrome critical region 8), Drosha, and p68/72 DEAD-box RNA 
helicase, binds to the stem loop and cleaves it to produce an ~70-100nt precursor 
miRNA (pre-miRNA; Lee et al., 2003).   DGCR8 appears to act as the ‘molecular 
ruler’ by binding to the junction where the dsRNA of the stem loop meets the ssRNA, 
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and ‘counting’ up 11bp (one helical RNA turn; Han et al., 2006).  Most pri-miRNA 
have a bulge or mismatched base at this site (Yi et al., 2003).  The p68/72 helicases 
bind to the dsRNA of the stem loop and present the site to Drosha (Fukuda et al., 
2007).  Drosha cleaves the phosphodiester bond leaving a 2nt 3’overhang, and the 
resulting pre-miRNA is released into the nucleus (Lee et al., 2003).  In some cases, 
other proteins are required for the interaction of Drosha with the pri-miRNA; for 
instance, KSRP (KH-type splicing regulatory protein) is an RNA-binding protein that 
binds to G-containing stretches in the terminal loop of the stem loop structure and is 
necessary for Drosha:pri-miRNA interaction for a subset of miRNA (such as miR-21; 
Trabucchi et al., 2009). 
The pre-miRNA is exported from the nucleus by exportin 5 (Bohnsack et al., 
2004; Lund et al., 2004).   In the cytoplasm, pre-miRNA is further cleaved by a 
second RNase III enzyme, Dicer, to form a transient ~19-23nt RNA duplex 
(Hutvagner et al., 2001).  Although Dicer is an RNase III enzyme like Drosha, it has 
an extra domain, the PAZ domain that allows it to act as a molecular ruler without the 
need for a cofactor.  The PAZ domain binds to the 2nt 3’overhang at the base of the 
pre-miRNA, forcing the dsRNA binding domain to bind to the stem (Tahbaz et al., 
2004).  Dicer’s two RNAse III domains form an intramolecular dimer ~22nt from the 
base of the pre-miRNA, and this dimer cleaves the pre-miRNA to form an ~19-23nt 
RNA duplex that has 2nt overhangs on its 3’ ends (Tahbaz et al., 2004).  The miRNA 
duplex has multiple mismatches and G:U wobble pairs, which causes one end of the 
duplex to be less stable at the 5’ end, and this strand is preferentially loaded onto the 
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RNA-induced silencing complex (RISC; Khvorova et al., 2003; Schwarz et al., 2003).   
The RISC is composed of Dicer, TRBP (TAR RNA-binding protein), and one 
of several different Argonaute proteins (four in the human, AGO1-4; and five in the 
mouse, AGO1-5; Hutvagner and Simard, 2008).  TRBP recruits Argonaute to the 
Dicer:miRNA complex, thus forming miRISC (Chendrimada et al., 2005).   The 5’ 
end of the miRNA tucks into a binding pocket on the Argonaute protein, and bases 2-
8 bind to the target mRNA with perfect or close to perfect complementarity 
(Brennecke et al., 2005; Pratt and Macrae, 2009).  These bases make up the ‘seed 
sequence’ of the miRNA, and are especially important for conferring target 
specificity (Brennecke et al., 2005; Lai, 2002).  The seed sequence is exposed on the 
outside of the Argonaute protein, allowing the sequence to probe for a target through 
the cellular milieu and passing mRNA (Pratt and Macrae, 2009). In addition, many 
other proteins have been shown to interact with Argonaute proteins, but their exact 
roles in the miRISC are still being studied (Peters and Meister, 2007).   
 
MicroRNA Mechanisms of Action 
Binding of miRISC to target mRNA are postulated to cause:  1) mRNA 
cleavage and degradation; 2) mRNA deadenylation and degradation; 3) mRNA 
inhibition of translation initiation; 4) mRNA inhibition of translation elongation; or 5) 
mRNA translational enhancement.  The first possibility is thought to be the most used 
by miRNA in plants, but in vertebrates the others are thought to be more often used.  
For mRNA cleavage, the miRISC must contain a catalytically active Argonaute (only 
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AGO2 in mammals, Liu et al., 2004), and the miRNA and mRNA must be almost a 
perfect complementary match.  Messenger RNA degradation, however, can also be 
mediated by the other Argonautes even without perfect complementarity by 
interaction of the Argonaute protein with GW182 (Rehwinkel et al., 2005).  GW182 
recruits the decapping enzymes DCP1 and DCP2, and decapping of the mRNA leads 
to exonuclease degradation of the transcript (Rehwinkel et al., 2005).  In other cases, 
miRNA:mRNA binding causes translational repression.  Binding of miRNA to 
mRNA blocks translation due to RISC interaction with translation initiation factors, 
such as eIF6, eIF4E, and eIF4G, which prevents assembly of 80S ribosomes 
(Chendrimada et al., 2007).  Other reports also suggest that miRNA represses mRNA 
translation during the elongation step, and this idea is supported in that translationally 
repressed mRNA were found to still associate with polysomes (Jackson and Standart, 
2007; Maroney et al., 2006; Nottrott et al., 2006; Petersen et al., 2006).  However, 
recent reports have also indicated that a change in proteins associated with RISC can 
cause a shift from translational inhibition to translational enhancement (Vasudevan et 
al., 2007).   
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 Naming MicroRNA 
To provide structure in naming and characterizing the thousands of recently 
identified miRNA, the Sanger Institute miRNA Registry was established 
(http://microrna.sanger.ac.uk/ ; Griffiths-Jones et al., 2006).   The names of miRNA 
consist of four components, each conveying a specialized piece of information about 
the given miRNA: species, form (precursor or mature), identification number, and 
origin of miRNA (either processing origin or chromosomal origin).   Each component 
is separated by dashes and is represented by the following template: xxx-miR-#-
suffix.  The xxx signifies the species (i.e., hsa=human, mmu=mouse).  To distinguish 
between the precursor and mature forms of miRNA, a small case ‘r’ (‘mir’) represents 
the precursor form of the miRNA, while an uppercase ‘R’ (‘miR’) represents the 
mature form of the miRNA.  Generally, an identification number is assigned in 
sequential order of discovery, thus recently identified miRNA have larger numbers.  
The suffix identifier (which may or may not be separated by a dash depending on the 
suffix, Table V-1) denotes either the processing origin or the chromosomal origin of 
the miRNA.  For the processing origin, opposite arms from a single pre-miRNA are 
denoted ‘5p’ and ‘3p’.  After one arm is experimentally identified as the predominant 
arm, the less predominant arm is labeled with an asterisk suffix.   For genomic origin, 
miRNA that arise from different genomic loci but have identical mature sequences 
are labeled with numbered suffixes, and if they arise from paralogous genomic loci 
and have highly similar mature sequences, they are labeled with lettered suffixes.  
Rarely, miRNA genes have been identified at the same chromosomal location but on 
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opposing DNA strands (sense versus antisense), and thus have unique mature miRNA 
sequences.  The miRNA on the antisense chromosome is identified with an ‘as’ 
suffix.   A given miRNA can have several suffixes.  For example, hsa-miR-19b-1, 
which originates from chromosome 13, is identical to hsa-miR-19b-2 which 
originates from chromosome X, and both of these are paralogous (share 70% of 
mature sequence) to hsa-miR-19a which also originates from chromosome 13. 
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Table V-1.  Nomenclature of MiRNA Suffixes.   
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Regulation of microRNA Expression 
Many miRNA are expressed in specific cell types or at specific time periods, 
therefore indicating that, like protein-coding genes, miRNA expression is highly 
regulated (Lagos-Quintana et al., 2002; Landgraf et al., 2007).  However, the 
sequence and functional elements of miRNA promoters is only just starting to be 
examined.  The few miRNA promoters that have been examined, however, appear to 
be very similar to those of protein-coding genes.  Pri-miR-375, for example, is a 
miRNA that is expressed only in pancreatic islets (Avnit-Sagi et al., 2009).  Promoter 
studies indicated that its promoter has transcription factor binding sites for pancreatic-
specific transcription factors, such as HNF1 and Ngn3, and, in addition, chromatin 
immunoprecipitation studies confirmed interaction of Ngn3 with the pri-miR-375 
promoter (Avnit-Sagi et al., 2009; Keller et al., 2007).  In addition, approximately 
50% of miRNA are found as genomic clusters, and thus are probably coordinately 
transcribed as one primary transcript.  For example, the embryonic-stem cell (ES cell) 
specific miRNA gene cluster miR-290 to miR-295 is coordinately transcribed to help 
maintain ES cell pluripotency (Houbaviy et al., 2003).  Finally, some miRNA genes 
lie within the intron or exon of a protein-coding gene, and thus are co-expressed with 
their host gene and rely on transcriptional activation of the host gene promoter for 
their expression (Kim and Kim, 2007; Raver-Shapira and Oren, 2007). 
The processing of the primary or precursor forms of the miRNA can also be 
regulated, thus resulting in a form of post-transcriptional regulation.  Indeed, 
Thomson et al. found a discreprency between the primary/precursor levels of miRNA 
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and the corresponding mature miRNA during mouse embryonic development 
(Thomson et al., 2006).  Specific cases of miRNA being post-transcriptionally 
regulated have also been reported.  In pluripotent stem cells the RNA-binding protein 
Lin28-homolog (LIN28) selectively binds to the pri-let-7 family members to prevent 
their interaction with Drosha, thus preventing let-7 mediated differentiation 
(Viswanathan et al., 2008).  Another miRNA, miR-138, is found only in the brain, 
although its precursor forms are found ubiquitously in all tissues, suggesting that it is 
processed by Dicer only in the brain (Obernosterer et al., 2006).  In another case, two 
RNA-binding proteins, nuclear factor 90 (NF90) and NF45, bind to pri-miRNA to 
prevent Drosha cleavage into pre-miRNA (Sakamoto et al., 2009).  Interestingly, this 
binding appears to be differential, and in human embryonic kidney 293T cells, NF90 
and NF45 had a higher affinity for pri-let-7a than pri-miR-21(Sakamoto et al., 2009).  
It would be interesting to examine whether NF90 and NF45 bind distinct pri-miRNA 
in different cells or in response to different treatments.   
 
MicroRNA Functions 
MicroRNA have been shown to be important in many biological processes, 
including cell proliferation, differentiation, and apoptosis (Asangani et al., 2008; 
Cloonan et al., 2008; Silber et al., 2008).  In embryonic stem (ES) cells, for example, 
Dicer null mouse ES cells are viable, but they display major problems in growth and 
differentiation (Kanellopoulou et al., 2005).  The ES cell specific miR-290-295 
cluster has been shown to play an important role in preventing ES cell self-renewal by 
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indirectly decreasing the activation of Oct4 (Sinkkonen et al., 2008).  In addition, to 
promote differentiation, miR-21 targets Nanog and Sox2, important regulators of ES 
cell pluripotency and self-renewal (Singh et al., 2008).  MicroRNA have also been 
shown to be involved in the differentiation of adult stem cells during haematopoiesis, 
myogenesis, cardiogenesis, neurogenesis, and osteogenesis.  During erythropoiesis, 
miR-221 and miR-222 decrease during erythroid differentiation, releasing their 
inhibition of C-kit protein translation, leading to the expansion of early erythroblasts 
(Fontana et al., 2008).   
Because of their vital roles in cell growth and apoptosis, miRNA have also 
been associated with many disease states.  MicroRNA-133 and miR-1, for example, 
have been associated with the increase in cardiomyocyte hypertrophy that occurs 
during heart failure (Care et al., 2007).  Within the brain, several miRNA are 
upregulated in the diseased temporal lobe neocortex of Alzheimer’s patients, (Sethi 
and Lukiw, 2009), and a single nucleotide polymorphisms effecting miRNA binding 
sites have been associated with Tourette’s Syndrome and obsessive compulsive 
disorder (Abelson et al., 2005; Muinos-Gimeno et al., 2009).  Within the female 
reproductive tract, miRNA have been shown to play a role in endometriosis and 
uterine leiomyomas (Marsh et al., 2008; Wang et al., 2007; Peng et al., 2008; Pan et 
al., 2007). 
Perhaps the most studied is the role of miRNA in cancer development, 
progression, and prognosis.  Many miRNA genes are located in genomic regions that 
are amplified, deleted, or rearranged in cancer (Fontana et al., 2008).  Thus, it was not 
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surprising that many of these miRNA have been shown to play a role in cancer, and 
have even been given the designation “oncomir”.  Three of the most studied oncomirs 
are miR-34, miR-17-5p, and miR-21 (Esquela-Kerscher and Slack, 2006).  
MicroRNA-34 is downregulated in cancer, and studies have indicated that it acts as a 
tumor supressor and induces cell growth arrest and apoptosis by activating the p53 
pathway (Yamakuchi et al., 2008).  MicroRNA-17-5p and MiR-21 are both 
upregulated in many types of cancer and tumors, and have been demonstrated in 
many cases to prevent apoptosis and promote differentiation (Esquela-Kerscher and 
Slack, 2006).   
Because miRNA have been demonstrated to be important in other 
developmental and differentiation systems, we propose that miRNA also play a vital 
role in the development and function of reproductive tissues.   
 
Methods for Studying MicroRNA 
The first step in beginning a microRNA study is to determine the microRNA 
that are expressed within a given tissue or at a given period.  These preliminary 
studies can include miRNA cloning analysis or miRNA microarray analysis.  
MicroRNA cloning is useful to identify novel microRNA, and cloning frequency can 
give a general idea of abundance.  Most microRNA are identified first by cloning 
(Lagos-Quintana et al., 2001; Lau et al., 2001; Lee and Ambros, 2001), and cloning is 
especially useful in identifying miRNA that are novel to a specific tissue (Ro et al., 
2007a; Ro et al., 2007b).  With the establishment of a list of known miRNA, miRNA 
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microarrays were developed to allow for high throughput profiling of miRNA 
expression.  MicroRNA microarrays provide a rapid means in establishing the 
miRNAome of a cell, and can provide a fairly good idea of miRNA abundance and 
changes between treatment groups (Li and Ruan, 2009).  However, novel miRNA 
will be missed in a miRNA microarray study.   
Once a miRNA is identified by one of these two methods, its expression 
pattern is confirmed using Northern blot analysis or quantitative real time PCR (qRT-
PCR).  As new qRT-PCR  methods have been developed that allow for increased 
specificity, qRT-PCR has become the method for choice as it has a higher sensitivity 
than Northern blotting and provides a greater means for studying quantitative 
changes.  While several qRT-PCR methods have been introduced that allow for 
amplifying and quantifying these extremely small miRNA, we have chosen to use a 
modified oligo d(T) method for analyzing miRNA in our system due to ease of use 
and an improved ability to normalize the data (Fiedler, 2009).  In this method, a 
poly(A) tail is added to all RNA transcripts.  The transcript is then reverse transcribed 
with an oligo d(T) primer that has the addition of a universal tag on its 5’end.  The 
first strand synthesis in qRT-PCR is initiated with an miRNA-specific forward 
primer, and then a reverse primer specific to the universal tag finishes the 
amplification.   
After a miRNA has been shown to be expressed in a given tissue or at a given 
time period, the next question is, ‘what is its function’?  There are two ways to 
ascertain the function of a miRNA:  1) inhibit the miRNA; 2) add exogenous miRNA.  
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MicroRNA function can be inhibited by using modified synthetic antisense 
oligonucleotides that bind to the miRNA and prevent its interaction with its target.  
Ideally, these synthetic oligonucleotides will have a high biostability and will bind to 
the miRNA with high affinity.  2’O-methyl oligonucleotides are RNA molecules that 
have a methyl group at the 2’ position of the ribose (Figure V-2B) that increases 
nuclease resistance and thus makes the oligonucleotide more stable (Grunweller et al., 
2003).  The interaction of a 2’O-methyl oligonucleotide with its target miRNA is with 
similar affinity as a normal RNA:RNA interaction.  Another option, locked nucleic 
acids (LNA), have a 2’-O,4’-C methylene bridge that locks the structure in a bicyclic 
formation (Figure V-2).  This bridge dramatically increases the biostability of the 
molecule, and, furthermore, increases the melting temperature of the LNA:miRNA 
duplex by several degrees (Grunweller et al., 2003).  Therefore, LNA molecules often 
have a more potent and lasting effect than 2’O-methyl oligonucleotides (Grunweller 
et al., 2003).  We have utilized both molecules in this work.  In addition, miRNA can 
be overexpressed by adding exogenous pre-miRNA.  The exogenous pre-miRNA is 
cleaved by Dicer and incorporated into RISC in the same manner as endogenous pre-
miRNA.   
Knockdown or overexpression of the microRNA will cause a change in the 
expression of target proteins.  To identify these target proteins, a two-dimensional gel 
approach can be used.  For example, protein from cells treated with a nonspecific 
control LNA and protein from cells treated with an LNA to the specific miRNA can 
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FIGURE V-2.  Synthetic antisense oligonucleotides used to knockdown miRNA 
function.  (A) RNA molecule.  (B) The 2’O-methyl oligonucleotide has a methyl 
group at the 2’ position of the ribose (red) .  (C) The locked nucleic acid 




 be isolated and labeled with either Cy3 (green) or Cy5 (red), respectively.  The 
labeled protein is run on a single two-dimensional gel, separating the protein by both 
size and by isoelectric point.  Unchanged proteins are visualized as yellow spots, 
while changed proteins are visualized as either red or green spots.  The spots can be 
excised from the gel and analyzed by mass spectrometry to determine the identity of 
the protein.  The changed proteins can be analyzed using bioinformatics software to 
find miRNA-binding sites in their 3’UTR, and the presence of a site can indicate that 
the protein is a direct target of the miRNA. 
If a protein is predicted to be a direct target of the miRNA, luciferase assays 
provide an approach for confirming the interaction.  The 3’UTR of the predicted 
target mRNA is ligated into a plasmid containing the luciferase gene.  The plasmid 
can be co-transfected with the LNA to the miRNA, and if luciferase activity 
increases, the miRNA likely directly interacts with that particular 3’UTR.  To confirm 
the interaction, various mutations can be made within the 3’UTR so the miRNA 
binding sites can be disrupted, and luciferase activity can be measured.    
 
4.  MicroRNA in the Ovary  
 Recruitment of growing follicles, atresia, ovulation, luteal tissue formation 
and regression are dynamically regulated events that reoccur on a cyclical basis 
within the ovary.  Few tissues exhibit the ephemeral lifecycle seen in follicular and 
luteal tissues within the adult, making this system very unique.  These events involve 
dramatic changes in cellular growth, angiogenesis, steroidogenesis, cell cycle status, 
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and apoptosis, and are tightly regulated at the endocrine and tissue level.  Defects in 
regulatory control can lead to ovarian failure due to disruption of folliculogenesis, 
block of ovulation, and corpus luteum insufficiency, etc. Although the transcriptional 
regulation of ovulation and luteinization has been well studied, it stands to reason that 
post-transcriptional gene regulation may be critical for reproductive tissue function. 
Understanding the molecular events, including the role of miRNA in post-
transcriptional gene regulation, that occur during these transitory periods might 
provide insight into how we might be able to enhance reproductive efficiencies and 
alleviate deficiencies. 
Recently, Otsuka and coworkers, demonstrated that a Dicer1 hypomorph 
mouse (Dicer1d/d; ~75% loss of Dicer1 mRNA levels), developed using a gene trap 
method, exhibited female infertility (Otsuka et al., 2008).  Transplantation of wild 
type ovaries into Dicer1d/d females resulted in offspring, but wild type females 
transplanted with Dicer1d/d ovaries failed to establish pregnancies, indicating that the 
fertility defect was inherent to the ovary. Further characterization of Dicer1d/d mice 
indicated that ovulation occurred normally and that the ovulated eggs were fertilized 
and underwent the first embryonic cell division.  In contrast, serum progesterone 
levels and expression of LH receptor, cytochrome p450 11a1 (Cyp11a1), and 
prolactin receptor, genes necessary for progesterone production and corpus luteum 
formation/maintenance, were all decreased in Dicer1d/d mice.  Proper corpus luteum 
function requires a dramatic increase in vasculature, and miRNA have previously 
been shown to be important for angiogenesis in embryonic development (Yang et al., 
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2005).  Therefore, Otsuka et al. (2008) examined vasculature in these Dicer1d/d mice 
and found a decrease in both the number and the length of the blood vessels in the 
corpus luteum and correlated this with the upregulation of anti-angiogenic factors, 
TIMP1 and platelet factor 4, in Dicer1d/d mice.  MicroRNA-17-5p and let-7p were 
found to regulate TIMP1 expression and loss of these in Dicer1d/d mice were 
predicted to cause the reduction in angiogenesis.  Knockdown of these two miRNA in 
wild type mice impaired corpus luteum angiogenesis and decreased serum 
progesterone levels.  Furthermore, injection of miR-17-5p and let-7p into the ovarian 
bursa of Dicer1d/d mice restored the vasculature within the corpora lutea and 
increased progesterone levels, but failed to maintain pregnancy, indicating that other 
miRNA might still be involved (Otsuka et al., 2008). 
 Our laboratory mated the anti-Mullerian hormone receptor, type 2 (Amhr2)-
Cre mouse (Jamin et al., 2002) with a mouse homozygous for locus of crossover in 
P1 (loxP) insertions surrounding the second RNase III domain of Dicer1 (Harfe et al., 
2005).  This selectively knocked out Dicer1 expression in Mullerian duct derivatives 
(the oviduct, uterus, and cervix) and in the granulosa cells of secondary and small 
antral follicles (Hong et al., 2008).  The female Dicer1fl/fl;Amhr2Cre/+ mice were 
infertile as evidenced by failure to deliver offspring over a 5 month period, but the 
male mice were able to sire offspring (Hong et al., 2008).  Dicer1fl/fl;Amhr2Cre/+ 
female mice mated normally and had normal estrous cycles, but exhibited a reduced 
ovulation rate (10.7 ± 0.9 and 7.0 ± 1.1, for the wild type and Dicer1fl/fl;Amhr2Cre/+ 
mice, respectively).  This effect was not due to a disruption in the secretion of 
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hormones, as the reduced ovulation rate was also observed in gonadotropin-
stimulated immature mice (16.2 ± 1.4 and 3.7 ± 1.5, for the wild type and 
Dicer1fl/fl;Amhr2Cre/+ mice, respectively).  Moreover, these Dicer1fl/fl;Amhr2Cre/+ mice 
had reduced ovarian weights compared to wild type controls (Hong et al., 2008). 
Ovulated oocytes from Dicer1fl/fl;Amhr2Cre/+ mice collected at d1 post-coitus 
underwent in vitro embryonic development that mirrored that observed in the wild 
type mice (Hong et al., 2008).  These results suggest the loss of Dicer1 expression 
impacts ovarian function, however, since these mice were still able to ovulate 
competent oocytes, the ovarian loss of Dicer1/miRNA does not explain the infertility 
seen in these mice. 
 Three other groups have also examined reproduction in Dicer1fl/fl;Amhr2Cre/+ 
mice (Gonzalez and Behringer, 2009; Nagaraja et al., 2008; Pastorelli et al., 2009).  
Two of these groups did not extensively characterize ovarian defects in the 
Dicer1fl/fl;Amhr2Cre/+ mice, but one group noted the decrease in ovulation and 
increase in trapped oocytes that we observed in our laboratory (Nagaraja et al., 2008).  
In addition, they performed TUNEL staining on the ovary to examine granulosa cell 
apoptosis, and they saw a significant increase in apoptotic granulosa cells in the 
Dicer1fl/fl;Amhr2Cre/+ mice (Nagaraja et al., 2008). 
To examine the importance of specific miRNA within the ovary, four studies 
have examined ovarian miRNA expression using several different methodologies and 
experimental paradigms (Choi et al., 2007; Fiedler et al., 2008; Kim et al., 2006; Ro 
et al., 2007b).  In 2006, a computational analysis of the pig genome identified 58 
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miRNA, and northern blot analysis confirmed the expression of two of these miRNA 
(i.e., miR-31 and miR-92) within the porcine ovary, but no functional analysis of 
these miRNA in the ovary has been reported (Kim et al., 2006).   Ro et al (2007)  
used a cloning technique to identify miRNA expressed in the ovaries of 2-wk-old and 
adult mice (Ro et al., 2007b).  Combined, they identified 122 miRNA from whole 
ovaries of the immature and mature mice.  Because whole ovarian tissue was used 
and the stage of the estrous cycle of the adult ovaries was unknown, the usefulness of 
this data set is limited.  Similarly, Choi et al. (2007) cloned miRNA in newborn 
mouse ovarian tissue from wildtype and newborn ovary of homeobox gene (Nobox) 
knockout animals.  Nobox is a transcription factors necessary for oocyte 
differentiation and survival (Choi et al., 2007).  They identified 177 miRNA in the 
newborn ovary and found that 4 were decreased ~2-fold in the Nobox-/- ovaries (Choi 
et al., 2007).   
To examine somatic cell miRNA expression and test whether LH can regulate 
miRNA expression, we performed a microRNA microarray on mouse granulosa cells 
before (0h) and 4h after hCG (Fiedler et al., 2008).  We identified 196 and 206 
miRNA as detectable before and 4h after hCG respectively, with 31 miRNA showing 
high abundance, 64 intermediate abundance, and 117 low abundance.  Of the total 
212 miRNA detected, only thirteen miRNA were differentially expressed between 0h 
and 4h post-hCG, with 3 upregulated and 10 downregulated (p<0.05; (Fiedler et al., 
2008).  Among the upregulated miRNA were miR-132 and miR-212.  MicroRNA-
132 has previously been shown to be transcriptionally regulated by cAMP in neuronal 
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cells (Vo et al., 2005), and to post-transcriptionally regulate the expression of several 
different genes (Klein et al., 2007).  Included among the miR-132 targets was the 
transcriptional co-repressor C-terminal binding protein (CtBP1; Klein et al., 2007).  
Interestingly, CtBP1 in conjunction with steroidogenic factor-1, was recently shown 
to regulate adrenal steroidogenesis (Dammer and Sewer, 2008).  We demonstrated 
that cultured granulosa cells respond to cAMP with an increase in miR-132 and miR-
212 levels, and that LNA oligonucleotide knockdown of miR-132 and miR-212 
caused an increase in CtBP1 protein levels, suggesting that these miRNA post-
transcriptionally regulate CtBP1 expression in granulosa cells (Fiedler et al., 2008).    
In this array, an established oncomiR, miR-21, was also shown to be upregulated in 
response to LH.  This dissertation examines the expression and function of miR-21 in 
periovulatory granulosa cells.   
 
5.  MicroRNA-21 
 MicroRNA-21 (miR-21) was identified as upregulated in mouse granulosa 
cells within 4 h following LH (Fiedler et al., 2008).  In the mouse, the gene for miR-
21 lies on chromosome 11 and the promoter overlaps with exon 12 of TMEM49.  The 
transcription of miR-21 results in a 5’ capped and polyadenylated pri-miR-21 
transcript (Cai et al., 2004).  The promoter for pri-miR-21 is one of a few miRNA 
promoters that has been well mapped and studied, and early reports indicate that 
transcription of the pri-miR-21 is regulated by promoter elements in the same way 
protein-coding genes are.  The promoter has AP-1, NFIB, REST, STAT3, CEBP, 
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SRF, and p53 binding sites, and has been experimentally shown to be regulated by the 
first five of these (Chen et al., 2008a; Fujita et al., 2008; Loffler et al., 2007; 
Ramachandra et al., 2008; Singh et al., 2008).  In a couple of instances, miR-21 has 
been shown to indirectly promote its own transcription, such that miR-21 mediated 
post-transcriptional downregulation of an mRNA causes an increase in miR-21 
transcription (Fujita et al., 2008; Talotta et al., 2009).  For example, in a RAS-
inducible thyroid cell line, RAS-induced differentiation increased Jun/Fos, which 
acted on AP-1 sites within the miR-21 promoter to increase in miR-21 transcription 
(Talotta et al., 2009).  In addition, miR-21 post-transcriptionally represses translation 
of PDCD4, a strong inhibitor of AP-1 activity (Talotta et al., 2009).   In another case, 
in vascular sooth muscle cells, miR-21 was shown to target NFIB, a transcription 
factor that binds to the miR-21 promoter to inhibit its transcription (Fujita et al., 
2008).  Therefore, miR-21 has the ability to repress inhibitors of its own transcription, 
thus promoting and sustaining its own synthesis (Fujita et al., 2008; Talotta et al., 
2009).  DNA hypomethylation has also been indicated to increase miR-21 expression, 
as treatment of OVCAR3 cells with the demethylation treatment 5-aza-2’-
deoxycytidine caused an increase in miR-21 expression (Iorio et al., 2007).  
Interestingly, miR-21 has also been shown to be regulated post-transcriptionally.  The 
mature form of miR-21 was found to increase in vascular smooth muscle cells in 
response to bone morphogenic protein 4 (BMP4), but, unexpectedly, pri-miR-21 
levels were unchanged.  The SMAD signal transducers were found to increase the 
interaction of pri-miR-21 with p68 helicase, a component of the Drosha complex.  
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This interaction initiated Drosha-facilitated cleavage of the pri-miR-21 (Davis et al., 
2008a).   
 Functions of miR-21 have been determined by either knocking down miR-21 
or overexpressing miR-21.  The loss of miR-21 increased apoptosis in several cell 
types, including glioblastomas (Chan et al., 2005), JHU-012 head and neck cancer 
cells (Chang et al., 2008), gastric cancer cell lines (Zhang et al., 2008b), and vascular 
smooth muscle cells (Ji et al., 2007).  Furthermore, miR-21 increases cell 
proliferation in hepatocellular cancer cells (Meng et al., 2006), A549 lung cancer 
cells (Fei et al., 2008), gastric cancer cell lines (Zhang et al., 2008b), and vascular 
smooth muscle cells (Ji et al., 2007).  Overexpression of miR-21 also causes an 
increase in cell growth, as seen in JHU-012 (Chang et al., 2008) and MCF-7 breast 
cancer cell lines (Frankel et al., 2008), and induces cellular hypertrophy in 
cardiomyocytes (Cheng et al., 2007; Tatsuguchi et al., 2007).  MiR-21 has also been 
associated with an increase in cell motility and migration (Meng et al., 2006; Tsai et 
al., 2009).  Finally, miR-21 is upregulated during embryonic stem cell differentiation 
and T cell differentiation (Singh et al., 2008; Wu et al., 2007).  In embryonic stem 
(ES) cells, it prevents ES cell self-renewal and causes the downregulation (most 
likely indirectly) of Oct4, Sox2, and Nanog (Singh et al., 2008).   
 The mRNA targets of miR-21 directly correspond to its demonstrated 
functions.  The first identified miR-21 target was the tumor suppressor PTEN in 2006 
in malignant cholangiocytes (Meng et al., 2006), and the identification of other tumor 
suppressor genes as targets for miR-21 soon followed.  The pro-apoptotic genes 
 62 
tropomyosin 1 (TPM1), programmed cell death 4 (PDCD4), Sprouty, reversion 
inducing-cystein-rich protein with kazal motifs (RECK), heterogenous nuclear 
ribonucleoprotein K (HNRPK), and tumor protein p63 (Tap63) have all been 
identified as direct miR-21 targets (Chen et al., 2008b; Meng et al., 2006; 
Papagiannakopoulos et al., 2008; Thum et al., 2008; Zhu et al., 2007).  However, 
miRNA targets can vary widely by cell type, in that a target in one cell type may not 
be a target in another cell type (Frankel et al., 2008; Papagiannakopoulos et al., 
2008).   
 As would be expected from its identified functions, the dysregulation of miR-
21 has been found in many diseases and cancers.  In fact, miR-21 is identified as 
overexpressed in nearly every cancer or tumor examined, and thus has been labeled as 
an “oncomir” (Cho, 2007; Table V-2).  The anti-apoptotic, pro-growth and pro-
migration functions of miR-21 make it a prime candidate for the driving force behind  
the rapid metastasis and invasion that are needed for the advancement of cancer.  
Examples of cancers that miR-21 is upregulated in include breast, prostate, 
pancreatic, ovarian, cervical, heritable cancers such as Cowden’s Syndrome, and 
viral-induced cancers such as hepadnavirus-associated hepatocellular carcinoma 
(Table V-2).  It is also induced in vascular inflammation, LPS-induced inflammation 
of lung cells, and in uterine leiomyomas (Table V-2).  In several cases, such as non-
small cell lung cancer and pancreatic cancer, the expression of miR-21 correlated 
with a poorer patient outcome.  Therefore, because of its upregulation in a variety of  
 63 








cancers and diseases, miR-21 has become a target for therapeutic intervention (Tong 
and Nemunaitis, 2008), and is currently one of the most studied miRNAs.  
 
 6.  Study Significance  
Most individuals envision parenthood as an exciting part of their future.  
However, for seven million couples a year in the US who suffer from infertility, this 
future may seem impossible.  Infertility is a $2 billion/year business, and causes 
emotional distress for the individuals involved (Albers, 1999).  The number of 
couples suffering from primary infertility has drastically increased from 500,000 a 
year in 1965 to 7.7 million a year in 2006 (Chandra and Stephen, 1998; Nachtigall, 
2006; Stephen and Chandra, 1998).  A rise in the average age of the mother and 
increases in sexually transmitted diseases that affect fertility are the main causes for 
increased infertility (Chandra and Stephen, 1998; Stephen and Chandra, 1998). 
Therefore, the medical community is dealing with a growing number of infertile 
patients that are desperate for a solution.   
 On the opposite side is contraception.  Almost all women desire to 
delay/prevent pregnancy at some point in their reproductive years.  Half of all 
pregnancies in the United States are unplanned, and half of these unplanned 
pregnancies result in abortion (Henshaw, 1998).  If unplanned pregnancies in the 
United States was reduced by just half, the number of abortions performed would 
decrease by 800,000 a year (Brown, 1995).  In addition, children born from 
unplanned pregnancies are more likely to have low birth weight, increased mortality 
in their first year of life, and their parents are more likely to suffer from depression, 
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economic and marital problems (Brown, 1995).  Current contraceptive choices 
include barrier methods, intrauterine devices, spermicides, natural family planning, 
sterilization, and steroid formulations.  Most of these methods are not user-friendly, 
and hormonal contraceptives can have negative side effects and have a 
discontinuation rate of almost 50% after one year (Strauss and Kafrissen, 2004).  
Therefore, it is vital that new contraceptive choices be introduced that are user-
friendly, have few side effects, and promote a high continuation rate. 
The goal of this study was to further our understanding of the molecular 
networks that occur during ovulation and luteinization so that we can better 
understand how to treat infertility as well as derive new mechanisms for controlling 
fertility in women.  Specifically, one microRNA, miR-21, was identified as 
upregulated in granulosa cells following LH, and thus this work further characterizes 
its expression after LH and explores its function both in vitro and in vivo.   
In the first study, “Rapid Effects of Luteinizing Hormone on 
Transcriptional Gene Expression in the Mural Granulosa Cells of Mouse 
Periovulatory Follicles”, gene expression was examined immediately (1 h ) after the 
LH surge.  This study provided a novel list of genes regulated by LH, and identified a 
novel EGF-like factor as promoting cumulus expansion following LH.  In addition, 
several transcription factors were identified for the first time as upregulated following 
LH, and further analysis of these factors will give valuable insight into the molecular 
pathways activated by LH in granulosa cells. 
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In the second study, “MicroRNA-21 is induced by LH and blocks 
apoptosis in granulosa cells”, we examined the expression and function of miR-21 
after LH in vivo.  After showing that miR-21 is increased following LH, we used an 
in vitro model of cultured granulosa cells to examine the function of miR-21, and by 
inhibiting miR-21 function we found that miR-21 is necessary to prevent granulosa 
cell apoptosis.  Furthermore, in vivo knockdown of miR-21 increased granulosa cell 
apoptosis. 
 In the third study, “MicroRNA-21 enhances global translation”, we 
expanded our study on miR-21 function in cultured granulosa cells and found that 
miR-21 promotes global translation by indirectly affecting the phosphorylation of 
elongation factor 2 (EF2).  This change in EF2 corresponded with a change in activity 
of the upstream Akt/mTOR pathway.  We also showed that changes in EF2 
phosphorylation in granulosa cells are seen in vivo following hCG administration. 
 Finally, we summarized what is currently known about the role of miRNA in 
reproductive tissue and disease in a comprehensive review, “MicroRNA in the 
Ovary and Female Reproductive Tract”.   
 Therefore, these studies move the field forward by showing that individual 
miRNA are important to ovarian function.  These studies use an in vivo knockdown 
method to demonstrate that miR-21 is necessary for ovarian function, and use an in 
vitro model to assist with the identification of miR-21 function in granulosa cells.  
This understanding of miR-21 in ovarian function will help unravel the molecular, 
specifically post-transcriptional, events that are occurring during ovulation and 
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luteinization.  Understanding the molecular mechanisms that underlie these processes 
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1.   Abstract 
Luteinizing hormone (LH) acts on periovulatory granulosa cells by activating 
the PKA pathway as well as other cell signaling cascades to increase the transcription 
of specific genes necessary for ovulation and luteinization.  Collectively, these cell 
signaling responses occur rapidly (within minutes), however, presently no high 
throughput studies have reported changes before 4 h after the LH surge.  To identify 
early response genes that are likely critical for initiation of ovulation and 
luteinization, mouse granulosa cells were collected before and 1 h after hCG.  Fifty-
seven gene transcripts were significantly (p<0.05) upregulated and 3 downregulated 
following hCG.  Twenty-four of these transcripts were known to be expressed after 
the LH/hCG surge at later time points, while 36 were unknown to be expressed by 
periovulatory granulosa cells. Temporal expression of several transcripts, including 
the transcription factors Nr4a1, Nr4a2, Egr1, Egr2, Btg1, and Btg2, and the EGF-like 
ligands Areg and Ereg, were analyzed by quantitative RT-PCR, and their putative 
roles in granulosa cell function are discussed.  Epigen (Epgn), another member of the 
family of EGF-like ligands, was identified for the first time in granulosa cells as 
rapidly induced by LH/hCG.  We demonstrate that Epgn initiates cumulus expansion, 
similar to the other EGF-receptor ligands Areg and Ereg.  These studies illustrate that 
a number of changes in gene expression occur in vivo in response to LH, and that 
many of the differentially expressed genes are transcription factors that we would 
predict in turn modulate granulosa cell gene expression to ultimately impact the 
processes of ovulation and luteinization.   
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2.  Introduction 
Luteinizing hormone (LH) activates a number of cellular signaling cascades 
within the preovulatory granulosa cell, including the canonical PKA pathway 
(Bachelot and Binart, 2005).  These pathways induce changes in gene expression that 
ultimately cause phenotypic and physiological changes in the cells, culminating in 
ovulation and luteinization.  These molecular changes include the coordinated 
expression of a number of genes important for, among other events, the shift from 
estrogen synthesis to progesterone synthesis, the structural remodeling of the follicle, 
and the maturation of the oocyte.  A number of genes known to be critical for 
ovulation and luteinization have been identified downstream of the LH surge, 
including early growth regulatory factor-1 (Egr1; Espey et al., 2000), CCAAT 
enhancer binding protein beta (C/EBPβ; Sirois and Richards, 1993), cyclin D2 
(Sicinski et al., 1996), steroid acute regulatory protein (StAR; Clark and Stocco, 
1995), and progesterone receptor (Park and Mayo, 1991).  Disruption of these genes 
in the mouse leads to either failure to ovulate or luteinization defects (Richards et al., 
1998; Sterneck et al., 1997).  However, while most of these critical genes have been 
shown to be upregulated between 2-6 hours after the LH surge, the transcriptional 
changes occurring in granulosa cells in the moments immediately (within 1h) after the 
LH surge are not well defined.  
Global gene expression analyses at later time points after LH have yielded a 
wealth of information about genes that were not known to be involved in ovarian 
function.  For example, Espey and co-workers (2002) have linked the expression of 
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many genes previously unknown to be regulated by LH in the rat ovary through the 
use of RT-PCR differential display (Espey and Richards, 2002).  They identified the 
EGF-like ligand, epiregulin (Ereg), as being induced by LH, and subsequent studies 
have demonstrated that Ereg and several other EGF-like growth factors, amphiregulin 
(Areg) and betacellulin, are important for oocyte maturation and cumulus expansion 
(Espey and Richards, 2002; Park et al., 2004).  A sample of 20 genes differentially 
regulated at various time points after LH (2, 4, 8, 12 and 24 hours) in rat whole ovary 
were reported; however, a comprehensive list has not yet been published (Espey and 
Richards, 2002).  In another study, suppression subtractive hybridization analysis in 
mice yielded 36 ovary-specific genes, 22 of which were under hormonal regulation, 
as indicated by their expression 3, 6, 9, 12, 24, and 48h after hCG (Hennebold et al., 
2000).  McRae et al. (2005) used serial analysis of gene expression (SAGE) in mouse 
granulosa cells before and 12 h after hCG treatment, and identified four genes not 
previously known to be expressed in the granulosa cells.  Finally, microarray analysis 
performed before and 6 h after hCG treatment in rat granulosa cells identified several 
more LH-regulated targets, including cutaneous fatty acid-binding protein, a factor 
important in lipid metabolism (Leo et al., 2001).  Since the advent of global gene 
expression analysis methods, researchers have primarily focused on time points 3-12 
h after the LH surge (Espey and Richards, 2002; McRae et al., 2005; Richards et al., 
1998).  In the one exception, Kawamura et al (2005) using a very comprehensive 
array approach identified brain-derived neurotrophic factor as an LH-regulated gene.  
In 2008 the same array data was used again to identify fractalkine (Zhao et al., 2008), 
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however, with the exception of these two genes the results of these arrays have yet to 
be released. 
Therefore, to date, no comprehensive gene expression array analysis of the 
murine periovulatory granulosa cells has been published at any time point earlier than 
6 h after LH.  However, Northern blot and quantitative RT-PCR analyses of 
differential display studies and individual gene analysis studies have shown that many 
of the genes identified at later time points were upregulated earlier.  For example, the 
mRNA levels of the transcription factor Egr1 and the acute early response gene 5-
aminolevulinate synthase increased within 1 h after hCG treatment (Espey et al., 
2000; Park et al., 2003).  The rapid expression of Egr1 has been associated with 
increased transcription of a number of other genes that modulate the ovulatory and 
luteinization processes, and its importance in these processes is emphasized in Egr1-
null mice that are infertile due to a lack of both ovulation and luteinization (Richards 
et al., 2002).  This suggests that there is an unexplored realm of LH-regulation that 
occurs in the early minutes to hours after the LH surge, and these rapidly (and often 
transiently) upregulated genes may be playing a necessary, as of yet unidentified, role 
in ovulation and luteinization.   
In this report, we utilized microarray gene expression analysis to identify 
rapidly LH-induced genes in mouse granulosa cells.  We anticipate that the genes 
identified here will be pivotal to understanding the cascades of coordinated gene 
expression that occur in granulosa cells in response to the LH surge.  
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3.  Experimental Procedures 
Animals and Granulosa Cell Isolation 
Twenty-one-day old CF-1 female mice were given intraperitoneal injections of 5 IU 
equine chorionic gonadotropin (eCG) (Sigma) to induce follicular stimulation.  After 
44 h, mice ovaries were either collected (0 h time point) or the mice were injected 
with 5 IU of hCG to trigger ovulation and luteinization and the ovaries collected 1 h 
later for array analysis.  For temporal expression analysis, ovaries were collected 44 h 
after eCG (hereafter referred to as 0 h) or after eCG + hCG for ¼, ½, 1, 2, 4, 6, 8, or 
12 h (n=4 for each time point).  Granulosa cells were expressed from the ovarian 
tissue by follicular puncture into ice-cold PBS.  The cells were pelleted by 
centrifugation at 700 x g, then resuspended in either 500 uL of Tri Reagent (Sigma) 
for array and quantitative RT-PCR analysis, or in 100 uL cell lysis buffer (Cell 
Signaling) for protein analysis.  All procedures involving animals were reviewed and 
approved by the Internal Animal Care and Use Committee at the University of 
Kansas Medical Center and performed in accordance with the Guiding Principles for 
the Care and Use of Laboratory Animals.  All experiments were performed using CF-
1 female mice from Charles River Laboratories (Wilmington, MA). 
RNA Isolation and Amplification 
 RNA was isolated with Tri Reagent following the manufacturer’s protocol 
(Sigma), yielding >2 ug of total RNA per sample. The quantity and quality of RNA 
was determined using the Agilent Bioanalyzer 2001 (Agilent Inc., Palo Alto, CA), 
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and 0.4 ug of the RNA was subjected to two rounds of linear amplification using 
Gene Chip Eukaryotic Small Sample Target Labeling Assay Version II (Affymetrix).   
Microarray Hybridization 
Biotin-labeled cRNA was fragmented according to Affymetrix protocols. The 
fragmented cRNA from each sample was hybridized to individual Affymetrix 430A 
gene array chips using the GeneChip Fluidics Station 400 protocol (Affymetrix), and 
the hybridized chips were scanned using the Agilent GeneArray Scanner 
(Affymetrix).  A scaling factor was applied to each chip using the Affymetrix 
Microarray Suite 5.0 software to normalize the mean raw fluorescence intensity for 
each chip to an average base-line fluorescence level.  To allow for statistical analysis, 
4 replicates were completed for both the 0 h samples and 1 h samples.   
Gene Expression Analysis   
Each transcript was determined to be present or absent in each sample using 
the statistical expression algorithm of the Affymetrix Microarray Suite 5.0 software 
package and was identified as expressed if it was present in at least three samples in 
each group.  Genes that showed a statistically different expression pattern between 0 
h and 1 h after hCG treatment were determined using the NIA Array Analysis Tool 
(Sharov, 2005).  The statistical relevance of these genes was confirmed using 
GeneSpring GX (Agilent).   
Quantitative RT-PCR 
Total RNA (5 ug) isolated from additional granulosa cell samples (n=4) 
collected from mice at 0, ¼, ½, 1, 2, 4, 6, 8, and 12 h post-hCG were treated with 
 79 
DNase I (Promega, Madison, WI) and Moloney murine leukemia virus reverse 
transcriptase (Promega) as previously described (Christenson et al., 2001).  
Quantitative RT-PCR (qRT-PCR) was conducted as previously described (Jabara et 
al., 2003).  Primer sets were designed for each target using Primer Express 2.0 
software and qRT-PCR was carried out on an Applied Biosystems HT7900 sequence 
detector.  To account for differences in starting material and RNA isolation, qRT-
PCR was also performed on each sample with primers and probe to glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) (Applied Biosystems).  A standard curve was 
run in each assay, with an arbitrary value assigned to the highest standard and 
corresponding values assigned to the subsequent dilutions.  Each cDNA sample was 
run in triplicate, and the relative abundance of each target was divided by the relative 
abundance of GAPDH to normalize for the amount of starting material.  Dissociation 
analysis was used to confirm the presence of a single transcript and lack of primer 
dimer amplification in all PCR reactions.  Fold changes were calculated by dividing 
the normalized values of a transcript at a given time point by the normalized value of 
the transcript at 0h.   
Immunoblotting 
Granulosa cells were suspended in protein lysis buffer (Cell Signaling) and 
centrifuged at 16000 x g for 5 minutes to pellet the cellular membrane debris.  
Supernatants were transferred to a new tube and stored at -80°C until use.  An aliquot 
of the supernatant was used for protein measurement using BSA as the standard. Each 
protein sample (15 ug) was denatured by diluting the sample 1:2 with sample buffer 
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(2.8mL distilled water; 1.0mL 0.5M Tris-HCl, pH6.8; 0.8mL glycerol; 1.6mL 10% 
SDS; 0.4mL 2-β-mercaptoethanol; 0.4mL 0.05% (w/v) bromophenol blue) and 
heating for 5 minutes at 95°C.  The proteins were separated on 12% SDS-PAGE gels 
in 5X electrode running buffer, pH 8.3 (25mM  Tris-HCl, pH 8.3, 192mM glycine, 
0.1% (w/v) SDS), then transferred to PVDF membranes (Millipore) in transfer buffer 
(12mM Tris-HCl, pH 8.3, 96mM glycine, 20% (v/v) methanol).  Blots were incubated 
for 1 h at RT in a 5% milk solution to block nonspecific binding, then blots were 
incubated overnight at 4°C with either epigen (R&D Systems, AF1127) or actin 
(Santa Cruz, sc-1616) antibodies.  After washing and incubation with the appropriate 
secondary antibody, protein-antibody complexes were visualized using West Pico 
Chemiluminescent Substrate (Pierce) following the manufacturer’s protocol.   
Cumulus Oocyte Complex (COC) Cultures 
 Ovaries from 19-day old CF-1 mice (Charles River) were injected with 5 IU 
eCG, and 44 h later the ovaries were isolated and follicles punctured with a 30-gauge 
needle.  COCs were collected into collection media (MEM with Earle’s Salts, 
supplemented with 25 mM HEPES, 0.25 mM sodium pyruvate, 3 mM L-glutamine, 
and 1 mg/mL BSA), and transferred into 4-well plates (5-7 COCs/well) containing 
COC expansion media  (collection media with 1% FBS).  COCs were cultured with 
one of the following treatments: COC expansion media alone, 1.26 nM EGF, 2 IU 
FSH, 2 IU LH, 100 nM of control protein (HUTR10002PET1), or 1, 10, or 100 nM of 
recombinant EPGN.  Cumulus expansion was assessed following 16 h of culture 
using light microscopy.  Quantitative analysis of  cumulus expansion was determined 
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using MetaMorph software (Universal Imaging, Media, PA) with COCs (n=5 for each 
treatment) traced and the area (um2) under the tracing (“region of interest”) 
determined.  Recombinant EPGN was generously provided by Dr. Greg Murison at 
Genesis Research and Development Corporation of Auckland, New Zealand. 
Statistics 
  Means and standard errors (n=4) were determined for the normalized 
abundance of each target in the samples, and one-way ANOVA was used to 
determine whether expression was affected by time (h post-hCG) and followed by 
post-hoc analysis using Tukey means separation tests were completed to determine 
differences among means over time.  Heterogeneity of variance was tested for using 
Bartlett’s Test, if present the data was log transformed prior to ANOVA.  Linear 
regression analysis comparing microarray and qRT-PCR data was performed to 
establish correlation coefficients between these methods.  Statistical significance was 
considered as p<0.05.  
 
4.  Results and Figures 
LH/hCG Rapidly Affects Gene Expression in Granulosa Cells 
Of the 22,690 genes and ESTs on the Affymetrix microarray chips, 43% were 
identified as present in at least 3 of the 4 steady state samples for both 0 h and 1 h.  
The induction ratio for each of the 9756 genes was determined by calculating the ratio 
of signal detected at 1 h versus that at 0 h following hCG treatment.  Seventy-three 
genes exhibited a statistical difference in total RNA levels between 0 h and 1 h, with 
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70 genes statistically upregulated 1 h after hCG and 3 genes statistically 
downregulated (Figure VI-1).  However, due to redundancy of the oligonucleotide 
probes on the 430A chip, only 60 independent genes were differentially regulated (57 
upregulated and 3 downregulated).  Table VI-1 depicts twenty-four genes that were 
previously known to be expressed in the ovary, and these genes were grouped by their 
putative ovarian function based on previous publications (Table VI-1).  Table 2 
depicts the remaining 36 gene transcripts that were identified for the first time within 
the ovary, and more specifically within granulosa cells. In Table VI-2 genes were 
grouped by their molecular function within gene ontology.  
Temporal gene expression profiles were determined for a subset of these 
identified genes using qRT-PCR on samples collected throughout the periovulatory 
period (0, ¼, ½, 1, 2, 4, 8, and 12 h post-hCG).  The correlation coefficient on the 
array versus the sixteen genes analyzed by qRT-PCR at 1h post-hCG was r=0.6825 
(p<0.0001). 
 
EGF-like Ligands are Rapidly Upregulated After LH/hCG 
The genes encoding the epidermal growth factor (EGF)-like ligands, 
amphiregulin (Areg), epiregulin (Ereg), and epigen (Epgn) were dramatically 
upregulated 1 h after hCG.  Areg had the highest induction of all genes present on the 
array with a 81.2-fold induction 1 h after hCG, while Ereg was the third most 
upregulated transcript with a 19.9-fold induction (Table VI-1).  Temporal gene 
expression analysis by qRT-PCR confirmed the marked upregulation of both Areg 
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(21-fold) and Ereg (5.5-fold) at ½ h after hCG, by 1 h Areg increased further (133-
fold, p<0.05) while Ereg (27.5-fold) did not increase significantly until 2 h post-hCG 
(170-fold, p<0.05).  As reported (Panigone et al., 2008), the expression of Areg and 
Ereg after hCG was rapid and transient.  The expression of Areg (867-fold) and Ereg 
each reached peak levels at 2 h post-hCG before returning to much lower levels (i.e., 
equivalent to those values seen at ½ h after hCG treatment) at 6 h post-hCG where 
they remained through 12 h (Figure VI-2A, B; all fold changes are in comparison to 
levels of transcript detected in 0 h treatment group). 
In addition, another member of the EGF-like ligand family, epigen (Epgn), 
was shown for the first time to be expressed by granulosa cells.  Microarray data 
indicated a 2.6-fold upregulation 1 h after hCG (Table VI-2), while qRT-PCR 
indicated a 14-fold increase at 1 h post-hCG.  Quantitative RT-PCR confirmed that 
the expression of Epgn, like that of Areg and Ereg, was rapid and transient with 
mRNA levels peaking at 2 h post-hCG (28-fold, p<0.05; Figure VI-2), before 
returning to lower levels at 6 h post-hCG. Western blot analysis of mural granulosa 








FIGURE VI-1.  Sixty genes were differentially expressed between 0 and 1h post-
hCG.   
Genes present in 3 of the 4 microarrays are categorized with the averaged log 
intensity for all the steady state transcripts along the horizontal axis, and the log ratio 
of signal intensity for each gene between 0 and 1 hour on the vertical axis (NIA Array 







FIGURE VI-2. Granulosa cell expression of amphiregulin (A; Areg), epiregulin (B; 
Ereg), epigen (C; Epgn), and ERBB receptor feedback inhibitor 1 (D; Errfi1) 
throughout the periovulatory period (i.e., 0 - 12 h after hCG).   Quantitative RT-PCR 
data are normalized to Gapdh expression.  Means ± SEM with different superscripts 





FIGURE VI-3.  Representative EPGN Western blot of granulosa cell protein 
extracted from PMSG-primed ovaries at 0-8h after hCG injection, with control Actin 
below.  Histogram depicts the levels of EPGN after normalization to Actin. Means ± 




confirmed the presence of a rapid and transient increase (~2.6-fold) in protein expression 2 h 
post-hCG followed by a return to basal levels by 4 h post-hCG (Figure VI-3).  Lastly, we 
identified that the ERBB receptor feedback inhibitor 1 (Errfi1; a.k.a., Mig6, RALT, Gene 
33) was upregulated 3.8-fold in granulosa cells by microarray (Table VI-2) and 2.3-fold by 
qRT-PCR at 1 h post-hCG.  This was the only time point that Errfi1 expression in granulosa 
cells was significantly different from all the other time points.   
Since AREG and EREG have previously been demonstrated to stimulate 
cumulus expansion in response to LH, we hypothesized that EPGN might have the same 
effect.  To test this hypothesis, we treated isolated cumulus-oocyte-complexes (COCs) with 
1, 10, or 100 nM of EPGN.  Like the positive controls EGF (Figure VI-4D), FSH (Figure 
VI-4E), which are known to cause cumulus expansion (Conti et al., 2006), EPGN 
significantly increased cumulus expansion compared to that of the negative controls (media 
alone; Figure VI-4B) or a control unrelated protein (Figure VI-4C).  We observed a dose 
response effect of EPGN on cumulus expansion with the intermediate and highest dose 
causing expansion similar to that seen with positive controls (Figure VI-4G, H, I).  
Quantitative assessment of cumulus expansion indicated that COCs maintained for 16 h in 
cumulus expansion medium containing 1% FBS exhibited no change in expansion (Figure 
VI-5).  Similarly, control protein and LH treated COCs showed no significant expansion 
(Figure VI-5) compared to the 16 h media alone controls.  In contrast, EGF, FSH and the 
intermediate and high doses of EPGN treated COCs exhibited significant increases in COC 
expansion (Figure VI-5).  
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FIGURE IV-4.  Isolated cumulus-oocyte complexes directly after isolation (A) or 16 h after 
incubation with media alone (B), 100nm control protein (C), 1.65 nM EGF (D), 2 IU FSH 
(E), 2 IU LH (F), 1 nM EPGN (G), 10 nM EPGN (H), or 100 nM EPGN (I).  The bar 




FIGURE VI-5.  Quantification of COC expansion (area of the COCs, um2) directly 
after isolation (0 h) or 16 h after incubation with media alone, 100 nM control 
protein, 1.65 nM EGF, 2 IU FSH, 2 IU LH, 1 nM EPGN, 10 nM EPGN, or 100 nM 
EPGN.  One-way Anova was used to determine statistical differences between 




Transcription Factors and a Cell Signaling Regulator are Rapidly Upregulated After 
LH/hCG 
 Microarray analysis indicated that multiple transcription factors were upregulated in 
response to hCG.  Microarray analysis indicated that B-cell translocation 1 (Btg1; Table VI-
2) and B-cell translocation 2 (Btg2; Table VI-1) were upregulated 2.5- and 7.7-fold, 
respectively at 1 h post-hCG.  Quantitative RT-PCR indicated that the expression of both 
Btg1 and Btg2 were significantly increased within 30 min after hCG (15-fold and 12-fold, 
p<0.05), and reached peak levels at 1 h post-hCG (31-fold and 19-fold) before returning to 
basal levels within 4 h (Figure VI-6A and B).   
Early growth response 1 (Egr1) and early growth response 2 (Egr2) were 
upregulated 4- and 14.3-fold, respectively, in granulosa cells 1 h after hCG by microarray 
analysis (Tables VI-1 and VI-2).  Temporal expression analysis using qRT-PCR indicated 
that their expression was also transient, with expression of both increased (p < 0.05) within 
30 min and reached their maximal values 1 h post-hCG  (45-fold and 59-fold, p<0.05) 
where it remained until returning to basal levels at 4 h post-hCG (Figure VI-6C and D).   
The nuclear receptor subfamily 4 group A member 1 (Nr4a1) and Nr4a2 transcription factors 
were also identified as significantly induced 1 h after hCG administration, with increases of 
11.3- and 3.3-fold, respectively (Tables VI-1 and VI-2).  Quantitative RT-PCR indicated both 
Nr4a1 and Nr4a2 were increased (p<0.05) within 15 minutes of hCG (17- and 19-fold, 
respectively), before reaching their highest levels (153- and 172-fold,respectively), before 
returning to basal levels by 6 h after hCG (Figure VI-7A and B).  Hairy enhancer of split-
related with YRPW motif 1 (Hey1) was upregulated 11.2 fold by microarray analysis (Table 
 98 
VI-2).  Quantitative RT-PCR analysis confirmed the rapid upregulation of the Hey1 
transcript with peak levels of Hey1 occurring at 2 h post-hCG (10-fold) (Figure VI-7C). 
Growth arrest and damage inducible, beta (Gadd45b) was upregulated 2.8 fold by 
microarray analysis (Table VI-1).  Quantitative RT-PCR analysis confirmed the upregulation 
of Gadd45b within 30 min (16-fold) where it remained at high levels through 2 h post-hCG 
before returning to basal levels at 4 h post-hCG (Figure VI-7D). 
 
Steroidogenic, Angiogenic and Inflammatory Genes are Rapidly Upregulated after LH/hCG.    
Microarray analysis indicated that cytochrome p450 19a1 (Cyp19a1) exhibited a 4.1-
fold induction in granulosa cells 1 h after hCG (Table VI-1).  Quantitative RT-PCR temporal 
analysis of Cyp19a1 expression indicated that this induction (5.5-fold at 30 min) was 
transient with levels returning to basal levels by 4 h post-hCG (Figure VI-8A).  Prostaglandin 
endoperoxide synthase 2 (Ptgs2) expression was upregulated 24.8-fold by microarray 
analysis at 1 h post-hCG (Table VI-1), however, qRT-PCR indicated a 13-fold increase at 1 h 
and peak expression at 4 h post-hCG (73.5-fold), before rapidly decreasing to basal levels at 
6 h post-hCG (Figure VI-8B). 
 Kit Ligand (Kitl) was upregulated 2.1-fold following hCG by microarray analysis 
(Table VI-1), while qRT-PCR analysis indicated that it was increased 2-fold at 1 h but did 
not reach significance until 2 h (4.2-fold; Figure VI-8C).  Microarray analysis identified 
coagulation factor 3 (F3) as upregulated 14.3-fold at 1 h post-hCG (Table VI-1).  Temporal 
gene expression analysis  
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FIGURE VI-6.  Expression of Btg1 (A), Btg2 (B) Egr1 (C), and Egr2 (D) transcripts 0-12h 
after hCG and 0-4h after hCG (insets) as quantitated by quantitative RT-PCR.  Data are 
normalized to Gapdh expression.  One-way Anova was used to determine statistical 





FIGURE IV-7. Expression of Nr4a1 (A) and Nr4a2 (B), Hey1 (C), and Gadd45b (D) 
transcripts 0-12h after hCG as quantitated by quantitative RT-PCR.  Data are 
normalized to Gapdh expression.  One-way Anova was used to statistical differences 





FIGURE VI-8. Expression of Cyp19a1 (A) and Ptgs2 (B),  KitL (C), and  
Coagulation factor F3 (D) transcripts 0-12h after hCG as quantitated by quantitative 
RT-PCR.  Data are normalized to Gapdh expression.  One-way Anova was used to 
statistical differences between timepoints; Means ± SEM with different superscripts 




indicated that F3 was increased 88-fold at 1 h, peak expression occurred at 2 h (269-
fold) before returning to basal levels at 6 h post hCG (Figure VI-8D). 
 
5.   Discussion 
 This study is the first to define the changes in gene expression (transcriptome) 
of mural granulosa cells in the moments immediately (i.e., 1 h) after the LH/hCG 
surge.  Identification of genes that rapidly respond to the ovulatory surge of LH has 
provided a number of key regulatory genes (transcription factors, growth factors) 
previously unknown to be expressed within granulosa cells (Table VI-2).  These 
genes may regulate key molecular and cellular events occurring within granulosa 
cells that facilitate the processes of ovulation (which occurs ~14 h later) and 
luteinization.  In addition, a number of genes already known to be expressed within 
the ovary (Table VI-1) are now shown to be expressed specifically within granulosa 
cells of the periovulatory follicle.  The temporal expression of genes already 
implicated in a variety of ovarian processes by granulosa cells specifically supports 
these earlier observations.  Interestingly, the surge of LH/hCG predominantly caused 
an increase in gene expression with 57 of the 60 genes being upregulated and only 3 
significantly down regulated.  This fits with most other early (i.e., 4-12 h) ovarian 
profiling studies, and although about half of the total genes as detected as expressed 
were below the threshold, few reached significance.  These observations would be 
indicative of a system whereby LH/hCG regulates mostly from a positive 
(stimulatory) manner the expression of mRNA transcripts associated with ovulation 
 106 
and luteinization, and not the rapid destruction of specific mRNA transcript(s) to 
allow these cells to precede to their ultimate final terminal differentiation.  However, 
because only a single very early time point was examined in these studies, it is 
possible that the loss of mRNA transcripts associated with granulosa cell functions 
may have not yet occurred, or that loss of these transcripts is gradual or is regulated 
post-transcriptionally.  
 
Steroidogenic, Angiogenic and Inflammatory Genes  
The role of Kit ligand (Kitl) in the ovary has been studied extensively.  The 
expression of Kitl has been shown to be localized to granulosa cells, and the 
expression of its receptor is localized to oocytes and theca cells (Doneda et al., 2002; 
Horie et al., 1991; Keshet et al., 1991), so Kitl is most likely important for the 
granulosa cell – oocyte/thecal cell communication.  It has been demonstrated to be 
important for many aspects of folliculogenesis, including the growth and survival of 
oocytes (Huang et al., 1993; Thomas and Vanderhyden, 2006), steroidogenesis of 
theca and granulosa cells (Reynaud et al., 2000), and the proliferation of granulosa 
cells (Reynaud et al., 2000).  Previous studies have shown that Kitl expression 
increases in granulosa cells in response to hCG (Ismail et al., 1996), with levels 
increasing at 3h post-hCG, the earliest time point examined, and then peaking at 6 h 
post-hCG.  Our results indicate that Kitl increases within 1 h, suggesting that its 
effects on ovarian function could be broader than previously envisioned.  
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Coagulation factor F3 (F3) is a cell surface glycoprotein that is a potent 
initiator of the coagulation protease cascade.  F3 has previously been found in 
follicular fluid, along with high levels of its inhibitor, tissue factor pathway inhibitor 
(TFPI; Shimada et al., 2001).  Surprisingly, there is little information about the role of 
coagulation during the ovulatory process.  In the chicken, coagulation factor XIIIA 
was identified as secreted from theca cells and acts to stabilize the follicle wall during 
oocyte growth and may aid in the clotting of small capillaries that are ruptured during 
ovulation (Recheis et al., 2000).  F3 may be playing a similar role in preventing 
microbleeding during ovulation, especially since it undergoes such a rapidly and 
dramatic upregulation in response to LH.   
It is well established that the LH surge initiates a shift in granulosa cell 
steroidogenesis.  A major player in this shift is the dramatic decrease in the 
expression of Cyp19a1 (P450 aromatase), which catalyzes the formation of estrogens 
from androgens (Hickey et al., 1990; Stocco, 2008).  This loss of Cyp19a1 
dramatically reduces the amount of estrogen produced by granulosa cells, and, in 
combination with an increase in progesterone-producing steroidogenic enzymes (i.e., 
CYP11A1 and 3βHSD), results in the shift from an estrogen-producing cell to a 
progesterone-producing cell.  Similar to our observations of a rapid and transient 
increase in Cyp19a1 expression, Hickney et al. (1988) observed an almost identical 
pattern in rat granulosa cells following in vivo hCG administration.  The transient 
increase in Cyp19a1 occurring within granulosa cells is likely a hold over effect of 
pulsatile LH secretion occurring in the later stages of folliculogenesis, however, after 
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the initial response to the increasing LH, the surge levels of LH induce other cell 
signaling cascades / transcription factors that ultimately repress Cyp19a1 expression, 
leading to the conversion of an estrogen-producing granulosa cell to a progesterone-
producing luteal cell.   
Prostaglandin-endoperoxide synthase 2 (PTGS2) is an inducible enzyme that 
catalyzes the key step in the production of prostaglandins from arachidonic acid.  
Prostaglandins have been shown to be involved in a wide array of ovulatory and 
luteal events, including follicular rupture, angiogenesis, and progesterone production 
(Sakurai et al., 2003; Tsafriri, 1996).  Targeted deletion of Ptgs2 confirmed its critical 
role in the processes of ovulation and luteinization and female fertility (Lim et al., 
1997).  The expression of Ptgs2 was previously shown to be rapidly (within 2 h post-
hCG) and transiently increased within granulosa cells (Huslig et al., 1987; Sirois et 
al., 1992).  Our study confirms these observations and indicates that Ptgs2 expression 
occurs even earlier (at 1 h post-hCG) in granulosa cells. 
 
Transcription Factors 
Early growth response 1 (Egr1) has previously been demonstrated to be 
induced by hCG in granulosa cells, and it is hypothesized that this early response 
gene binds to the promoter of later LH-responsive genes, such as the proteases 
cathepsin L and ADAMTS-1, thus impacting the structural events that occur during 
the periovulatory period (Espey et al., 2000; Russell et al., 2003).  Studies of Egr1 
knockout mice suggest that it is vital to the processes of ovulation and luteinization 
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(Topilko et al., 1998).  To the best of our knowledge, this is the first study to show 
expression of Egr2 in periovulatory follicles and its induction by LH.  In adipose 
tissue, EGR2 has been shown to increase C/EBPβ expression (Chen et al., 2005).  In 
granulosa cells, C/EBPβ plays a necessary role in ovulation and luteinization 
(Christenson et al., 1999; Sterneck et al., 1997), and future studies may find that 
EGR2 also stimulates C/EBPβ expression in LH-induced granulosa cells, thus 
allowing these downstream events to occur.  In peripheral nerve cells, EGR2 has been 
shown to indirectly activate the transcription of genes important for lipid and 
cholesterol biosynthesis (Leblanc et al., 2005). While Egr2 has been knocked out in 
mice, its effect on reproduction has not been reported (Jacquin et al., 1996).  Further 
studies on Egr1 and Egr2 will give insight into their regulatory roles that impact 
ovulation and luteinization.   
The transcription factors Btg1 and Btg2 were also rapidly upregulated within 
granulosa cells following hCG administration.  Btg2 is upregulated during 
differentiation in neuronal cells, and is important for inhibiting proliferation during 
this process (Montagnoli et al., 1996). Both BTG1 and BTG2 have been shown to 
play roles in terminal differentiation events, such as the differentiation of 
hematopoetic cells in response to retinoic acid (Passeri et al., 2006) and myoblast 
differentiation (Rodier et al., 1999), and both are anti-proliferative (Rouault et al., 
1996; Rouault et al., 1992). Whole ovary expression of Btg2 after hCG adminstration 
was examined in the rat, and was found to not change, however, the earliest time 
point examined was 12 h after hCG treatment (Schmidt et al., 2006).  This is the first 
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study to describe the rapid and transient upregulation of Btg1 and Btg2 after hCG 
within granulosa cells, and due to their role in DNA methylation it is interesting to 
speculate that these two proteins could play a vital role in the terminal differentiation 
of granulosa cells as they transform into luteal cells.  
NR4A1 (NUR77) and NR4A2 (NURR1) are transcription factors that have 
previously been shown to be upregulated by hCG/LH in the rat and in the human 
granulosa tumor-like cell line KGN  (Park et al., 2003; Wu et al., 2005).  Here we 
show that they are also upregulated in the mouse within 15 minutes of hCG treatment.  
NR4A1 and NR4A2 are orphan nuclear receptors that generally act as transcriptional 
activators or repressors, although they can also affect apoptosis by binding to B-cell 
lymphoma protein 2 in the mitochondria (Li et al., 2006).   Nr4a1 is upregulated in 
the rat by the actions of LH-induced protein kinase C zeta (Park et al., 2007).  NR4A1 
binds the Cyp19a1 (aromatase) promoter to repress its expression, which may explain 
why Cyp19a1 expression levels decrease after the LH surge (Wu et al., 2005).  
Consistent with our array data, the LH/hCG surge indicates that Cyp19a1 expression 
increases at ½ h after hCG (Table VI-1 and Figure VI-7A), perhaps before Nr4a1, 
whose transcript is increased at 15 minutes (Figure VI-6A), is able to be converted to 
protein and subsequently repress Cyp19a1 expression.  NR4A1 upregulates 3β-
hydroxysteroid dehydrogenase expression within granulosa cells and this enzyme is 
necessary for progesterone synthesis (Havelock et al., 2005).  The promoters for 
several other steroidogenic enzymes, including Cyp11a1, Cyp11b1, and Cyp17 have 
binding sites for NR4A1 and NR4A2 (Morohashi et al., 1992; Park et al., 2003; 
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Zhang and Mellon, 1997), suggesting they may regulate the changes in 
steroidogenesis that occur during the differentiation of the granulosa cell to a luteal 
cell.   
Expression of another transcription factor, Hey1, was identified as 2.8-fold 
upregulated within 1 h post-hCG.  HEY1 is a transcriptional repressor that is 
transcriptionally activated by the cell membrane receptor Notch.  In response to 
Notch-mediated induction, HEY1 plays an essential regulatory role in angiogenesis 
(Fischer et al., 2004).  During the follicle to corpus luteum transformation, there is a 
considerable increase in angiogenesis, resulting in a highly vascularized corpus 
luteum.  While the pro-angiogenic vascular endothelial growth factor (VEGF) has 
been shown to play an important role in these processes, the Notch pathway, 




  GADD45b is a direct activator of the MEKK4 kinase, and thus an activator of 
the p38/JNK pathway.  Recent reports have indicated that this pathway is activated in 
response to LH-induced protein kinase C activation, and culminate in the expression 
of genes important in ovulation and luteinization (Sriraman et al., 2008b).  GADD45b 
has also been indicated to play a role in inhibiting the cell cycle through its 
interaction with the Cdk1/cyclinB1 complex, and has been proposed to play a role in 
terminal differentiation and apoptosis (Abdollahi et al., 1991; Vairapandi et al., 2002; 
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Zhang et al., 1999).  Therefore, GADD45b may be playing an important role in 
promoting the differentiation of the granulosa cell to the luteal cell.   
 
Growth Factors 
The importance of the EGF-like growth factors, AREG and EREG in cumulus 
expansion and oocyte maturation are established (Conti et al., 2006; Shimada et al., 
2006).  These two proteins are released from mural granulosa cells in response to LH 
and are postulated to then act on the LH receptor-deficient cumulus cells and the 
oocyte to initiate oocyte maturation and cumulus expansion (Conti et al., 2006). In 
our study, Areg had the highest upregulation among the genes expressed in granulosa 
cells with a 133-fold observed increase 1 h after hCG.  Amphiregulin has previously 
been shown to be highly upregulated at 4 h post-hCG, and remained elevated 
(compared to 0 h) through 12 h post-hCG by semi-quantitative RT-PCR analysis 
(Shimada et al., 2006).  While our results confirm this marked upregulation at 4 h it 
points to even a greater increase (>800-fold) at 2 h post-hCG.  Our quantitative RT-
PCR analysis indicated that, like Shimada et al., (2006), amphiregulin levels 
remained above basal levels at 8 and 12 h post-hCG.   
Similar to granulosa Areg expression, Ereg and Epgn, two other EGF-like 
ligands, also exhibited robust and transient increases in expression in response to the 
LH/hCG surge.  Ereg expression has previously been examined in granulosa cells 
(Shimada et al., 2006), this however is the first report of Epgn expression with 
ovarian tissue.  Phylogenetically, Epgn is most related to Ereg, although it has lower 
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affinity than EREG or AREG for their common receptor ERBB1 (Kochupurakkal et 
al., 2005).  Its lower affinity, however, makes it a more potent mitogen, in that the 
ERBB1 receptor is less likely to be downregulated and inactivated in response to the 
low affinity binding of EPGN (Kochupurakkal et al., 2005).  EPGN has been shown 
to stimulate epidermal cell proliferation in vitro and induce differentiation of 
mammary, prostate, pheochromocytoma and endothelial cells (Strachan et al., 2001).  
We hypothesize that EPGN, as another member of the EGF-like ligands, is important 
for cumulus cell function.  To test this hypothesis, we treated cumulus-oocyte-
complexes (COCs) with EPGN and found an increase in cumulus cell expansion 
(Figure VI-4 and VI-5).  While knockout Areg or Ereg mice do have delayed cumulus 
expansion, they remain fertile, indicating that these genes can compensate for each 
other (Hsieh et al., 2007; Lee et al., 2004a; Luetteke et al., 1999; Panigone et al., 
2008).  Here evidence is provided that indicates EPGN may be able to replace AREG 
or EREG function.  In addition because of its unique biochemical properties EPGN 
may be critical for maintaining cellular signaling as its lower affinity would not cause 
down regulation of the EGF receptor protein.   
In addition to identification of the novel EGF-ligand, EPGN, within granulosa 
cells, we also identified ERBB receptor feedback inhibitor 1 (Errfi1; a.k.a., Mig6, 
RALT, Gene 33) as upregulated in granulosa cells.  ERRFI1 binds to the activating 
kinase domain of the EGF receptor, thus preventing its activity (Ferby et al., 2006; 
Zhang et al., 2007).  The increase in this inhibitor of EGF receptor signaling suggests 
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that signaling through this pathway is much more dynamically regulated than 
previously envisioned.   
In conclusion, microarray analysis of mouse granulosa cells before and 1 h 
after hCG has allowed for the global identification of rapidly differentiated genes in 
response to LH.  The protein product of one upregulated gene, the EGF-like ligand, 
EPGN, was shown to stimulate cumulus expansion, and thus can join the other 
members of the EGF-like ligands, EREG, AREG, and betacellulin (BTC) in 
initiating/modulating the cumulus expansion process in response to LH.  These results 
allow a better understanding of the rapid molecular events that occur in granulosa 
cells after LH, and provide a starting point for future research to analyze the roles 
these newly identified genes play in ovulation and luteinization, and to analyze the 
early role of genes previously shown to be important in these processes.  Further 






VII.  Chapter Three: 
 
MicroRNA-21 is Induced by LH and Blocks Apoptosis in 
Granulosa Cells 
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1.  Abstract 
MicroRNA (miRNA) play important roles in many developmental processes 
including cell differentiation and apoptosis. Transition of proliferative ovarian 
granulosa cells to terminally differentiated luteal cells in response to the ovulatory 
surge of luteinizing hormone (LH) involves rapid and pronounced changes in cellular 
morphology and function.  MicroRNA-21 (miR-21) is one of three LH-induced 
miRNA in murine granulosa cells, and here we examine the function and temporal 
expression of miR-21 within granulosa cells as they transition to luteal cells. 
Quantitative RT-PCR analysis indicates that in vivo hCG/LH administration induced 
granulosa cell pri-miR-21 expression 10-fold within 2 h with mature miR-21 levels 
peaking ~4 h later. To examine function, granulosa cells were transfected with a miR-
21 blocking oligonucleotide (LNA-21) that decreased mature miR-21 levels 27-fold. 
LNA-21 depletion of miR-21 activity in cultured granulosa cells induced apoptosis 
(annexin V positive staining, caspase 3 cleavage). LNA-21 treatment showed no 
changes in global granulosa cell gene expression, indicating that miR-21 likely affects 
translation and not mRNA degradation. In vivo granulosa cell cleaved caspase 3 (i.e., 
apoptosis) levels decline 6 h after an ovulatory surge of hCG/LH, coincident with the 
rise in miR-21 expression. Furthermore, ovarian bursal injection of a phosphothioate 
LNA-21 oligonucleotide increased ovarian apoptosis. A number of miR-21 apoptotic 
target transcripts have been identified in other systems; currently none appear to play 
a role in the induction of ovarian granulosa cell apoptosis.   This study is the first to 
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implicate miR-21 (an oncogenic miRNA) as playing a clear physiologic role in 







2.  Introduction 
Luteinizing hormone (LH) acts on ovarian granulosa cells to induce both 
ovulation and luteinization.  The interval between ovarian recognition of the LH 
surge and follicular rupture (ovulation) is termed the periovulatory period, and lasts 
~13-15 h in the mouse.  In response to the ovulatory surge of LH, granulosa cells not 
only stimulate the resumption of oocyte meiosis, cumulus expansion, and breakdown 
of the follicular wall in preparation for ovulation, but also rapidly differentiate to 
form luteal cells, the primary endocrine cell in the corpus luteum.  Luteinization is a 
terminal differentiation process and is characterized by the rapid transition in 
morphology and function of the granulosa cell, with phenotypical changes becoming 
evident within 5-7 h of the ovulatory surge of LH/hCG (Chaffin and Stouffer, 2002; 
Oonk et al., 1989). Proper luteinization and sustained progesterone secretion are 
necessary for maintenance of pregnancy, and thus survival of periovulatory granulosa 
cells is obligatory for pregnancy.  Thus, in addition to its differentiative effects, LH 
also acts as a survival factor by preventing apoptosis of the differentiating granulosa 
cells (Chaffin et al., 2001; Robker and Richards, 1998a, b). While several anti-
apoptotic LH-induced factors have been identified in periovulatory granulosa cells, 
including progesterone receptor, pituitary adenylate cyclase-activating polypeptide, 
and atrial natriuretic peptide, it is expected that a conglomeration of factors are 
necessary for the molecular changes that need to occur to ensure both the survival and 
differentiation of these cells (Dineva et al., 2007; Lee et al., 1999; Shao et al., 2006). 
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MicroRNA (miRNA) are emerging as important mediators of differentiation, 
proliferation, and apoptotic events (Ademokun and Turner, 2008; Bueno et al., 2008; 
Chivukula and Mendell, 2008; Gangaraju and Lin, 2009; He et al., 2007; Jovanovic 
and Hengartner, 2006).  Studies have implicated miRNA in the differentiation of 
mouse embryonic stem cells (Singh et al., 2008), effector and memory T cells (Wu et 
al., 2007), and many other tissues/cells (Hashimi et al., 2009; Ketting, 2009; Yang et 
al., 2009a).  Recently, conditional-deletion of Dicer within granulosa cells using the 
anti-Mullerian hormone receptor-2 promoter–Cre (Dicer cKO) demonstrated that 
miRNA are essential for normal ovarian function (Hong et al., 2008; Nagaraja et al., 
2008). Female Dicer cKO mice exhibited reduced ovulation rates, presence of trapped 
oocytes within luteinized follicles and were infertile (Hong et al., 2008; Nagaraja et 
al., 2008). Our laboratory recently identified thirteen differentially regulated miRNA 
in murine granulosa cells collected before and 4 h after hCG/LH surge (Fiedler et al., 
2008).  Three of these miRNA were highly upregulated and two of these, miR-132 
and miR-212, were shown to be transcriptionally co-regulated and induced by cAMP 
in cultured granulosa cells (Fiedler et al., 2008). The remaining highly upregulated 
miRNA, miR-21, increased 7.5-fold by microarray analysis in response to in vivo 
hCG treatment and is the subject of manuscript.   
  Enhanced miR-21 expression is evident in multiple types of cancer, including 
breast, pancreatic, colorectal, and esophageal (Cho, 2007; Dillhoff et al., 2008; Feber 
et al., 2008; Schetter et al., 2008; Verghese et al., 2008).  Therefore, it has received a 
substantial amount of scientific attention to determine the signaling pathways that 
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dictate its regulation as well as to identify its target gene transcripts (Davis et al., 
2008a; Fujita et al., 2008; Thum et al., 2008).  Studies using locked nucleic acid- 
(LNA) or 2’O-methyl-oligonucleotides complementary to miR-21 demonstrate that 
loss of miR-21 action leads to increased cell apoptosis in a variety of cell culture 
systems (Chan et al., 2005; Si et al., 2007). Several miR-21 target transcripts have 
been identified to explain its anti-apoptotic effect, including programmed cell death 4 
(PDCD4), tropomyosin 1 (TPM1), phosphatase and tensin homologue (PTEN), 
maspin, reversion-inducing-cysteine-rich protein with kazal motifs (RECK), sprouty, 
and heterogeneous nuclear ribonucleoprotein K (HNRPK) and tumor protein p63 
(Tap63; (Frankel et al., 2008; Hu et al., 2008; Meng et al., 2006; Papagiannakopoulos 
et al., 2008; Thum et al., 2008; Zhu et al., 2007).  Although many different cell types 
undergo apoptosis in response to inhibition of miR-21 action, the miR-21 targets 
implicated vary widely for different cells (Frankel et al., 2008; Papagiannakopoulos 
et al., 2008).  
In this study, we examine the temporal expression of miR-21 in murine 
granulosa cells in response to LH/hCG, and examine the function of miR-21 in 
cultured granulosa cells and in vivo by depleting mature miR-21 function with LNA 
oligonucleotides complementary to miR-21. We provide evidence that miR-21 acts as 
an anti-apoptotic factor in cultured murine granulosa cells and in ovarian tissue.   
Furthermore, we show that miR-21 expression is transcriptional and post-
transcriptional regulated in ovarian granulosa cells.   
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3.  Experimental Procedures 
 
Animals and isolation of granulosa cells:  All procedures involving animals were 
reviewed and approved by the Institutional Animal Care and Use Committee at the 
University of Kansas Medical Center and performed in accordance with the Guiding 
Principles for the Care and Use of Laboratory Animals. All experiments were 
performed using CF-1 female mice from Charles River Laboratories (Wilmington, 
MA).  Granulosa cell isolation was performed as previously described (Fiedler et al., 
2008).  Briefly, for in vivo expression analysis, 19-day old female CF-1 mice were 
injected i.p. with 5 I.U. of eCG (Calbiochem, San Diego, CA, FSH analog) to 
stimulate follicular development, and ovaries were collected at 12, 24, 36, and 48 h 
later. To stimulate ovulation and luteinization, mice were injected 48 h after eCG 
with hCG (Sigma, St. Louis, MO, LH analog), and then collected 1, 2, 4, 6, 8, or 12 h 
later.  Granulosa cells were obtained from the ovarian tissue by follicular puncture 
into PBS.  For in vitro analyses, ovaries from 26-day old CF-1 female mice were 
collected, incubated for 15 min in M-199 media containing 0.5M sucrose, rinsed with 
M-199 media, and the cells were expressed by follicular puncture into M-199 media 
(Campbell, 1979).   
Ovarian bursal injections were completed as previously described (Otsuka et 
al., 2008).  Briefly, female mice (19 days of age) were injected i.p. with 2 I.U. eCG, 
24 h later, mice were anesthetized by i.p. injection of a 1:1 mixture of ketamine 
(0.75mg/animal; Ketaset, Fort Dodge, IA) and xylazine (0.75mg/animal, Anased, 
Lloyd Laboratories, Shenendoah, IA).  The ovaries and associated fat pad were 
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exteriorized through incisions in the dorsal abdominal wall. To deliver treatments, a 
Hamilton syringe (10 ul) outfitted with a 33-gauge needle (45° beveled tip) was 
passed through the fat pad into the ovarian bursa. Each animal served as its own 
control with one ovary receiving the blocking oligonucleotide and the other vehicle 
control or a nonspecific oligonucleotide. Animals were then closed and 20 h later 
(i.e., 44 h post-eCG) were injected i.p. with 2 I.U. hCG. In order to not mask a 
knockdown effect with excessive ovarian stimulation, a “physiologic” dose of 2 I.U. 
of eCG and hCG was administered to ovarian bursa treated mice.  Ovaries were fixed 
overnight in freshly made 4% paraformaldehyde (PFA). 
In vitro granulosa cell culture:  Isolated granulosa cells were seeded at 2.5x104 cells 
per well into 6-well fibronectin-coated tissue culture plates for gene expression and 
apoptosis analyses and 1.5x106 cells per 10 cm tissue culture dish for protein 
analyses. An aliquot of the isolated granulosa cells was placed in Trizol (Invitrogen, 
Carlsbad, CA) prior to culture to determine “before culture” expression values. Cells 
were cultured in DMEM/F12 (10%FBS, 1% gentamicin) at 37°C with 5% CO2. To 
determine if plating affects miR-21 expression, RNA from cells were collected in 
Trizol at 6, 12, 24, 48, and 72 h after plating, another group of cells were cultured for 
48 h in serum-containing medium and then cultured for 24 h in serum-free medium 
prior to RNA collection. Granulosa cells treated with 8-bromo-cAMP (Sigma) were 
cultured for 48 h in medium containing serum, then with serum-free medium for 24 h 
prior to treatment with 8-bromo-cAMP (1mM) for 1, 2, 4, 6, 8, or 12 h.   
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Oligonucleotide transfections were performed 48 h after plating, with the medium 
containing serum replaced with serum-free medium directly before transfection.  
Oligonucleotide transfections:  The control nonspecific scrambled (anti-NS) and anti-
21 2’-O-methyl RNA oligonucleotides were purchased from Ambion (Houston, TX).  
Locked nucleic acid (LNA) oligonucleotides were synthesized with a mix of 
LNA/DNA nucleotides:  LNA-21 5’-TCA GTC TGA TAA GCT A-3’, and the 
control nonspecific (LNA-NS), 5’-CGG CAG TAT GCG AAT C-3’  (underlined 
bases denote the LNA nucleotides; Integrated DNA Technologies, Coralville, IA). 
The in vivo LNA oligonucleotides, LNA-21pt and LNA-NSpt, (IDT) were identical in 
sequence and LNA base location to the in vitro oligonucleotides, the only difference 
being the addition of a nuclease-resistant phosphothioate backbone. The nonspecific 
scrambled control, LNA-NSpt, was synthesized with a rhodamine attached to the 5’ 
end to allow for visualization of injection efficiency and tissue incorporation.   
Oligonucleotides (42nM) were mixed with Lipofectamine 2000 reagent 
(Invitrogen) and then added to the isolated granulosa cells 48 h after culture at a final 
concentration of 42 nM.  Cells were transfected for 4, 8, 12 and 24 h then collected 
for protein, RNA, or apoptosis assays.  Granulosa cell protein lysates were obtained 
by resuspending cells in 200uL cell lysis buffer (Cell Signaling, Danvers, MA) with 
1mM phenylmethylsulphonyl fluoride (PMSF).  Cells were centrifuged at 1000 x g 
for 5 min to pellet the cellular membrane debris and supernatants were stored at -
80°C until use.  For RNA, cells were resuspended in 500uL Trizol and RNA was 
isolated following the manufacture instructions.   
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For in vivo transfections, the LNA-21pt and LNA-NSpt oligonucleotides 
(0.4nM) were mixed with Lipofectamine 2000 prior to bursal injection. Saline plus 
Lipofectamine was used as the vehicle control.   
Apoptosis assay:  Granulosa cells were trypsinized, washed twice with cold PBS, and 
resuspended in 1x-binding buffer (BD Pharmingen, San Jose, CA) at a concentration 
of 1x106 cells/mL.  One hundred uL (1x105 cells) of the solution was transferred to a 
5mL polystyrene tube, and incubated with 5uL of PE-conjugated annexin V (BD 
Pharmingen) and 1uL live/dead fixable violet dead cell stain (Invitrogen) for 10 
minutes at room temperature in the dark.  One mL of 1x binding buffer was added to 
the cells, centrifuged at 1000 x g for 5 minutes and the supernatant removed.  Cells 
were resuspended in 1% paraformaldehyde / PBS. The samples were analyzed by 
flow cytometry (BD Biosciences LSR II, San Jose, CA) using FACSDiva research 
software (BD Biosciences).  Annexin V positive cells were considered apoptotic. 
RNA isolation and quantitative RT-PCR: Total RNA was isolated using Trizol 
following the manufacture’s instructions.  Total RNA (250ng) was reverse 
transcribed using stem-loop primers specific to miR-21 (Applied Biosystems, 
Carlsbad, CA; (Fiedler et al., 2008). The resulting cDNA was used in the quantitative 
PCR reactions using miR-21 primers and probe (Applied Biosystems).  For analysis 
of pri-miR-21, TMEM49, and GAPDH expression, 1ug total RNA was reverse 
transcribed using oligo-(dT) primers, and for pri-miR-21 and TMEM49 the following 
primers were used for quantitative PCR: pri-miR-21, forward: 5’-GAC ATC GCA 
TGG CTG TAC CA-3’; reverse: 5’-CCA TGA GAT TCA ACA GTC AAC ATC A-
 125 
3’; TMEM49, forward:  5’-TGG CAT CGT CAA AGC ATT GT-3’, reverse: 5’-CCG 
CTG CAC ATA CTG TTG GT-3’. The TMEM49 primers spanned intron 4 to 
prevent any possible amplification of the pri-miR-21 transcript, which starts in intron 
10. GAPDH and snoRNA U6 were used to normalize miR-21 expression. GAPDH 
primers and probe were purchased from Applied Biosystems and the snoRNA U6 
primers were: forward: 5’-CTC GCT TCG GCA GCA CA-3’, reverse: 5’-AAC GCT 
TCA CGA ATT TGC GT-3’. 
Microarray analysis:  Cultured granulosa cells were transfected with LNA-NS or 
LNA-21 for 24 h as above.  Total RNA was isolated using Trizol and was biotin-
labeled and fragmented according to Affymetrix protocols.  Fragmented cRNA from 
each sample (n=2) was hybridized to individual Affymetrix 430A gene array chips 
using the GeneChip Fluidics Station 400 protocol (Affymetrix, Santa Clara, CA), and 
the hybridized chips were scanned using the Agilent Gene Array Scanner 
(Affymetrix).  A scaling factor was applied to each chip using the Affymetrix 
Microarray Suite 5.0 software to normalize the mean raw fluorescence intensity for 
each chip to an average base-line fluorescence level.  
 The microarray data was analyzed using the Partek Genomic Suite (Partek, St. 
Louis, MO).  Probe level intensity measurements were background corrected, 
normalized and summarized using RMA (Robust Multi-array Analysis; (Irizarry et 
al., 2003) after adjusting probe intensities for fragment length, GC content, and 
sequence allele position. Probe level fold changes and significances were computed 
using the least square mean (LS Mean) of each term of the linear contrasts performed 
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between LNA-21 and LNA-NS within the context of a 2-way mixed model ANOVA.  
List of genes involved in various KEGG pathways were identified through DAVID 
(Dennis et al., 2003), GenePattern (Kuehn, 2008) and oncological implications with 
relevant PubMed IDs for the most part were also identified through DAVID. The 
Ingenuity Pathway Analysis application (IPA, Ingenuity Systems, Redwood City, 
CA) was used to examine changed networks in the upregulated and downregulated 
genes (>1.5-fold). 
Immunoblotting: Granulosa cell protein lysate concentrations were determined using 
the Bio-Rad protein assay (Hercules, CA).  Each lysate (15 ug) was denatured by 
diluting the sample 1:2 with sample buffer (2.8mL distilled water, 1.0mL 0.5M Tris-
HCl, pH6.8; 0.8mL glycerol, 1.6mL 10% SDS, 0.4mL 2-β-mercaptoethanol and 
0.4mL 0.05% (w/v) bromophenol blue) and heating for 5 minutes at 95°C.  Proteins 
were separated on 12% SDS-PAGE gels in 5X electrode running buffer, pH 8.3 
(25mM Tris base; 192mM glycine; 0.1% (w/v) SDS), and transferred to PVDF 
membranes (Millipore, Billerica, MA) in transfer buffer (12mM Tris-HCl; 96mM 
glycine; 20% (v/v) MeOH).  Blots were incubated for 1 h at RT in a 5% milk solution 
to block nonspecific binding.  Blots were then incubated overnight at 4°C with one of 
the following antibodies:  caspase 3 antibody (Cell Signaling), sprouty 2 (Santa Cruz, 
Santa Cruz, CA), tropomyosin 1 (Santa Cruz), PDCD4 (ProSci, Poway, CA), PTEN 
(Sigma) and actin (Santa Cruz). After washing and incubation with the appropriate 
secondary antibody, protein-antibody complexes were visualized using West Pico 
Chemiluminescent Substrate (Pierce) following the manufacturer’s protocol.   
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MicroRNA in situ hybridization:  Double 5’ and 3’-digoxigenin (DIG)-labeled pre-
designed LNA probes for detection of miR-21 (same sequence as LNA-21) as well as 
a double-DIG-labeled scrambled control (5’-GTG TAA CAC GTC TAT ACG CCC 
A-3’) were purchased from Exiqon (Vedbaek, Denmark). In situ hybridization was 
performed on 4% PFA fixed and paraffin-embedded tissue as previously described in 
detail (Nuovo et al., 2009). Following deparaffinization, samples were subjected to 
pepsin (1.3mg/mL) digestion for 30 min.  The tissues were then incubated overnight 
with the LNA probes. Tissue sections were then incubated for 30 min at 37°C in anti-
digoxigenin-alkaline phosphatase conjugate (Roche, Nutley, NJ), followed by 
visualization with NBT/BCIP chromogen (Enzo Diagnostics, Farmingdale, NY).   
In situ apoptosis assay:  Tissue sections (5um) were deparaffinized and apoptotic 
cells were detected using the ApopTag Red In Situ apoptosis detection kit (Chemicon, 
Billerica, MA).  Briefly, samples (n=3) were digested with proteinase K (20ug/mL) 
for 15 min and then terminal deoxynucleotide transferase (TdT) was added to 
catalyze the addition of digoxigenin-dNTPs onto the DNA strand breaks.  For 
negative control, the TdT enzyme was inactivated by adding stop buffer to the 
enzyme to chelate the divalent cationic enzyme cofactor prior to applying to the tissue 
sections. Incubation with anti-digoxigenin-rhodamine allowed visualization of 
apoptotic cells.  Slides were also labeled with the nuclear binding dye Hoechst to 
visualize ovarian morphology.  Fluorescence was examined on an Olympus1x71 
inverted microscope.   
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4.  Results and Figures 
MiR-21 expression increases after in vivo hCG/LH and eCG/FSH 
administration.   
Mural granulosa cells collected from periovulatory follicles exhibit an 
increase in miR-21 expression, confirming earlier array analyses (Figure VII-1; 
Fiedler et al., 2008).  To determine if transcription of miR-21 increased in response to 
hCG, the primary-miR-21 transcript (pri-miR-21) levels were examined by qRT-
PCR.  Pri-miR-21 expression progressively increased through 2 h post-hCG, reached 
a maximal 10-fold induction, and then remained elevated through 12 h post-hCG 
(Figure VII-1A).  In vivo expression of mature (21 basepair) miR-21 trailed that of 
pri-miR-21 levels by several hours, with mature miR-21 levels reaching their 
maximum 5.8-fold induction at 6 h post-hCG, miR-21 levels remained elevated 
through 12 h post-hCG (Figure VII-1B).  Despite having its own promoter, a recent 
study indicated that miR-21 might be co-expressed with the gene TMEM49 in which 
it resides (Hu et al., 2008).  Expression of TMEM49 within granulosa cells showed 
no change following in vivo hCG administration (Figure VII-1C).    
To further examine miR-21 expression in the ovary, miR-21 levels were also 
examined during the preovulatory period (0-48 h post-eCG).  Levels of pri-miR-21 
increased 4-fold at 12 h following eCG, and then returned to basal levels (Figure VII-
1D).  Mature miR-21 levels followed pri-miR-21 levels, with levels increasing 6.4-
fold at 24 h post-eCG before returning to basal levels at 48 h (Figure VII-1E).  Once 
again, TMEM49 expression exhibited no change (Figure VII-1F).   
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FIGURE VII-1. Induction of miRNA-21 by eCG and hCG.  Quantitative RT-PCR of 
pri-miR-21 (A, D), mature miR-21 (B, E), or TMEM49 (C, F) in murine granulosa 
cells with eCG alone (0h) or 1, 2, 4, 6, 8, or 12h following hCG injection (A, B, C) or 
following 12, 24, 36, or 48 h eCG injection (D, E, F). All qRT-PCR data (n=3) were 
normalized to GAPDH; One-way ANOVA was used to determine statistical 
differences between time points and a,b means ± SEM with different superscripts are 




 To localize and confirm upregulation of miR-21 within granulosa cells in situ 
hybridization was conducted before and 6 h after hCG treatment.  In situ 
hybridization revealed miR-21 was expressed mostly in individual granulosa and 
cumulus cells, although some individual stroma cells expressed low levels at 0 h post-
hCG (Figure VII-2B, C).  Oocytes of primary and early antral follicles also expressed 
miR-21, with expression localized to the nucleus, and levels were unchanged in 
response to hCG (Figure VII-2B, C, E).  At 6 h post-hCG, miR-21 expression 
dramatically increased in cumulus and granulosa cells, especially of antral follicles 
(Figure VII-2E, F) and while expression increased in some stroma cells, it remained 
undetectable in others (Figure VII-2E, F).    
In contrast to in vivo miR-21 expression, which demonstrated a clear 
transcriptional response, mature miR-21 levels in cultured granulosa cells increased 
5- fold upon plating with no corresponding increase in pri-miR-21 levels (Figure VII-
3A). Granulosa cell expression of mature miR-21 increased (P<0.05) within 12 h of 
plating and reached its greatest levels at 48 h (Figure VII-3A).  Since subsequent 
cAMP treatments and transfection experiments were done with cells removed from 
serum-containing media and placed in serum-free media at 48 h post-plating, we 
examined the expression of miR-21 in granulosa cells cultured with serum for 48 h, 
then put in serum free media for the next 24 h.  Removal of serum had no significant 
effect on mature miR-21 levels (Figure VII-3A).  Pri-miR-21 levels did not change in 
response to plating (Figure VII-3B).  In addition, treatment of granulosa cells with the 
cell permeable  8-bromo-cAMP (i.e., the primary second messenger utilized by LH), 
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FIGURE VII-2. MiR-21 is upregulated in periovulatory granulosa cells after hCG.  
In situ hybridization with a locked nucleic acid (LNA) complementary to miR-21 
before (B, C) and 6h (E, F) after hCG.  A control scrambled LNA resulted in no 
signal at either time point (A, D). Similar results were obtained in four different 
replicates.  Bar = 500 um. 
 133 
 134 
 had no affect on miR-21 expression across time (Figure VII-3C). 
Differential knockdown of miR-21 by LNA and 2’-O-methyl oligonucleotides 
leads to functional differences.   
To analyze the function of miR-21, granulosa cells were treated with either a 
2’O-methyl oligonucleotide complementary to miR-21 (anti-21) or a control 
scrambled 2’-O-methyl oligonucleotide (anti-NS).  Mature levels of miR-21 
decreased 9-fold with addition of the anti-21 (Figure VII-4A).  The specificity of this 
anti-21 was confirmed as the levels of two other miRNAs, miR-132 and miR-212 
were not affected (data not shown). Similarly, knockdown of miR-132 and miR-212 
had no effect on miR-21 expression (Fiedler et al., 2008). LNA oligonucleotides have 
been shown to block miRNA expression and function to a greater degree than 2’-O-
methyl oligonucleotides (Marquez and McCaffrey, 2008; Orom et al., 2006). 
Consistent with these observations, granulosa cells treated with LNA-21 had a 27-
fold reduction in miR-21 levels when compared to a scrambled LNA (LNA-NS; 
Figure VII-4B).  
 The 3-fold difference in miR-21 knockdown between the different miR21 
inhibitors was associated with a marked difference in cell morphology as only the 
LNA-21 treated cells rounded up and pulled off of the dish, a well-described “late 
step” in the process of apoptosis (Falcieri et al., 1994; Figure VII-5A).  To confirm 
apoptosis, cells were stained with annexin V and live/dead violet stain, fixed and then 
analyzed by flow cytometry.  Annexin V labeling indicated that granulosa cells began 
undergoing apoptosis within 8 h of LNA-21 treatment and by 24 h of treatment 42%
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FIGURE VII-3. MiRNA-21 levels increase in response to plating and do not change 
in response to cAMP. Quantitative RT-PCR of mature miR-21 (panel A) and pri-miR-
21 (panel B) before culture/plating (BC), and 6, 12, 24, 48, 72h or SF which represent 
cells 72h after plating, with the last 24h in serum-free media.  Mature miR-21 levels 
in granulosa cell before culture (BC) and after 72h plating (minus serum for the last 
24 h) and then treated with 8-bromo-cAMP for 1, 2, 4, 6, 8, or 12h of 8-bromo-cAMP 
treatment are shown in panel C. Data (n=3) was normalized to GAPDH; one-way (A, 
B) and two-way ANOVA (C) was used to determine statistical significance; a,bmeans 
± SEM with different superscripts are different (p<0.05). 
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FIGURE VII-4. Knockdown of miR-21 by 2’-O-methyl oligonucleotides or locked 
nucleic acid (LNA) oligonucleotides in cultured granulosa cells. Quantitative RT-
PCR of mature miR-21 in cultured granulosa cells following transfection with 2’-O-
methyl “anti-21 or anti-NS oligonucleotides (Panel A) or with LNA-21 or LNA-NS 
(i.e., control) oligonucleotides (Panel B). Data (n=3) was normalized to GAPDH; t-
tests were used to determine statistical significance within the oligonucleotide 
treatment groups; *means ± SEM with different superscripts are different (p<0.05).  
Two-way ANOVA comparison of relative values across treatment groups indicated a 
3-fold decline (p<0.05) in miR-21 transcript levels between anti-21 and LNA-21 
treatment groups, with no difference between anti-NS and LNA-NS treated cells. 
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of the cells had undergone apoptosis (Figure VII-5B).  No change in apoptosis was 
observed in the control LNA-NS treated cells (Figure VII-5B).  Flow cytometry 
analysis also indicated that granulosa cells transfected with anti-21 or precursor-miR-
21 (which increases miR-21 levels) had no effect on apoptosis at 24 h and 48 h post-
transfection (data not shown).  To further confirm the increase of apoptosis in LNA-
21 treated cells, immunoblotting was performed for cleaved caspase 3, an active 
mediator of apoptosis (Earnshaw et al., 1999).  Cleaved caspase 3 levels were 
increased in LNA-21 treated cells within 8 h after transfection, but were not increased 
in anti-21 treated cells (Figure VII-5C).  Dose response analysis using decreasing 
concentrations of LNA-21 (20nM, 5nM, and 1.25nM; Figure VII-6A) displayed 
decreasing levels of cleaved caspase 3 (Figure VII-6B).  While the 1.25nM dose of 
LNA-21 showed a similar knockdown to anti-21 (9-fold), there was still a slight 
increase in cleaved caspase 3 levels (Figure VII-6A,B).   
Known apoptotic miR-21 target transcripts were unaffected by LNA-21 treatment of 
granulosa cells.   
MicroRNA-21 has been implicated in the post-transcriptional regulation of 8 
apoptotic genes in other cell systems (Frankel et al., 2008; Hu et al., 2008; Meng et 
al., 2006; Papagiannakopoulos et al., 2008; Thum et al., 2008; Zhu et al., 2007). 
Western blot analyses examined the expression of four of these proteins at 4 h, 8 h, 
and 24 h after transfection with the LNA-21 oligonucleotide (Figure VII-7). RECK 
and maspin were also analyzed by Western blot, but expression of both appeared 
extremely low in granulosa cells as evident by the almost nonexistent signal  
 140 
FIGURE VII-5. Induction of apoptosis upon LNA-21 treatment of cultured murine 
granulosa cells.  Bright field image of rounded up cells after 24h treatment with 
LNA-21 (panel A). LNA-NS and LNA-21 transfected cells were double-stained with 
annexin and live/dead violet stain and were analyzed by fluorescence activated cell 
sorting (FACS) 0-24h after transfection (panel B).  Line graph summaries the 
percentage of live cells 0-24h after transfection, and data (n=3) was analyzed by t-
test; *means ± SEM with different superscripts are different (p<0.05) between the 
LNA-21 and LNA-NS at that time point.  (C) Representative Western blot (n=3) of 
caspase 3 and cleaved (active) caspase 3 in LNA-NS and LNA-21 transfected 















FIGURE VII-6. Reduced concentrations of LNA result in a decrease in the amount 
of caspase 3 cleavage.  Quantitative RT-PCR of mature miR-21 in cultured granulosa 
cells with 1.25nM, 5nM, or 20nM LNA-NS or LNA-21 (panel A).  Cells transfected 
with 1.25nM LNA-21 had comparable fold reductions in mature miR-21 levels to 
those transfected with 42nM anti-21.  Data (n=3) was normalized to GAPDH; two-
way ANOVA was used to determine statistical significance; a,bmeans ± SEM with 
different superscripts are different (p<0.05).  Representative Western blot (n=3; panel 
B) of caspase 3 and cleaved (active) caspase 3 in granulosa cells transfected with 
1.25nm, 5nm, or 20nm LNA-NS or LNA-21.   
 143 
 144 
 and lack of differences between LNA-NS and LNA-21 samples (data not shown).  
With the exception of PTEN which exhibited a slight increase 4 h after treatment with 
LNA-21, none of the other proteins exhibited any change in protein expression 
(Figure VII-7). 
To determine whether the change in PTEN levels could affect granulosa cell 
apoptosis, granulosa cell PTEN levels were decreased by transfection with PTEN 
siRNA (Supplemental Figure VII-1A). After PTEN siRNA transfection (24 h), cells 
were transfected with LNA-NS or LNA-21.  However, apoptosis still occurred in 
LNA-21 treated cells even in the presence of PTEN siRNA (Supplemental Figure 
VII-1B).  To further rule out the role of PTEN in apoptosis in LNA-21 treated 
granulosa cells, oligonucleotides were designed to “block” the miR-21 sites on the 
PTEN 3’UTR.  Since basal miR-21 levels are high in plated granulosa cells, and 
presumably play a role in granulosa cell survival, the prevention of miR-21 from 
binding to PTEN should result in an increase in basal PTEN levels and possibly lead 
to apoptosis. We did not observe a change in apoptosis (Supplemental Figure VII-
1C). 
Loss of miR-21 fails to elicit changes in mRNA expression.  Microarray 
analyses of granulosa cells treated with LNA-21 (n=2) and the control LNA-NS (n=2) 
were completed to identify miR-21 target transcripts that might be post-
transcriptionally regulated through a mRNA-degradation mechanism. Overall, 203 
upregulated and 115 downregulated genes exhibited >1.5-fold change and 50 
upregulated and 12 downregulated exhibited >2-fold change. Statistical analyses, 
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FIGURE VII-7. Granulosa cell expression of known miR-21 targets are not affected 
by LNA-21 knockdown.   Representative western blots (n=3) for PDCD4, PTEN, 
TPM1, Sprouty2, and control actin after 4h, 8h, or 24h of transfection with LNA-NS 




however, failed to detect any transcripts that exhibited a significant change in 
response to loss of miR-21 action.  
To determine whether a particular cell biologic pathway is overrepresented we 
compiled all of the genes with predicted >1.5- fold differences and mapped them to 
KEGG pathways to perform pathway analysis using GenePattern. We identified 
apoptosis/cell death pathway as one of the significant and important pathways 
through this analysis. We used classification and regression tree methodology to 
identify the list of genes in various pathways. Table VII-1 contains the list of 
pathways identified using our approach. We also used Ingenuity Pathway Analysis to 
validate our results. Both analyses identified the apoptosis/cell death pathway as 
significantly overrepresented as shown in Table VII-1.  
Caspase 3 cleavage decreases in granulosa cells after administration of an ovulatory 
surge of LH/hCG. Levels of cleaved caspase 3 were analyzed by western blot 
following LH/hCG administration in vivo.  Uncleaved caspase 3 levels were 
unchanged following hCG, except for a slight increase at 4 h post-hCG (Figure VII-
8).  Levels of cleaved caspase 3, however, decreased at 6 h post-hCG and remained 
low at 8 h post-hCG (Figure VII-8).   
In vivo knockdown of miR-21 causes an increase in apoptosis.  To examine the effect 
of miR-21 on ovarian apoptosis, miR-21 function was knocked down in vivo. 
Following follicular stimulation (i.e., 24 h of eCG), an LNA-21pt oligonucleotide 
targeting miR-21 was injected into one ovarian bursa, while the other ovary received 




FIGURE VII-8.  Cleaved caspase 3 is decreased in vivo following LH/hCG.   
Representative Western blots (n=3) of caspase and cleaved caspase 3 and actin after 




FIGURE VII-9.  Ovarian bursal injections of LNA-21pt cause an increase in 
apoptosis. Representative fluorescence images (n=4) of mouse ovaries exposed to 
saline (A) or LNA-21pt (D) stained with the DNA-binding dye Hoechst.  TUNEL 
assay to detect apoptotic cells in the saline (B) and LNA-21pt (E, F) treated ovaries.  
Negative control TUNEL assay (C; non-working enzyme) in saline treated mouse 
ovary.  Panel F is a 10X magnification of E.  (G) Negative control TUNEL assay 
(non-working enzyme) of the LNA-21pt injected mouse ovary in G and H. Bar = 500 
um.   
 152 
 153 
surgery, animals were injected with hCG to stimulate ovulation and luteinization.  
Ovaries were collected 16 h post-hCG and were analyzed for apoptosis (Figure VII-
9).  Apoptosis was significantly increased in LNA-21 treated ovaries compared to 
saline treated ovaries (Figure VII-9).  Transfection efficiency was measured by 
distribution of the fluorescent-labeled LNA-NS (Supplemental Figure VII-2).  While 
labeling was found throughout the ovary, there were punctate regions of increased 
fluorescence (Supplemental Figure VII-2).  When tested for apoptosis, there was no 
increase in TUNEL fluorescence between the LNA-NS negative control and the 
TUNEL-labeled LNA-NS samples (Supplemental Figure VII-2).  
 In addition, ovaries treated with LNA-21 displayed decreased ovulation rates 
compared to LNA-NS or saline treated controls (Figure VII-10).  Histological 
analysis of LNA-21 treated ovaries showed an increased incidence of trapped oocytes 
within luteinized follicles, and in two cases there was an increased accumulation of 
red blood cells around the oocyte of the luteinized follicle (Figure VII-11).   
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FIGURE VII-10.  Ovulation rate is decreased in LNA-21 treated ovaries.  Number 
of cumulus-oocyte-complexes within the clutch (“ovulation rate”) of LNA-NS/saline 




FIGURE VII-11.  Ovarian sections from LNA-NS (A) and LNA-21 (B-D) treated 
ovaries.  Panel B, asterisks are luteinized follicles that have a trapped oocyte in 
another section, arrowheads are trapped oocytes that are visible in this section.  Panel 
C shows a magnified view of trapped oocyte (c) from panel B. Panel D, arrows point 
to two trapped oocytes in another LNA-21 treated oocyte, and white arrow points to 
an accumulation of red blood cells.   
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5.  Discussion 
 Recent in vitro studies in cultured cancer cells, cancer cell lines, and 
embryonic stem cells suggest that miR-21 expression is important for differentiation 
and apoptosis (Chan et al., 2005; Chen et al., 2008a; Si et al., 2007; Singh et al., 
2008; Zhang et al., 2008b).  Here we show for the first time that miR-21 also plays a 
role in apoptosis in a physiological system.  We show that miR-21 is upregulated in 
granulosa cells in response to LH.  During LH-induced terminal differentiation of the 
granulosa cell, it is necessary to block apoptosis to allow for the formation of a 
functional corpus luteum (Chaffin et al., 2001; Robker and Richards, 1998a, b).  We 
show here that the loss of miR-21 in periovulatory granulosa cells causes an increase 
in apoptosis, and thus may be important for the prevention of apoptosis that occurs 
during luteinization.   
To examine the function of miR-21 in granulosa cells, miR-21 action was 
knocked down in cultured granulosa cells using 2’O-methyl or LNA oligonucleotides. 
Consistent with other investigations using these two different types of inhibitors, we 
observed a greater effect (3-fold) with the LNA oligonucleotide (Marquez and 
McCaffrey, 2008; Orom et al., 2006; Papagiannakopoulos et al., 2008). The increased 
effectiveness in knockdown was associated with the appearance of the apoptotic 
phenotypic response associated with loss of miR-21 in other cell types (Chan et al., 
2005; Si et al., 2007).  One possible explanation for this may be that basal miR-21 
levels are much higher in granulosa cells, compared to cell lines examined by other 
investigators, and the reduction induced by 2’O-methyl oligonucleotides was 
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insufficient to knockdown miR-21 expression to levels that cause apoptosis.  Results 
similar to ours were recently described in glioblastoma cells, in which only the LNA-
21 oligonucleotides caused significant amounts of apoptosis, while the 2’O-methyl 
oligonucleotides had little effect (Papagiannakopoulos et al., 2008).   However, when 
we tested lower doses of LNA-21 at a dose that reached an equivalent (i.e., 9-fold loss 
in miR-21) to the 2’O-methyl, we still detected apoptosis (cleaved caspase 3: Figure 
VII-6).  It presently is unclear why similar levels of knockdown of miR-21 would not 
generate similar phenotypical responses; this is an interesting phenomenon and 
suggests that blocking miRNA action with different oligonucleotides can have 
dramatic differences in biological responses, a finding with important implications to 
the therapeutic potential of miRNA blockers.     
MicroRNA-21 has been shown to block apoptosis in a number of cell types, 
and several targets have been identified as directly regulated by miR-21 to mediate its 
anti-apoptotic activity (Frankel et al., 2008; Hu et al., 2008; Meng et al., 2006; 
Papagiannakopoulos et al., 2008; Thum et al., 2008; Zhu et al., 2007).    Tropomyosin 
1 (TPM1) was the first identified direct miR-21 target transcript (Zhu et al., 2007). 
Post-transcriptional regulation of TPM1 by miR-21 caused a 2-fold increase in TPM1 
protein in breast cancer cells following miR-21 knockdown, no effect on TPM1 
mRNA expression was detected (Zhu et al., 2007). TPM1 an actin-binding protein 
promotes the specialized type of apoptosis known as anoikis, by suppressing 
anchorage-independent growth (Raval et al., 2003).  Phosphatase and tensin homolog 
(PTEN) is another pro-apoptotic protein, which inhibits the AKT and mTOR kinase 
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pathways to cause apoptosis (Tamura et al., 1998). Knockdown of miR-21 in human 
hepatocytes caused a 2 to 3-fold increase in PTEN protein, but no change on PTEN 
mRNA (Meng et al., 2006).  We observed a slight increase in PTEN protein levels at 
4 h post-transfection, however, specific tests of PTEN regulation by blockade of 
PTEN expression, or masking potential miR-21 sites failed to prevent apoptosis.  
Programmed cell death 4 (PDCD4) inhibits global cell translation by inhibiting the 
translation initiation factor 4a (Yang et al., 2003).  Knockdown of miR-21 in human 
breast cancer cells causes an increase in PDCD4 mRNA and protein levels (Frankel et 
al., 2008).  Recently, two factors involved in p53 tumor suppression, the p53-
activator heterogeneous nuclear ribonucleoprotein K (HNRPK) and the p53 
homologue Tap63, were identified as direct miR-21 targets in glioblastoma cells 
(Papagiannakopoulos et al., 2008).  However, knockdown of these proteins in 
combination with miR-21 knockdown failed to rescue the apoptotic phenotype, 
suggesting that other miR-21 targets are involved in glioblastoma apoptosis 
(Papagiannakopoulos et al., 2008).  Maspin, RECK, and Sprouty1 have also been 
indicated to play roles in apoptosis, and all have been identified as direct miR-21 
targets (Thum et al., 2008; Zhu et al., 2007).    
In this work we examined the protein levels of four of these known targets in 
response to miR-21 knockdown in murine granulosa cells, and none showed any 
change (Figure VII-7). Our studies were unable to demonstrate that any of the known 
miR-21 target transcripts were factors in mediating apoptosis in granulosa cells. To 
facilitate the identification of granulosa cell miR-21 target transcripts, we conducted a 
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microarray study. No significant changes in mRNA expression between LNA-NS and 
LNA-21 treated cells were detected; despite the drastic change in cell morphology as 
the cells underwent apoptosis.  Nonetheless, pathway analysis of genes exhibiting a 
nonsignificant 1.5-fold or greater difference indicated that apoptotic genes were over 
represented.  Failure to change mRNA expression indicates that miR-21 is mediating 
its effects primarily through translational regulation and not mRNA degradation.  
This is in agreement with a recent study in MCF-7 breast cancer cells (Yang et al., 
2009b) where knockdown of miR-21 caused changes in protein levels, without 
corresponding changes in mRNA expression. Furthermore, Yang et al. (Yang et al., 
2009b) identified 58 putative miR-21 targets in their proteomic analysis. Examination 
of genes expressed in murine granulosa cells at 0 and 1 h post-hCG (microarray 
analysis see reference (Carletti and Christenson, 2009), indicated that 22 of these 58 
genes are expressed in periovulatory granulosa cells.  Further analysis of these genes 
will be necessary to determine if they are miR-21 target transcripts in ovarian 
granulosa cells.   
During the LH-induced transition of a granulosa cell to a luteal cell, apoptosis 
must be inhibited to allow the formation of a functional corpus luteum.  The cleavage 
of caspase 3 irrevocably commits the cell to apoptosis, and thus measurement of 
cleaved caspase 3 levels provides a measurement of the amount of cell death 
occurring.  We examined levels of cleaved caspase 3 in granulosa cells following LH 
and found that cleaved caspase 3 levels decrease within 6 h of hCG, concurrent with 
an increase in levels of miR-21. In caspase 3 knockout mice, atretic follicles fail to 
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undergo atresia (Matikainen et al., 2001).  To examine the effect of in vivo effect of 
miR-21 in granulosa cells, murine ovaries were injected with LNA-21pt and 
apoptosis was examined. Apoptosis was significantly increased in LNA-21pt treated 
ovaries.  Here, the knockdown of miR-21 may prevent the necessary decrease in 
cleaved caspase 3 levels, thus promoting atresia.  During atresia, granulosa cells 
undergo apoptosis and apoptotic bodies appear in the antral space, and our TUNEL 
assay does show staining within the granulosa and antrum of antral follicles 
(Matikainen et al., 2001; Figure VII-9F).  These follicles may be undergoing atresia 
due to miR-21 knockdown. Further studies are needed to examine the expression of 
miR-21 in healthy and atretic granulosa cells to determine its importance in atresia.  
Unexpectedly, there was a relatively low amount of TUNEL staining within corpus 
luteum of the LNA-21pt injected ovaries.  This may be because the apoptotic cells 
have already been cleared, and non-apoptotic cells (perhaps those that were not 
effectively transfected) remain.  Interestingly, granulosa cells from polycystic ovarian 
syndrome patients show a decrease in the amount of cleaved caspase 3 and an 
increase in anti-apoptotic proteins, perhaps due to high LH levels in these patients 
(Das et al., 2008; Diao et al., 2004).  It would be interesting to examine the 
expression of miR-21 in PCOS and non-PCOS granulosa cells 
Our in vivo expression profiling studies indicate that miR-21 gene expression 
in ovarian granulosa cells is regulated predominantly by increased transcription of the 
pri-miR-21 transcript. The miR-21 promoter is well conserved across a number of 
species and lies within the 10th intron of a protein-coding gene, TMEM49 (Fujita et 
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al., 2008).  While at least one study has suggested that TMEM49 and miR-21 are co-
expressed (Hu et al., 2008), we show here, in agreement with others, that TMEM49 
and miR-21 are expressed independently (Fujita et al., 2008; Wickramasinghe et al., 
2009).  Our results also indicate that in vivo, miR-21 is regulated by the endocrine 
hormones, FSH and LH, in the preovulatory and periovulatory follicular granulosa 
cells, respectively.  Within the first 300 bases of the miR-21 transcription start site, a 
number of known transcription regulatory element binding sites are located (Fujita et 
al., 2008).  Promoter analysis studies indicate that at least 5 regulatory elements (i.e., 
AP-1, Ets/IPU.1, NF1, Stat3, CCAAT/enhancer binding protein) impact miR-21 
expression in HL-60 cells and multiple myeloma cells (Fujita et al., 2008; Loffler et 
al., 2007).  Of these transcription factors, LH is known to upregulate the expression of 
3 of these transcription factors in mural granulosa cells (Carletti and Christenson, 
2009; Sharma and Richards, 2000; Sterneck et al., 1997).  Indeed, both Fos and Jun, 
which interact with AP-1 response elements was shown to be upregulated within 1 h 
of LH/hCG administration (Carletti and Christenson, 2009; Sharma and Richards, 
2000). Distinct AP-1 binding factors, different from those upregulated by LH, are 
induced in response to FSH (2-8 h post-FSH) and may account for FSH-induced 
upregulation of pri-miR-21 at 12 h post-eCG (Sharma and Richards, 2000).  In 
contrast to the positive evidence for a possible AP-1/Fos/Jun regulatory loop, 
evidence for CCAAT/enhancer binding protein site playing a role in miR-21 
expression is lacking, as granulosa cell expression of C/EBPβ is not increased prior to 
pri-miR-21 expression (Sterneck et al., 1997). Moreover, examination of miR-21 
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levels in C/EBPβ KO mice granulosa cells showed no difference in expression 
(Supplementary Figure VII-3).   While expression of mature miR-21 followed that of 
the pri-miR-21 in vivo, our in vitro studies suggested a much more complex 
regulatory mechanism.  
Quantitative RT-PCR analysis of mature miR-21 levels in cultured granulosa 
cells failed to show an increase in response to 8-Br-cAMP treatment.  This was 
unexpected as the other two LH-induced miRNA, miR-132 and miR-212, exhibited 
increased expression in cultured granulosa cells following 8-Br-cAMP treatment 
(Fiedler et al., 2008).  Further examination of in vitro granulosa cell pri-miR-21 and 
mature miR-21 expression indicated that mature levels increased in the absence of a 
change in transcription (i.e., pri-miR-21).  Recently, a similar observation in human 
smooth muscle cells was observed (Davis et al., 2008b).  In these cells, members of 
the transforming growth factor superfamily (BMP4, BMP2, and TGFβ) increased 
expression of the precursor and mature miR-21 transcripts, without affecting pri-miR-
21 expression (Davis et al., 2008b).  The mechanism of action, indicated that the 
ligands activate the signal transducer SMAD, which in turn recruits a RNA helicase 
p68 subunit of the Drosha microprocessor complex to the pri-miR-21, thus 
stimulating the processing of the abundantly present pri-miR-21 transcripts (Davis et 
al., 2008b).   The disconnection of LH activity and granulosa cell function in cultured 
granulosa cells is well known.  A large body of literature in rodents from the early 
1970s describes a phenomena known as “spontaneous luteinization” whereby 
granulosa cells when removed from their follicular environment take on the attributes 
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of luteal cells over a few days in culture (Channing, 1970; Channing and Ledwitz-
Rigby, 1975).  Interestingly, plating of the granulosa cells initiates some of the LH-
mediated molecular events occurring in the follicle after LH, such as increases in 
transcription factors involved in cell survival and cell signaling (Gonzalez-Robayna et 
al., 1999; Murphy, 2000). The phenomena of spontaneous luteinization has never 
fully been explained but is thought to result from a withdrawal of inhibitory signaling 
molecules once cells are dispersed and placed into culture. In these studies we show 
that levels of mature miR-21 increase in the absence of increased transcription. It is 
interesting to speculate that miR-21 levels may be one of several factors that 
contribute to the phenotypic changes occurring in luteinizing granulosa cells.  The 
fact that most cancer cell lines and tumors also exhibit increased levels of miR-21 
may be indicative of their disconnection with factors that normally prevent excessive 
miR-21 accumulation, which is then able to block apoptosis and promote 
oncogenesis.   
In conclusion, this study has demonstrated that miR-21 is transcriptionally 
upregulated in vivo in response to LH, and we show that this upregulation occurs 
synchronously with a decrease in cleaved caspase 3 levels.  In addition, we have 
provided evidence that both in vitro and in vivo miR-21 knockdown causes an 
increase in granulosa cell apoptosis.  These results suggest that miR-21 plays an 
important role in post-transcriptionally regulating transcripts that are involved in 
preventing apoptosis in LH-induced terminally differentiating granulosa cells. 
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6.  Supplemental Data. 
 
Methods 
PTEN Knockdown:  Cultured granulosa cells were transfected with PTEN siRNA 
(20nM, Ambion) or control siRNA (20nM, Ambion) in Lipofectamine 2000 
(Invitrogen)48 h after culture.  24 h after siRNA transfection, cells were transfected 
with LNA-NS or LNA-21 as above.  Cells were collected after 24 h for apoptosis 
analysis (Annexin V, live/dead staining) as above, or collected in cell lysis buffer for 
Western blot analysis. 
PTEN Blockers:  LNA oligonucleotides were designed to span miR-21 binding sites 
in the PTEN 3’UTR and prevent miR-21 binding (see Klein…Goodman 2007).  Two 
blockers were designed to two different miR-21 binding sites; blocker 1:  5’-
cagcccatcctttgttgaaagc-3’, blocker 2:  5’-cagccaatctctcggatgtcca-3’; and a control 
blocker designed to a site within the 3’UTR to which no known miRNA is predicted 
to bind (TargetScan):  control blocker: 5’-ctctagtgggtcctatgcaatc-3’.  Blockers (10nM) 
were transfected into cultured granulosa cells 48 h after culture.   Cells were collected 




FIGURE VII-S1.   PTEN siRNA or PTEN “blockers” do not affect cell viability.  (A) 
Apoptosis assay (Annexin and Live/Dead stain) of granulosa cells (n=3) transfected 
with control or PTEN siRNA alone, or co-transfected with control or PTEN siRNA 
and LNA-NS or LNA-21.  (B) Apoptosis assay (Annexin and Live/Dead stain) of 
granulosa cells (n=3) transfected with a control oligonucleotide or an oligonucleotide 
that blocks either one of the two miR-21 binding sites in the PTEN 3’UTR (blocker 1 
or blocker 2), or co-transfected with both blockers (blocker 1+2).  One-way ANOVA 
was used to determine statistical significance; a,bmeans ± SEM with different 






FIGURE VII-S2.  Fluorescence-tagged LNA-NSpt allows visualization of 
transfection efficiency in bursal-injected ovaries.  Representative fluorescence image 
(n=3) of a mouse ovary treated with fluorescence-tagged LNA-NSpt (A) stained with 
the DNA-binding dye Hoechst.  Negative control TUNEL assay (B; non-working 
enzyme) in LNA-NSpt treated mouse ovary.  Panel C is a 10X magnification of B.  
Neighboring section (D) of the LNA-NSpt treated ovary from A stained with the 
DNA-binding dye Hoechst.  TUNEL assay to detect apoptotic cells in LNA-NS 
treated mouse ovary (E).  Panel F is a 10X magnification of E.  Bar = 500um.   
 170 
 171 
FIGURE VII-S3.  Pri-miR-21 levels increase following hCG in C/EBPβ wildtype 
and knockout mice.   Quantitative RT-PCR of pri-miR-21 in murine granulosa cells 
with eCG alone (0h) or 2, 4, or 8 h following hCG injection in C/EBPβ wildtype 
(WT; black bars) or knockout (KO; white bars) mice.  All qRT-PCR data (n=4) were 
normalized to GAPDH; Two-way ANOVA (C) was used to determine statistical 









VIII.  Chapter Four: 
 
MicroRNA-21 Enhances Global Translation 
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1.  Abstract 
 Ovarian follicular granulosa cells respond to the ovulatory surge of luteinizing 
hormone with  hypertrophy and neovascularization to form the corpus luteum.  The 
rate of growth of the newly formed luteal tissue exceeds that of the most aggressive 
growing tumors, and many of the cellular/molecular events that occur during this 
transition are characteristic of transformed cells.  We recently identified the 
“oncomiR” microRNA-21 (miR-21) as upregulated in mouse granulosa cells during 
luteinization.  To determine the function of miR-21, granulosa cells were cultured in 
the presence of blocking 2’-O-methyl (anti-21) and locked nucleic acid (LNA-21) 
oligonucleotides.  Both anti-21 and LNA-21 increased elongation factor 2 (EF2) 
phosphorylation.  Phosphorylation of EF2 is associated with decreased protein 
synthesis, and 35S incorporation into granulosa cell protein was 3-fold (p<0.05) lower 
in the absence of miR-21.  Additionally, treatment with pre-miR-21 increased global 
translation 2.5-fold (p<0.05) compared to controls.  Since EF2 phosphorylation 
cannot be directly affected by miR-21, Akt/mTOR (upstream modulators of EF2) 
were examined and also shown to be differentially phosphorylated by both 
knockdown and overexpression of miR-21.  Furthermore, phosphorylated EF2 levels 
decreased in vivo following hCG.  These results suggest that miRNA-21 plays a role 
in promoting global translation in granulosa cells following LH.  This increase in 
global translation could play an important role in mediating the hypertrophy that 
occurs during the granulosa to luteal cell transition.   
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2. Introduction  
 Evidence for microRNA (miRNA) involvement in ovarian function has 
recently been described in mice lacking Dicer (Hong et al., 2008; Nagaraja et al., 
2008; Otsuka et al., 2008).  Conditional deletion of Dicer in murine granulosa cells 
using the anti-Mullerian hormone receptor-2 Cre recombinase caused a pronounced 
reduction in ovulation rates, increased incidence of trapped oocytes within luteinized 
follicles, and increased granulosa cell apoptosis (Hong et al., 2008; Nagaraja et al., 
2008).  Additionally, female Dicer hypomorph mice, which have ~20% of normal 
Dicer levels and a global reduction in miRNA expression, are infertile as a result of 
ovarian dysfunction (Otsuka et al., 2008).  Otsuka et al. go on to show that loss of two 
specific miRNA involved in angiogenesis, miR-17-5p and let-7b, contributed to the 
defect in ovarian function, and that replacement was able to partially correct the 
angiogenic defect, but not fertility (Otsuka et al., 2008).  These studies clearly 
implicate Dicer and its enzymatic byproducts, miRNA, within somatic cells of the 
ovary as playing a key role in ovarian function. 
In order to identify the potential miRNA involved in modulating ovarian 
function, our laboratory compared miRNA gene expression using microarrays of 
granulosa cells collected before and 4 h after an ovulatory surge of LH/hCG (Fiedler 
et al., 2008).  We identified three highly upregulated miRNA, miR-21, miR-132 and 
miR-212, and demonstrated in the case of miR-132 and miR-212 that expression was 
inducible by cyclic AMP, the primary transducer of LH action (Fiedler et al., 2008).  
While in vitro knockdown of miR-132 and miR-212 did impact the expression of c-
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terminal binding protein -1 a previously reported target (Vo et al., 2005) it failed to 
dramatically modulate granulosa cell function and/or viability (Fiedler et al., 2008).  
Examination of miR-21 expression in granulosa cells demonstrated a unique 
expression pattern, as in vivo miR-21 expression was clearly regulated at the 
transcriptional level with primary miR-21 levels preceding changes in mature miR-21 
levels (Carletti, 2009), while in vitro, mature miR-21 levels increased in the absence 
of preceding changes in transcription, and did not show a further increase upon cAMP 
stimulation (Carletti, 2009).  Also in contrast to miR-132 and miR-212, knockdown 
of miR-21 in granulosa cells had a dramatic effect on cell viability as evidenced by 
the rapid induction of apoptosis both in vitro and in vivo following treatment with 
locked nucleic acid oligonucleotides complementary to miR-21 (Carletti, 2009).  
Interestingly, comparison of antisense 2’O-methyl (anti-21) and  antisense 
locked nucleic acid (LNA-21) oligonucleotides demonstrated different responses, 
likely due to the level of knockdown achieved with the two approaches (Carletti, 
2009). Treatment of granulosa cells with anti-21 decreased miR-21 levels 9-fold, 
while the more potent LNA-21 reduced miR-21 levels 27-fold and elicited the 
increase in granulosa cell apoptosis (Carletti, 2009).  Knockdown of miR-21 
increases apoptosis in several cancer cell lines, including glioblastoma cell lines 
(Chan et al., 2005), breast cancer MCF-7 cells (Si et al., 2007), gastric cancer cell 
lines (Zhang et al., 2008b), and hepatocellular carcinoma cell lines (Connolly et al., 
2008).  We showed for the first time that miR-21 plays an anti-apoptotic role in a 
physiological system.  Several targets have been identified for miR-21 that explain its 
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anti-apoptotic role, including the pro-apoptotic phosphatase and tensin homologue 
(PTEN), programmed cell death 4 (PDCD4), tropomyosin 1 (TPM1), Sprouty, 
reversion inducing-cystein-rich protein with kazal motifs (RECK), heterogenous 
nuclear ribonucleoprotein K (HNRPK), and tumor protein p63 (Tap63) (Chen et al., 
2008b; Meng et al., 2006; Papagiannakopoulos et al., 2008; Thum et al., 2008; Zhu et 
al., 2007).  Because of the anti-apoptotic role of miR-21, as well as reported 
stimulatory roles on proliferation, hypertrophy, differentiation, and a drastic 
upregulation of mir-21 in virtually every cancer/tumor examined, miR-21 is 
suggested to play an important role in the initiation and progression of cancer.    
  In our previous study, we examined protein expression of known miR-21 
targets in LNA-21 treated cells (PTEN, PDCD4, TPM1, Sprouty (Chen et al., 2008b; 
Meng et al., 2006; Papagiannakopoulos et al., 2008; Thum et al., 2008; Zhu et al., 
2007)) and did not demonstrate any to be significantly changed upon miR-21 
knockdown, indicating that these are not miR-21 targets in granulosa cells.  In 
attempt to identify novel targets of miR-21 that may be responsible for its anti-
apoptotic role, we performed gene expression analysis on cultured granulosa cells 
treated with either a scrambled LNA (LNA-NS) or with LNA-21.  However, there 
were no significant differences in levels of any mRNA (Carletti, 2009).  Recently 
Yang et al. reported that miR-21 appears to act primarily through mRNA translational 
repression, rather than through mRNA degradation, and thus miR-21 knockdown 
does not have a significant effect on mRNA levels of its targets (Yang et al., 2009b).  
In fact, mRNA levels for the miR-21 targets PTEN, TPM1, and PDCD4 did not 
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change in LNA-21 treated cells, while protein levels increased (Asangani et al., 2008; 
Meng et al., 2007; Zhu et al., 2007).  Thus, proteomics analysis is necessary to fully 
understand the effect miR-21 is having on protein expression in the cell.   
Therefore, while our previous studies illustrate that miR-21 is playing an 
essential role in granulosa cell survival, the targets transcripts via which miR-21 acts 
on to prevent apoptosis remains to be determined.  In the study, we have chosen to 
use a direct proteomic approach (i e., two-dimensional gel electrophoresis) to 
elucidate the potential miR-21 target proteins (Zhu et al., 2007).   Interestingly, we 
are able to further our understanding of the function of miR-21 in ovarian granulosa 
cells, and show that miR-21 not only inhibits granulosa cell apoptosis, but also 
regulates global translation within the granulosa cell.   
   
3. Experimental Procedures 
In Vitro Granulosa Cell Culture.  Granulosa cells were cultured as previously 
described (Fiedler et al., 2008).  Briefly, ovaries from 26-day old CF-1 mice were 
isolated and incubated for 15 min in M-199 media containing 0.5M sucrose.  Ovarian 
follicles were punctured into M199 media to release granulosa cells.   Granulosa cells 
were seeded at 2.5x104 cells per well into 6-well culture plates or 1.5x106 cells per 10 
cm culture dish.  Wells and plates were coated with fibronectin before use. Cells were 
cultured in DMEM/F12 (10%FBS, 1% gentamicin) at 37°C with 5% CO2. 
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Oligonucleotide Transfection.  Transfections were performed as previously described 
(Fiedler et al., 2008).  Briefly, control (i.e., nonspecific scrambled; anti-NS) and anti-
miR-21 (anti-21) 2’-O-methyl RNA oligonucleotides were purchased from Ambion 
(Houston, TX).  Control (nonspecific; pre-NS) and pre-miR-21 (pre-21) were also 
purchased from Ambion (Houston, TX).  Locked nucleic acid (LNA) antisense 
molecules were synthesized as mixed LNA/DNA oligonucleotides with the following 
sequences:  LNA-21, 5’-tcagtctgataagcta-3’, and control LNA-NS, 5’-
cgtcagtatgcgaatc-3’  (underlined bases denote the LNA nucleotides) (IDT, Coralville, 
IA).  Oligonucleotides were individually complexed with Lipofectamine 2000 reagent 
(Invitrogen) and added to the isolated granulosa cells 48 h after culture at a final 
concentration of 42 nM.  Cells were transfected for 4, 8, or 24 h for protein analysis, 
or transfected for 8 h for [35S] incorporation analysis.  
Two-Dimensional Gel Electrophoresis.   Following two days of culture, cells were 
plated and transfected as above.  Transfected cells were collected after either 8 h (for 
LNA-NS and LNA-21 treated cells) or 24 h (for anti-NS and anti-21 treated cells) 
into 150 uL cold lysis buffer (Cell Signaling) containing 1mM PMSF, 40uM 
phenylarsine oxide (Sigma), and 10uM calyculin A (Calbiochem).   Protein 
concentration was determined using Bio-Rad protein assay (Hercules, CA).  Protein 
extracts (300ug/treatment) were sent directly to Applied Biomics (Hayward, CA) for 
2-D DIGE and mass spectrometry analysis.  Briefly, protein extract from control cells 
(anti-NS or LNA-NS) was covalently linked to Cy3 and protein extract from treated 
cells (anti-21 or LNA-21) was covalently linked to Cy5.  Labeled proteins were 
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separated on a single 2-dimensional gel, with first dimension isoelectric focusing and 
second dimension SDS-PAGE.  An image of the gel was taken at excitation 
wavelengths of 550nm (Cy3) and 650nm (Cy5) and images were overlayed using 
DeCyder software to find differentially regulated proteins.  Differentially regulated 
proteins were picked and identified by mass spectrometry (MALDI/TOF/TOF). 
 
Immunoblotting.  Granulosa cell protein was collected into lysis buffer as above. 
Protein concentration of granulosa cell lysates was quantified using the Bio-Rad 
protein assay (Hercules, CA).  Five to fifteen ug of each sample was denatured by 
diluting the sample 1:2 with sample buffer (2.8mL distilled water; 1.0mL 0.5M Tris-
HCl, pH6.8; 0.8mL glycerol; 1.6mL 10% SDS; 0.4mL 2-β-mercaptoethanol; 0.4mL 
0.05% (w/v) bromophenol blue) and heating for 5 minutes at 95°C.  The proteins 
were separated on 12% SDS-PAGE gels in 5X electrode running buffer, pH 8.3 
(25mM Tris base; 192mM glycine; 0.1% (w/v) SDS), and transferred to PVDF 
membranes (Millipore, cat# IPVH20200) in transfer buffer (12mM Tris-HCl; 96mM 
glycine; 20% (v/v) MeOH).  Blots were incubated for 1 h at RT in a 5% milk solution 
to block nonspecific binding.  Blots were then incubated overnight at 4°C with one of 
the following antibodies:  EF2 (Cell Signaling #2332), phospho-EF2 (Thr56; Cell 
Signaling #2331), Akt (Cell Signaling #9272), phospho-Akt (Ser473; Cell Signaling 
#9271), TSC1 (Cell Signaling #4906), TSC2 (Cell Signaling #3612), phospho-TSC2 
(Thr1462; Cell Signaling #3611), mTOR (Cell Signaling #2983), phospho-mTOR 
(Ser2448; Cell Signaling #2971), p70S6k (Cell Signaling #9202), phospho-p70S6k 
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(Thr389; Cell Signaling #9206), 4EBP1 (Cell Signaling #9452), phospho-4EBP1 
(Thr37/46; Cell Signaling #9459), PPP2CA (Novus Biologicals NB100-844), and 
actin (Santa Cruz).  After washing and incubation with the appropriate secondary 
antibody, protein-antibody complexes were visualized using West Pico 
Chemiluminescent Substrate (Pierce) following the manufacturer’s protocol. 
Analysis of protein synthesis by [35S] incorporation.  Granulosa cells were cultured as 
above and transfected for 8 h with LNA-NS or LNA-21.  Cells were then washed and 
incubated for 2 h with methionine-free DMEM.  Then, 1mL of the methionine-free 
DMEM was added together with 5 µCi of [35S] methionine (PerkinElmer, Boston) 
and cells incubated for 1 h at 37°C.  Cells were lysed in 1mL lysis buffer, and then 
trichloroacetic acid (TCA) was added to a final concentration of 10% and cells were 
put on ice for 10 min.  Precipitated protein was pelleted by spinning at 12000 x g for 
10 minutes.  TCA was extracted by addition of ether, and then 1M Tris base (pH 8.0) 
was added dropwise.  The solution was placed on the scintillation counter and 
radiolabel was quantified to give the amount of “incorporated” label. 
 
4.  Results and Figures 
Phosphorylation of Elongation Factor 2 is Increased Following Knockdown of 
MicroRNA-21 in Cultured Murine Granulosa Cells.  To identify targets of miR-21, 
protein was collected from cultured granulosa cells transfected with anti-NS or anti-
21 for 24 h.  Isolated protein was labeled with Cy3 (anti-NS) or Cy5 (anti-21) and 
subjected to two-dimensional gel electrophoresis.   Changed proteins were visualized 
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as red or green, indicating upregulated or downregulated proteins, respectively 
(Figure VIII-1).  Three spots were detected as changed between LNA-NS and LNA-
21, and all three spots exhibited the same molecular weight.  Mass spectrometry 
identified all three spots as elongation factor 2. (Figure VIII-1A inset and VIII-1B).  
Elongation factor 2 has two primary phosphorylation sites (Nairn et al., 2001), and 
the two spots upregulated in the anti-21 treated cells (red, Figure VIII-1) correspond 
to an increase in EF2 phosphorylation at these two spots.  One EF2 spot was 
downregulated (green, Figure VIII-1A), the unphosphorylated form of EF2.  Western 
blot analysis confirmed the upregulation in phospho-EF2 in anti-21 cells (Figure 
VIII-1B). 
 Because microRNA cannot directly affect protein phosphorylation. a second 
2-D gel/tandem mass spectrometry analysis at an earlier timepoint (8 h) was 
completed using a more potent (LNA-21) miR-21 inhibitor.  In this analysis a number 
of proteins were identified (Supplemental Table VIII-1) including elongation factor 2. 
Ingenuity pathway analysis (IPA) was used to determine if any of these proteins were 
linked to regulation of EF-2 and apoptosis and, with the exception of  
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FIGURE VIII-1. (A) Two-dimensional gel electrophoresis of fluorescent labeled 
protein from anti-NA (control, Cy3) or anti-21 (Cy5) treated granulosa cells.  
Isoelectric focusing was carried out in pH3-10 and second dimensional separation 
was carried out on 8-14% SDS-PAGE.  Inset is three spots that represent elongation 
factor 2 (EF2).  (B) Top, Western blotting confirming the upregulation of phospho-
EF2 following Anti-21 treatment or, middle, LNA-21 treatment.  Bottom, Western 
blotting indicating that phospho-EF2 is decreased following Pre-21 treatment.  
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Annexin A5, none of the proteins linked to either of these pathways.  Furthermore, 
none of the proteins had recognizable miR-21 target sites in their 3’UTR using 4 
different miRNA prediction algorithms (Supplemental Table VIII-1).  Additionally, 
changes in Annexin A5 could not be validated by Western blot analysis.  Increased 
EF-2 phosphorylation was confirmed following LNA-21 treatment (Figure VIII-1C).  
The differential response was greater in LNA-21 versus antimir-21 treated cells and 
this was correlated with the 3-fold greater reduction in miR-21 levels in the LNA-21 
treated cells (Carletti, 2009).     
Exogenous administration of pre-miR-miR-21 to cultured granulosa cells 
increased mature miR-21 levels 95-fold above basal levels within 24 h after 
transfection (Supplemental Figure VIII-2).   Levels of phospho-EF2 significantly 
decreased upon pre-miR-21 treatment compared to control (pre-NS) transfected cells, 
while total EF2 levels remained unchanged (Figure VIII-1B). 
 In a further attempt to identify targets specific to induction of apoptosis, 
proteins from granulosa cells treated with LNA-21 were compared to antimir-21 
treated cells. Two-dimensional gel electrophoresis identified more than 40 spots, 14 
of these were upregulated in LNA-21 treated cells, and thus would be direct pro-
apoptotic targets of miR-21.  Mass spectrometry identified these proteins 
(Supplemental Table VIII-2), but none of these have been previously linked to 
apoptosis by Ingenuity Pathway Analysis. Elongation factor 2 did not appear on this 




Global translation decreases following knock down of miR-21.  Elongation factor 2 is 
a necessary for translational elongation, and phosphorylation of EF2 inhibits its 
activity by preventing its ability to associate with ribosomes (Carlberg et al., 1990).  
Cultured granulosa cells transfected with LNA-21 for 8 h exhibited a 3-fold decrease 
in the amount of incorporated 35S-methionine compared to the LNA-NS control 
(Figure VIII-2A). Transfection with pre-21 caused a 2.5-fold increase in incorporated 
35S-methionine compared to Pre-NS control (Figure VIII-2B).   
 
MicroRNA-21 knockdown caused deactivation of the Akt/mTOR pathway.  Elongation 
factor 2 is downstream of the Akt and mTOR pathways (Connolly et al., 2006), and 
therefore we explored the activation of these pathways following miR-21 knockdown.  
Both mTOR and Akt are deactivated when dephosphorylated, resulting in 
deactivation (i.e., phosphorylation) of EF2 (Connolly et al., 2006).  Both total and 
phosphorylated Akt levels decreased following miR-21 knockdown (Figure VIII-3).  
TSC2, a direct target of Akt, showed a slight decrease in phosphorylated levels, while 
total levels remained unchanged (Figure VIII-3).  The structural component of the 
TSC complex, TSC1, also was unchanged.  When dephosphorylated, the TSC1/2 
complex inhibits mTOR phosphorylation and activity.  mTOR phosphorylation 
decreased following miR-21 knockdown, while total levels were unchanged (Figure 
VIII-3).  4EBP1 and p70S6kinase are both direct targets of mTOR, and both showed 
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FIGURE VIII-2. Granulosa cells transfected with LNA-21 (A) or pre-21 (B) were 
pulse labeled with 35S methionine for 1 h and incorporated label was detected in TCA 
precipitated protein pellets.  *Means ± SEM are different (p<0.05).   
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FIGURE VIII-3.  Representative western blots (n=3) of proteins (total, left panel, or 




a decrease in phosphorylation following miR-21 knockdown.  Levels of the direct 
activator of EF2, PPP2CA, were not changed (Figure VIII-3).   
Total EF2 levels increase following hCG, and phospho-EF2 levels decrease.  
Previously, we have shown that miR-21 increases within 4 h post-hCG.  Examination 
of phospho-EF2 levels following hCG showed that total EF2 levels increase within 1 
h post-hCG and phospho-EF2 levels decrease by 4 h post-hCG (Figure VIII-4).   
 
5.  Discussion 
Previously we have shown that miR-21 is upregulated following LH and, in 
agreement with others, has anti-apoptotic function.  Here we show for the first time a 
role for miR-21 in promoting global translation. 
MicroRNA-21 is upregulated in a variety of cancers and tumors (for review, 
Krichevsky and Gabriely, 2009).  MicroRNA-21 has been implicated in the inhibition 
of apoptosis and the promotion of cell growth and cell proliferation, and is 
upregulated during ES cell and T cell differentiation (Singh et al., 2008; Wu et al., 
2007).  MicroRNA-21 levels have also been shown to increase during cardiac cell 
hypertrophy, however a mechanism has not been identified (Cheng et al., 2007).  Bon 
a fide targets have been identified for miR-21, including the pro-apoptotic PTEN, 
PDCD4, TPM1, Sprouty, HNRPK, and Tap63 (Chen et al., 2008b; Meng et al., 2006; 
Papagiannakopoulos et al., 2008; Thum et al., 2008; Zhu et al., 2007).  In addition, 
miR-21 expression has been shown to influence several cell signaling pathways, 
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FIGURE VIII-4.  Representative western blots (n=3) of phosphorylated EF2, EF2, 
and control actin after 0, ¼, ½, 1, 2, 4, 6, and 8 h after hCG administration.
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 including the ERK-MAP kinase pathway through inhibition of Sprouty (Thum et al., 
2008), the Akt pathway, perhaps through inhibition of PTEN (Zhang et al., 2009), and 
  Elongation factor 2 promotes the translocation of the newly formed mRNA –
tRNA complex from the A site in the ribosome to the P site (Carlberg et al., 1990; 
Nairn and Palfrey, 1987; Ryazanov et al., 1988).  Phosphorylation of EF2 by EF2 
kinase prevents the ability of EF2 to bind to the ribosome, which almost completely 
halts protein synthesis (Carlberg et al., 1990; Nairn and Palfrey, 1987; Ryazanov et 
al., 1988).  EF2 kinase is activated by mammalian target of rapamycin (mTOR) 
(Browne and Proud, 2004), a large, multidomain kinase that plays a key role in cell 
growth and proliferation, apoptosis, differentiation, and oncogenesis (Hedhli et al., 
2005; Meric-Bernstam and Gonzalez-Angulo, 2009; Schmelzle and Hall, 2000; Tyler 
et al., 2009).  Besides EF2, mTOR also stimulates the translation initiator p70S6 
kinase (p70S6K) and inhibits the translation suppressor 4EBP1 (Ma and Blenis, 
2009).  mTOR is activated by the phosphoinositide 3-kinase  (PI3K) – Akt pathway 
(Sekulic et al., 2000), which inhibits an inhibitor of mTOR, the tumor suppressor 
complex TSC1/2 (Potter et al., 2002).    Here we show that miR-21 regulates the 
activation of the Akt/mTOR pathway, as all members of the pathway examined 
demonstrate a change in phosphorylation/activity following miR-21 knockdown 
(Figure VIII-5).   
 Interestingly, while only the phosphorylation statuses of most of the proteins 
in the Akt/mTOR pathway were affected by miR-21 knockdown, and not their total 
levels.  However, total levels of Akt were reduced.  Several possibilities can explain 
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this decrease.  First, Akt mRNA could be a direct target of miR-21.  However, 
bioinformatics analysis of the Akt 3’UTR does not indicate any miR-21 binding sites.  
In addition, the decline in Akt levels following miR-21 knockdown would suggest 
that miR-21 is acting by enhancing Akt levels, and while this phenomenon has been 
described, it does not appear to be a common miRNA mechanism.  It is possible, 
however, that miR-21 targets and down regulates a transcriptional repressor of Akt.  
In fact, a predicted transcriptional repressor of Akt, estrogen receptor alpha, has fairly 
conserved miR-21 binding sites in its 3’UTR (Miranda et al., 2006).  Another 
possibility is that Akt levels are reduced due to the suppression of global translation 
caused by miR-21 knockdown.  Akt has a short half life (~180 minutes; (Baker et al., 
2005)), and thus the change in translation could have a more rapid effect on Akt 
protein levels compared to the protein levels of proteins with longer half lives, such 
as mTOR, which has a half life of 18 h (Polak and Hall, 2009).  Studies are ongoing 
to examine the protein expression levels of other short-half life proteins.   
 Previously we have shown that miR-21 knockdown induces apoptosis in 
periovulatory granulosa cells through a novel mechanism (Carletti, 2009).  Akt 
activity is necessary for cell survival (Datta et al., 1999), and thus the downregulation 
of Akt induced by miR-21 knockdown could cause the observed increase in 
apoptosis.   
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FIGURE VIII-5.  Model of miR-21 action on the Akt/mTOR pathway.  Akt, mTOR, 
and p70S6k are activated by phosphorylation (gray circles), and the others are 
inactivated by phosphorylation (red circles).  
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6.  Supplemental Data 
 
TABLE VIII-S1.  Proteins Changed between LNA-NS and LNA-21 transfected cells 
(8 h) as determined by two-dimensional gel electrophoresis and mass spectrometry.  
The 3’UTR for changed proteins was analyzed using four different bioinformatic 
tools for predicted miR-21 binding sites.  
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TABLE VIII-S2.  Proteins Changed between LNA-21 and ANTI-21 transfected cells 






Tandem MSMS Predicted Protein 
 
Fold Change (Anti-21/LNA-21) 
Stathmin 1 1.39 
Destrin 1.25 
Ferritin Light Chain 1 -1.86 
Alpha Isoform of Regulatory Subunit 
A, Protein Phosphatase 2 
-1.95 
Guanosine Disphosphate (GDP) 
Dissociation Inhibitor 1 
-2.17 
Apolipoprotein A-1 -2.34 
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FIGURE VIII-S1.  Addition of exogenous pre-miR-21 increases mature miR-21 










IX.  Chapter Five: 
 
MicroRNA in the Ovary and Female Reproductive Tract 
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1.  Introduction 
 The ability to enhance reproductive efficiency or inhibit reproductive activity 
is dependent upon a solid understanding of reproductive physiology.  In the female, 
reproductive success relies on the coordinated actions of the hypothalamic- pituitary-
gonadal axis and its regulation of the cervical, uterine, and oviductal tissues.   The 
reproductive tract responds to the cyclical changes in pituitary and ovarian hormones 
to provide an optimal environment for gamete transport and development, a suitable 
site for implantation and pregnancy, and protection against pathogens.  Whereas 
much is known about the effect the pituitary and gonadal hormones have on 
reproductive function, there still remain many unanswered questions concerning the 
molecular mechanisms related to how these hormones elicit their action(s).  The past 
forty years have shed considerable light on transcriptional gene regulation and 
cellular signaling pathways within reproductive tissues.  However, much less is 
known about post-transcriptional gene regulation in these tissues, even though it plays 
an essential role in the synthesis of all proteins and is known to be important in the 
general regulation of cell differentiation and proliferation.  Post-transcriptional gene 
regulation includes the splicing, editing, transport, storage, turnover, and translation 
of mRNA, and can result in a difference in expression levels between the 
transcriptome (mRNA) and the proteome (proteins) of the cell (Glisovic et al., 2008; 
Gygi et al., 1999; Ideker et al., 2001). All mRNA transcripts pass through some type 
of post-transcriptional processing, and although some post-transcriptional gene 
regulation may be considered almost constitutive in manner, other forms are 
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dynamically regulated (Hammarskjold, 2001; Medina et al., 2008). Therefore, it is 
easy to envision that post-transcriptional gene regulation may be important for 
coordinating the changes in gene expression that are necessary for the rapid 
phenotypic changes that occur in the reproductive tract of cycling and pregnant 
females.   
In the female reproductive system several examples of post-transcriptional 
gene regulation have been shown to be involved in gonadal and reproductive tract 
function.  In ovarian granulosa cells, degradation of the LH receptor transcript is 
increased after the LH surge, and this is mediated by mevalonate kinase, an enzyme 
in the cholesterol biosynthetic pathway, that also acts as an RNA binding protein 
(Wang and Menon, 2005). Connexin43, a major component of granulosa cell and 
oocyte gap junctions, is also translationally repressed in granulosa cells after the LH 
surge, although the mechanism(s) that mediates this repression has not been identified 
(Kalma et al., 2004).  Additionally, in the ovine uterus, estrogen treatment caused the 
RNA-binding protein AUF1p45 to stabilize the expression of estrogen receptor α (Ing 
et al., 2008).  Because of the difficulties in examining post-transcriptional gene 
regulation, few examples exist in reproductive tissues; however, the large numbers of 
expressed RNA-binding proteins and now microRNA (miRNA) suggests this form of 
gene regulation may play an important role in reproductive tissues (Berezikov et al., 
2006; Keene, 2001).  
The recent identification of miRNA as important post-transcriptional gene 
regulators has led to an explosion in our knowledge of the role post-transcriptional 
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gene regulation plays in organ function.  MicroRNA are ~21nt RNA molecules that 
bind to the 3’UTR of target mRNA to affect their translation. It is predicted that 1-5% 
of genes encode for miRNA, and they regulate the expression of as many as 30% of 
mRNA (Berezikov et al., 2005; Lewis et al., 2005).  Thousands of miRNA have now 
been identified in a multitude of organisms (microRNA.sanger.ac.uk/).  However, the 
functional importance of individual miRNA and the identity of their specific mRNA 
targets are just now beginning to be elucidated in rodents and human cell lines.  It 
remains to be determined if the function of miRNA is conserved across species in the 
same manner as protein-encoding genes.  MicroRNA have been shown to be 
important in many biological processes, including cell proliferation, differentiation, 
and apoptosis (Asangani et al., 2008; Cloonan et al., 2008; Silber et al., 2008).  
Because miRNA have been demonstrated to be important in other developmental and 
differentiation systems, we propose that miRNA also play a vital role in the 
development and function of reproductive tissues.  In this review we will discuss the 
current findings that support this hypothesis for the uterus, oviduct, ovary, and 
oocyte/early embryo and how the dysregulation of miRNA may lead to reproductive 
disease. 
 
2.  MicroRNA Biogenesis and Function 
MicroRNA genes reside between genes (i.e., intergenic) and within introns of 
genes, and in a few cases reside within exons or makeup the entire intron (i.e., 
mirtrons; Berezikov et al., 2007; Saini et al., 2007).  As a result miRNA can be 
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transcribed either independently (intergenic and intronic) or in succession with a 
mRNA if they reside within an intron or exon.  The initial long primary RNA 
transcript (pri-miRNA; Figure IX-1) is capped (methyl-7-GpppG) and 
polyadenylated, and thus transcription most likely is mediated by polymerase II or III 
(Cai et al., 2004).  Within the nucleus, the pri-miRNA is bound by the RNA-binding 
protein DGCR8 (DiGeorge syndrome critical region 8) and cleaved by the RNase III 
enzyme Drosha to form an ~70nt stem-loop pre-miRNA (Figure 1).  Following export 
from the nucleus by exportin 5, the pre-miRNA is further cleaved by a second RNase 
III enzyme, Dicer, to form a transient ~21nt RNA duplex.  One strand of the duplex is 
preferentially loaded onto the RNA-induced silencing complex (RISC), a large 
protein complex composed of Dicer, TRBP (TAR RNA-binding protein), and one of 
several different Argonaute proteins (Hutvagner and Simard, 2008).  Within RISC the 
miRNA binds to the 3’ untranslated region (UTR) of the target mRNA transcript with 
almost exact target specificity between the 5’ end of the miRNA and the mRNA, a 7-
8 nucleotide region called the ‘seed sequence’.  Usually, this binding blocks 
translation through RISC interaction with eIF6, which prevents assembly of 80S 
ribosomes (Chendrimada et al., 2007), or through inhibition of translation after 
initiation (Jackson and Standart, 2007).  However, recent reports have also indicated 
that a change in the particular Argonaute protein within RISC can cause a shift from 
translational inhibition to translational enhancement (Vasudevan et al., 2007).  Other 
reports have also suggested that miRNA, with or without perfect sequence 
complementarity, can cause an increase in mRNA degradation by endonucleolytic  
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FIGURE IX-1.  Working model of miRNA biogenesis and function.  Within the 
nucleus, microRNA (miRNA) are transcribed by RNA polymerase II (Pol-II) into 
single strand RNA which folds into a double stranded primary miRNA (pri-miRNA). 
Pri-miRNA are subsequently bound in the cell nucleus by DiGeorge syndrome 
critical region 8 (DGCR8) and then cleaved by Drosha yielding the precursor pre-
miRNA.  Pre-miRNA are then transported from the nucleus via exportin-5 (Exp5) to 
the cytoplasm where they are further cleaved by the RNAse III endonuclease Dicer 
into a double-stranded miRNA duplex.  The double stranded miRNA separates into 
two single strands with one being degraded and the other strand forming a complex 
with the Argonaute proteins (Ago), forming the RNA-inducing silencing complex 
(RISC).  The RISC then binds to target mRNA leading to either translational 




cleavage or deadenylation, respectively (Jackson and Standart, 2007).  Therefore, 
miRNA have been shown to affect post-transcriptional gene regulation in one of three 
ways:  translational inhibition, translational enhancement, and mRNA degradation.  
Reproductive tissues may use all of these mechanisms or just one; future experiments 
will enhance our understanding of miRNA mediated post-transcriptional regulation in 
these tissues. 
Presently, the role of miRNA in reproductive tissues is primarily investigated 
using four different methods: 1) knocking down global miRNA expression by 
creating tissue specific conditional Dicer1 knockout mice [complete deletion of 
Dicer1 is embryonic lethal (Bernstein et al., 2003)]; 2) identifying miRNA expression 
profiles within cells and tissues using cloning and microarray analyses; 3) 
investigating specific miRNA function through the use of complementary 2’O-methyl 
or locked nucleic acid (LNA) oligonucleotide inhibitors; and 4) identifying specific 
individual miRNA using a candidate gene approach, in which genes are individually 
analyzed for regulation by miRNA.  In this review we will discuss the reproductive 
tissue miRNA profiles that have been completed and what has been discovered about 
the role miRNA play in reproductive tissues through the use of conditional Dicer 
mutants and candidate gene approaches. 
 
3.  MicroRNA in the Ovary 
 Recruitment of growing follicles, atresia, ovulation, luteal tissue formation 
and regression are dynamically regulated events that reoccur on a cyclical basis 
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within the ovary.  Few tissues exhibit the ephemeral lifecycle seen in follicular and 
luteal tissues within the adult, making this system very unique.  These events involve 
dramatic changes in cellular growth, angiogenesis, steroidogenesis, cell cycle status, 
and apoptosis, and are tightly regulated at the endocrine and tissue level.  Defects in 
regulatory control can lead to ovarian failure due to disruption of folliculogenesis, 
block of ovulation, and corpus luteum insufficiency, etc. Although the transcriptional 
regulation of ovulation and luteinization has been well studied, it stands to reason that 
post-transcriptional gene regulation may be critical for reproductive tissue function. 
Understanding the molecular events, including the role of miRNA in post-
transcriptional gene regulation, that occur during these transitory periods might 
provide insight into how we might be able to enhance reproductive efficiencies and 
alleviate deficiencies. 
Recently, Otsuka and coworkers, demonstrated that the Dicer1 hypomorph 
(Dicer1d/d; ~75% loss of Dicer1 mRNA levels) mouse, developed using a gene trap 
method, exhibited female infertility (Otsuka et al., 2007; Otsuka et al., 2008).  
Transplantation of wild type ovaries into Dicer1d/d females resulted in offspring, but 
wild type females transplanted with Dicer1d/d ovaries failed to establish pregnancies, 
indicating that the fertility defect was inherent to the ovary. Further characterization 
of Dicer1d/d mice indicated that ovulation occurred normally and that the ovulated 
eggs were fertilized and underwent the first embryonic cell division.  In contrast, 
serum progesterone levels and expression of LH receptor, cytochrome p450 11a1 
(Cyp11a1), and prolactin receptor, genes necessary for progesterone production and 
 213 
corpus luteum formation/maintenance, were all decreased in Dicer1d/d mice.  Proper 
corpus luteum function requires a dramatic increase in vasculature, and miRNA have 
previously been shown to be important for angiogenesis in embryonic development 
(Yang et al., 2005).  Therefore, Otsuka et al. (2008) examined vasculature in these 
Dicer1d/d mice and found a decrease in both the number and the length of the blood 
vessels in the corpus luteum and correlated this with the upregulation of anti-
angiogenic factors, Timp1 and platelet factor 4, in Dicer1d/d mice.  MicroRNA-17-5p 
and let-7p were found to regulate Timp1 expression and loss of these in Dicer1d/d 
mice were predicted to cause the reduction in angiogenesis.  Knockdown of these two 
miRNA in wild type mice impaired corpus luteum angiogenesis and decreased serum 
progesterone levels.  Furthermore, injection of miR-17-5p and let-7p into the ovarian 
bursa of Dicer1d/d mice restored the vasculature within the corpora lutea and 
increased progesterone levels, but failed to maintain pregnancy, indicating that other 
miRNA might still be involved (Yang et al., 2005). 
 Our laboratory mated the anti-Mullerian hormone receptor, type 2 (Amhr2)-
Cre mouse (Jamin et al., 2002) with a mouse homozygous for locus of crossover in 
P1 (loxP) insertions surrounding the second RNase III domain of Dicer1 (Harfe et al., 
2005).  This selectively knocked out Dicer1 expression in Mullerian duct derivatives 
(the oviduct, uterus, and cervix) and in the granulosa cells of secondary and small 
antral follicles (Hong et al., 2008).  The female Dicer1fl/fl;Amhr2Cre/+ mice were 
infertile as evidenced by failure to deliver offspring over a 5 month period, but the 
male mice were able to sire offspring (Hong et al., 2008).  Dicer1fl/fl;Amhr2Cre/+ 
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female mice mated normally and had normal estrous cycles, but exhibited a reduced 
ovulation rate (10.7 ± 0.9 and 7.0 ± 1.1, for the wild type and Dicer1fl/fl;Amhr2Cre/+ 
mice, respectively).  This effect was not due to a disruption in the secretion of 
hormones, as the reduced ovulation rate was also observed in gonadotropin-
stimulated immature mice (16.2 ± 1.4 and 3.7 ± 1.5, for the wild type and 
Dicer1fl/fl;Amhr2Cre/+ mice, respectively).  Moreover, these Dicer1fl/fl;Amhr2Cre/+ mice 
had reduced ovarian weights compared to wild type controls (Hong et al., 2008). 
Ovulated oocytes from Dicer1fl/fl;Amhr2Cre/+ mice collected at d1 post-coitus 
underwent in vitro embryonic development that mirrored that observed in the wild 
type mice (Hong et al., 2008).  These results suggest the loss of Dicer1 expression 
impacts ovarian function, however, since these mice were still able to ovulate 
competent oocytes, the ovarian loss of Dicer1/miRNA does not explain the infertility 
seen in these mice. 
 To examine the importance of miRNA within the ovary, four studies have 
examined ovarian miRNA expression using several different methodologies and 
experimental paradigms (Choi et al., 2007; Fiedler et al., 2008; Kim et al., 2006; Ro 
et al., 2007).  Choi et al. (2007) examined the expression of miRNA in the newborn 
mouse ovary, and further examined the effect that knocking down newborn ovary of 
homeobox gene (Nobox), a transcription factor necessary for oocyte differentiation 
and survival, had on miRNA expression (Choi et al., 2007).  They identified 177 
miRNA in the newborn ovary and found that 4 were decreased ~2-fold in the Nobox-/- 
ovaries (Choi et al., 2007).  In 2006, a computational analysis of the pig genome 
 215 
identified 58 miRNA, and northern blot analysis confirmed the expression of two of 
these miRNA (i.e., miR-31 and miR-92) within the porcine ovary (Kim et al., 2006).  
Ro et al used a cloning technique to identify miRNA expressed in the ovaries of 2-
wk-old and adult mice (Ro et al., 2007).  Combined, they identified 122 miRNA from 
whole ovaries of the immature and mature mice.  Because whole ovarian tissue was 
used and the stage of the estrous cycle of the adult ovaries was unknown, the 
usefulness of this data set is limited. 
To examine somatic cell miRNA expression and test whether LH can regulate 
miRNA expression, we performed a microRNA microarray on mouse granulosa cells 
before (0h) and 4h after hCG (Fiedler et al., 2008).  We identified 196 and 206 
miRNA as detectable before and 4h after hCG respectively, with 31 miRNA showing 
high abundance, 64 intermediate abundance, and 117 low abundance.  Of the total 
212 miRNA detected, only thirteen miRNA were differentially expressed between 0h 
and 4h post-hCG, with 3 upregulated and 10 downregulated (p<0.05; Fiedler et al., 
2008).  Among the upregulated miRNA were miR-132 and miR-212.  MicroRNA-
132 has previously been shown to be transcriptionally regulated by cAMP in neuronal 
cells (Vo et al., 2005), and to post-transcriptionally regulate the expression of several 
different genes (Klein et al., 2007).  Included among the miR-132 targets was the 
transcriptional co-repressor C-terminal binding protein (CtBP1; Klein et al., 2007).  
Interestingly, CtBP1 in conjunction with steroidogenic factor-1, was recently shown 
to regulate adrenal steroidogenesis (Dammer and Sewer, 2008).  We demonstrated 
that cultured granulosa cells respond to cAMP with an increase in miR-132 and miR-
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212 levels, and that LNA oligonucleotide knockdown of miR-132 and miR-212 
caused an increase in CtBP1 protein levels, suggesting that these miRNA post-
transcriptionally regulate CtBP1 expression in granulosa cells (Fiedler et al., 2008).    
These early experiments demonstrate a role for miRNA in ovarian function and, 
furthermore, several miRNA have been identified and their role in ovarian function is 
currently under investigation. 
 
4.  MicroRNA in the Oviduct  
 The oviduct is responsible for the transport and protection of the oocyte and 
embryo during fertilization and early development, respectively.  The cells 
surrounding the oviductal lumen are either secretory cells, which secrete proteins to 
maintain the embryo in a healthy environment, or ciliated cells, which shuttle the 
oocyte/embryo towards the uterus.  High levels of estrogen increase the activity of 
both of these cells, and the subsequent high levels of progesterone decrease their 
activity.  Therefore, like the ovary, the oviduct undergoes cyclic phenotypic changes, 
and thus miRNA may be important for these changes as well. 
 Presently, expression of miRNA within the oviduct has not been reported.  
However, our gross morphological analysis of the Dicer1fl/fl;Amhr2Cre/+ mouse 
oviduct demonstrated that it was less than half the normal length and diameter of wild 
type females (Hong et al., 2008; Figure IX-2).  Histological examination indicated a 
reduced or absent smooth muscle layer in the isthmus portion of the oviduct, which 
was likely associated with the transparent and fragile nature of this tissue (Hong et al.,  
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FIGURE IX-2.  Wild type (top) and Dicer1fl/fl;Amhr2Cre/+ (bottom) oviducts and 
ovaries and from immature age-matched mice.  The Dicer1fl/fl;Amhr2Cre/+ oviducts are 
approximately one-third the length of the wild type and note the transparency of this 
tissue compared to the wild type particularly in the isthmus region due to a 




2008). Additionally, embryos maintained within the oviduct of the 
Dicerfl/fl;Amhr2Cre/+ mouse through day 3 (d3) and d4 of pregnancy, exhibited delayed 
development and increased fragmentation and degeneration.  Furthermore, on d4 of 
pregnancy, when embryos within wild type females had all traversed through the 
utero-tubal junction to reside in the uterus, none of the embryos in the 
Dicer1fl/fl;Amhr2Cre/+ mice had (Hong et al., 2008).  Indeed, it appears that the failure 
of oviductal support and transport is the primary cause of infertility in these mice 
(Hong et al., 2008). 
The truncated oviductal phenotype has similarities with changes seen in the β-
catenin and wingless-type MMTV integration site family 7a (Wnt7a) knockout mice 
(Arango et al., 2005; Deutscher and Hung-Chang Yao, 2007; Miller and Sassoon, 
1998).  Interestingly, β-catenin protein levels were reduced in the oviducts of 
Dicerfl/fl;Amhr2Cre/+ mice (Hong et al., 2008), suggesting that Dicer1 and the resulting 
miRNA may be involved in the expression of members of the Wnt signaling pathway. 
 
5.  MicroRNA in the Uterus 
 Like the ovary and oviduct, the uterus undergoes drastic changes throughout 
the menstrual/estrous cycle.  The uterus transitions from a highly proliferative state 
that is nonreceptive to blastocyst implantation when estrogen is high, to a highly 
secretory state that is receptive to blastocyst implantation when progesterone is high.  
A global analysis of miRNA expressed both in the uterus and ovary suggests that the 
miRNA profiles of the two are very similar, indicating that similar mechanisms may 
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be in place to regulate these cyclic changes (Shingara et al., 2005).  The identification 
of miRNA expressed in the uterus, and the functional analysis of individual expressed 
miRNA, has shed light onto the physiological changes that occur in the uterus in 
response to steroids and pregnancy. 
 Similar to the effects deletion of Dicer1 had on the oviduct, we observed that 
the Dicer1fl/fl;Amhr2Cre/+ mouse uterus was less than half the normal length and 
diameter of wild type females.  In addition, the Dicer1fl/fl;Amhr2Cre/+ uterus was one-
third the weight of wild type uteri (Hong et al., 2008).  Histology indicated a reduced 
smooth muscle layer and reduced presence of uterine glands (Hong et al., 2008).  
Presently, it is unknown whether the uteri of these mice are capable of establishing 
and maintaining a pregnancy.   
 To examine whether estrogen affects uterine miRNA expression, Nothnick 
treated ovariectomized mice with estradiol 17-β or vehicle (control), and performed 
miRNA microarrays on whole uterine tissue (Nothnick, 2008).  One-hundred and 
twenty-three miRNA were expressed within the uterus, with 30 miRNA upregulated 
and 19 miRNA downregulated after estradiol treatment.  One of the downregulated 
miRNA, miR-705, was predicted to target matrix metalloproteinase-9 (MMP-9) 
mRNA.  Prior to estrogen treatment, MMP-9 protein expression was low but its 
mRNA expression was high, and following estradiol treatment these expression 
profiles were inversed. Therefore, a model was proposed in which prior to estradiol 
treatment miR-705 is highly expressed, resulting in the translational repression of 
MMP-9, and following estrogen treatment miR-705 levels fall so MMP-9 can be 
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translated (Nothnick, 2008). 
 Two studies have examined the expression of miRNA in the uterus in 
response to embryo implantation.  In the first study, a miRNA microarray was 
performed on uteri from d1 pregnant mice, during which the uterus is pre-receptive to 
embryo implantation because estrogen is high, versus uteri from d4 pregnant mice, 
during which the uterus is receptive to embryo implantation because progesterone is 
high (Chakrabarty et al., 2007).  Two miRNA upregulated in the receptive stage, 
miR-101a and miR-199a*, are regulators of prostaglandin-endoperoxide synthase 2 
(Ptgs2).  The expression of Ptgs2 in the uterine luminal epithelium is necessary for 
embryo implantation.  Thus, miR-101a and miR-199a* may play a role in tightly 
regulating Ptgs2 expression at the site of embryo implantation, thereby preventing 
unnecessary growth elsewhere in the uterus.  Furthermore, Ptgs2 expression is 
necessary for decidualization of the uterine stromal cells, and the expression profiles 
of miR-101a and Ptgs2 are inversely correlated during decidualization.  Therefore, 
miR-101a and miR-199a are likely important regulators of Ptgs2 during embryo 
implantation and the concurrent decidualization (Chakrabarty et al., 2007). 
The second study directly examined the expression of miRNA at implantation 
sites by performing miRNA microarrays on implantation sites versus non-
implantation sites in the mouse uterus (Hu et al., 2008).  Thirteen miRNA were 
identified as upregulated in the implantation sites, and two downregulated.  
Interestingly, Northern blot analysis indicated that only the precursor forms of two 
miRNA, miR-290-5p and miR-292-5p, were upregulated, even though the mature 
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forms were not changed.  Recent evidence suggests that miRNA themselves can be 
post-transcriptionally regulated (Davis et al., 2008), and these two transcripts may be 
being stored for later use during placenta development.  Additionally, a miRNA 
previously shown to be involved in cellular proliferation and differentiation, miR-21, 
was upregulated in the implantation sites, with high expression in the sub-luminal 
stroma around the blastocyst (Hu et al., 2008).  MicroRNA-21 was not expressed on 
d1-4 of pregnancy, but was upregulated on d5 of pregnancy only at the implantation 
site, and then was high at d6-8 in the decidua.  MicroRNA-21 was not expressed 
during pseudopregnancy, so its expression was dependent on the presence of the 
embryo. Within these implantation sites, miR-21 was shown to target the Reck 
transcript for degradation.  Reck inhibits MMP-2 and MMP-9 secretion and/or 
activity (Nothnick, 2008).  In the inter-implantation sties, when miR-21 was low, 
Reck was high; and in implantation sites, when miR-21 was high, Reck was low, thus 
allowing for active MMP.  The authors speculate that this allows for the breakdown 
of the extracellular matrix and the angiogenesis necessary for placenta development.  
Interestingly, miR-21 has binding sites for signal transducer and activator of 
transcription 3 (STAT3) in its promoter that have been shown to enhance miR-21 
transcription (Loffler et al., 2007).  Leukemia inhibitor factor (Lif) is necessary for 
embryo implantation, and Lif causes STAT3 to be activated and translocated to the 
nucleus in mouse uterine epithelium (Cheng et al., 2001).  As the authors point out, 
future studies may reveal that the expression of miR-21 in the implantation sites is 
mediated by Lif expression.  Future studies may also identify other potential targets 
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of miR-21 during embryo implantation and placental development. 
 
6.  MicroRNA in the Oocyte and Fertilized Egg 
 When the oocyte is growing and arrested in prophase I of meiosis, it is 
transcriptionally active and accumulates and stores a number of transcripts for later 
use.  However, after the LH surge as oocyte maturation is initiated, transcriptional 
activity decreases to barely detectable levels (Kinloch et al., 1993; Paynton et al., 
1988).  Therefore, the precisely timed events of oocyte maturation and early 
embryogenesis rely on post-transcriptional and post-translational regulation of 
maternal RNA transcripts and proteins.  Stored RNA transcripts are recruited for 
translation in response to specific physiological cues (Eichenlaub-Ritter and Peschke, 
2002).  For example, the mRNA of maturation promoting factor is recruited to the 
polysome in response to LH, and plays an initiating and necessary role in the process 
of meiotic maturation (Dekel, 2005).  Recent evidence suggests that miRNA may 
play a role in translationally repressing these stored mRNA until they are needed. 
 Dicer1 was shown to be highly expressed in oocytes, with the highest 
expression in the transcriptionally repressed germinal vesicle oocyte (Cui et al., 2007; 
Murchison et al., 2007).  Dicer1 expression progressively decreased during oocyte 
maturation and fertilization, with the largest decrease at the two-cell stage when 
maternal transcripts are globally degraded (Cui et al., 2007; Murchison et al., 2007).  
The importance of miRNA to the oocyte has been demonstrated through the use of 
oocyte-specific Dicer1 knockout mice (Murchison et al., 2007; Tang et al., 2007).  
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These Dicer1-/- mice are infertile, although their ovaries are histologically normal and 
responsive to gonadotropins.  The germinal vesicle oocytes are also normal, so 
oocyte-expressed Dicer1 does not appear necessary for oocyte development and 
ovarian function.  However, further examination revealed that in 90% of the Dicer1-/- 
oocytes the spindles were misaligned and disorganized, resulting in a loss of meiotic 
maturation and polar body production (Murchison et al., 2007; Tang et al., 2007).  
Microarray analysis of these Dicer1-/- oocytes indicated that 861 mRNA were 
upregulated >2-fold, and 173 of these were previously shown to be degraded during 
meiotic maturation (Murchison et al., 2007).  Therefore, the maintenance of these 
transcripts could be responsible for the defects seen in chromosomal segregation and 
meiotic maturation.   
 Oocyte-sperm fusion causes oocyte activation, which results in a further 
decrease in transcription (Ram and Schultz, 1993).  Therefore, the resumption of 
meiosis and the cytoplasmic events that occur during the activation are based on post-
transcriptional regulation.  In the mouse, transcription does not resume until the late 
one-cell stage, 12 h later (Ram and Schultz, 1993).  The first indication that miRNA 
were important during the fertilization and early embryogenesis events came in 
zebrafish, with the discovery that miR-430 binds to over 300 maternal transcripts to 
cause their down regulation directly prior to the start of embryonic transcription 
(Giraldez et al., 2006).  In the human, sperm were shown to transfer their RNA to the 
oocyte (Ostermeier et al., 2004), and an appealing hypothesis is that sperm-borne 
miRNA are responsible for the downregulation of maternal transcripts, this 
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hypothesis was tested in the mouse (Amanai et al., 2006).  Since only the nuclear and 
perinuclear structures of the sperm enter the oocyte, these structures were subjected to 
miRNA microarray analysis, and 54 miRNA were consistently found to be present.  
This miRNA profile was compared to that of recently fertilized eggs and unfertilized 
eggs.  All 54 of the sperm miRNA were present in the unfertilized egg, suggesting 
that the sperm does not make a meaningful contribution to the oocyte.  To further 
show that sperm borne miRNA are not important to the process, they treated sperm 
with 2’O-methyl oligonucleotide inhibitors complementary to each of the five 
miRNA and saw no effect on fertilization or early embryogenesis (Amanai et al., 
2006).  However, the microarray used in this study only had 238 probes, 
corresponding to 238 miRNA, so more recently identified miRNA may still play an 
important role in the process. 
 Finally, two studies have examined the expression of miRNA in the early 
embryo, one in the murine embryo and one in the bovine embryo.  Tang et al. used a 
real-time PCR-based miRNA expression profile method to identify the miRNA 
expression profiles of the murine oocyte, one-cell zygote, two-cell embryo, four-cell 
embryo, and eight-cell embryo (Tang et al., 2007).  Interestingly, between the one-
cell and two-cell stage there was a 60% decrease in miRNA expression levels, 
indicating that miRNA may be degraded as the maternal mRNA are.  However, 
between the two-cell and four-cell stage, as embryonic transcription proceeds, 
miRNA-expression increases ~2.2-fold.  Among the first miRNA to be transcribed 
are those from the miR-290 cluster, which have previously been shown to play a role 
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on DNA methylation and telomere-length homestasis (Benetti et al., 2008; Tang et 
al., 2007).  Coutinho et al. examined miRNA expression in d30 bovine embryos 
(Coutinho et al., 2007).  Included among miRNA specifically expressed in the 
embryo (compared to the thymus, small intestine, mesenteric lymph node, and 
abomasums lymph node) were miR-122a and miR-199a* (Coutinho et al., 2007).  
MicroRNA-122a has previously been shown to target cyclin G1 (Gramantieri et al., 
2007), and miR-199a* has previously been shown to be pro-apoptotic by targeting the 
Met proto-oncogene, resulting in decreased extracellular signal-regulated kinase 2 
(ERK2) levels (Kim et al., 2008).  Due to the remarkable events occurring during 
early embryonic development, it is likely that miRNA mediated post-transcriptional 
gene regulation may play a greater role in gene expression in those developing tissues 
than that  seen in adult tissues (Blakaj and Lin, 2008). 
 
7.  MicroRNA in Reproductive Disease 
 Since miRNA play such a vital role in cell differentiation events, it is easy to 
envision how the dysregulation of miRNA expression could lead to a disease state.  
MicroRNA have been demonstrated to be important in multiple types of cancer 
including ovarian, endometrial, and cervical; as well as non-malignant pathologies, 
such as uterine fibroids and endometriosis.  In fact, miRNA have arguably been more 
thoroughly studied in the disease state of reproductive tissues than the normal state, 
and here we will briefly touch on some recent findings in respect to miRNA and their 
dysregulation in diseased reproductive tissues of women. 
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Ovarian cancer is the sixth most common cancer in women, and miRNA 
expression has been studied in several types of ovarian cancer and a variety of cancer 
cell lines (Corney et al., 2007; Dahiya et al., 2008; Iorio et al., 2007; Nam et al., 
2008; Yang et al., 2008; Zhang et al., 2008a).  To date, the predominant work focuses 
on elucidation of miRNA signatures that can be used for diagnosis.  These studies 
compare cancerous tissue to either normal tissue or to immortalized cancer cell lines.  
Interestingly, a set of common miRNA associated with ovarian cancer has not been 
generated, which may be due to the nature of the controls or reference samples used 
to compare the cancer tissues. 
 In the uterus, endometrial carcinogenesis affects almost 40,000 women per 
year.  Boren et al. examined the expression of miRNA in endometrial 
adenocarcinomas versus normal endometrial tissue and identified thirteen miRNA as 
differentially expressed (Boren et al., 2008).  They also identified mRNA differences 
between the two tissues and found that 9% of the differentially expressed mRNA 
were predicted targets of the changed miRNA. 
 Uterine leiomyomas (i.e., fibroids) are a benign uterine pathology that affect 
30 to 50% of women.  Several studies have examined the expression of miRNA in 
uterine leiomyomas.  In two studies, miRNA microarrays were performed to examine 
the differential miRNA profiles of uterine leiomyomas and normal myometrium.  
Marsh et al. identified 81 miRNA as differentially expressed, including increased 
expression of an anti-apoptotic miRNA, miR-21, and decreased expression of a 
miRNA previously shown to be decreased in pancreatic adenocarcinoma, miR-139 
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(Marsh et al., 2008).  Wang et al identified 45 miRNA as differentially expressed and 
further grouped the miRNA expression profiles from the uterine leiomyomas based 
on tumor size and demographics (Wang et al., 2007).  Members of the let-7 miRNA 
family showed high expression in small leiomyomas, but low expression in large 
leiomyomas (Wang et al., 2007). These miRNA target high-mobility group A2 
(HMGA2), a transcription factor highly expressed in large leiomyomas that positively 
regulates cell growth and proliferation and negatively regulates apoptosis (Peng et al., 
2008).  Members of the let-7 miRNA family were shown in vitro to prevent HMGA2 
expression, and therefore high levels of let-7 miRNA can prevent HMGA2 expression 
and thus tumor growth. 
Endometriosis, a disease characterized by the presence of endometrial tissue 
outside the uterine cavity, causes infertility in 30-40% of patients with the condition.  
Pan et al. performed a miRNA microarray on human samples of normal 
endometrium, eutopic endometrium, and ectopic endometrium (Pan et al., 2008).  
Forty-eight miRNA were identified as differentially expressed. MiR-18a, miR-181a 
and miR-142-5p were shown to have predicted target transcripts that were already 
implicated in endometriosis including estrogen receptor alpha, estrogen receptor beta, 
and progesterone receptor, respectively.  Moreover, the expression of several miRNA 
(miR-20a, miR-21, and miR-26a) was regulated by treatment with the ovarian 
steroids estrogen or progesterone (medroxyprogesterone acetate), as well as the 
steroid receptor antagonists ICI-182780 and RU486 (Pan et al., 2007). 
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8.  Summary and Conclusions 
The role of miRNA in reproductive tissue function and development are presently 
being elucidated.  To date much of the work has focused on miRNA profiling of the 
reproductive organs, but the expression, regulation, and function of miRNA within 
specific tissues and cells still needs to be determined.  To help establish functional 
connections, conditional Dicer knockout mice have been used to show the 
consequences that the lack of miRNA have on ovarian, oviductal, uterine, and 
oocyte/embryo function and development.  Much less is known about the specific 
miRNA and their targets that cause these phenotypic effects, but this area of research 
is rapidly moving forward. Within the next several years it is expected that a wealth 
of information regarding miRNA-mediated post-transcriptional gene regulation in 
reproductive tissues will be known.  Because of the importance miRNA have in a 
variety of tissues and in diseases, understanding the role of miRNA in reproductive 
tissues will provide insight into how we can better enhance reproductive efficiency or 




















 Gaining a better understanding of the molecular events occurring in 
reproductive tissues is important in order to identify molecular networks and targets 
that can be perturbed to either enhance or inhibit fertility.  Because of the central role 
of LH in inducing ovulation and luteinization, we have focused on understanding the 
molecular events that occur in periovulatory granulosa cells in response to LH.  
Interestingly, while much work has gone into studying the transcriptional changes 
that occur in periovulatory granulosa cells in response to LH, little research has been 
dedicated to studying the post-transcriptional changes that occur, even though these 
changes are just as important in establishing the final proteome and thus phenotype of 
the cell.  In this dissertation we extend current knowledge on the transcriptional 
events initiated by LH, and, furthermore, elucidate a role of a specific post-
transcriptional regulator, miR-21, in periovulatory granulosa cells.  
 
1.  LH rapidly effects gene expression in granulosa cells.   
 Previous studies examining LH regulation on gene expression following LH 
were performed at late timepoints following LH (4-12 h), and thus may miss 
transiently expressed genes that play just as important a role in the granulosa cell 
response to LH.   Here we identified a large group of genes that are rapidly (within 1 
h) changed following LH.  Many of these genes are transcription factors that may be 
upregulating the expression of genes that play a direct role in ovulation and 
luteinization.  Future studies will identify the direct targets of these transcription 
factors.  In addition, we performed temporal expression analysis of identified genes, 
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which may allow for functional connections between genes to be identified.  Our data 
therefore provides a list of LH-regulated genes that can be further analyzed to 
establish functions and connections of the molecular pathways identified as changed.  
In addition, we identify a novel protein, epigen, as rapidly upregulated following LH, 
and show that it stimulates cumulus cell expansion.   
 
2. MicroRNA-21 transcription is upregulated in murine granulosa cells following 
LH administration. 
 This study was originally undertaken to confirm a microRNA expression 
assay that indicated miR-21 upregulation following LH.  We validated this result, and 
further showed that primary miR-21 levels preceded mature miR-21 levels, and thus 
transcription of miR-21 is increased following LH.  Future studies are needed to 
identify the molecular mechanism behind this increase.  In the above study, we 
identify a number of transcription factors as upregulated preceding miR-21 
upregulation, and an investigation of these genes may indicate that one is responsible 
for the induction of miR-21.  Interestingly, the miR-21 promoter has sites for several 
of these upregulated genes, including Jun/Fos, and has sites for other genes 
previously shown to be upregulated following LH, such as C/EBPβ.  However, miR-
21 levels appear to be only marginally changed in C/EBPβ knockout mice, and thus it 
is doubtful that C/EBPβ is the primary transcriptional regulator of miR-21. 
Future studies should also be directed towards identifying other miRNA that 
are changed in response to LH and thus may play a role in ovarian function.  It would 
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be especially interesting to identify miRNA that are different between cumulus and 
granulosa cell populations, especially because the subtle changes in gene/protein 
expression that is mediated by miRNA can explain the differences in function and 
responses of two closely related populations of cells.     
 
3.  MicroRNA-21 has an anti-apoptotic role in granulosa cells. 
 Knockdown of miR-21 both in vitro and in vivo caused an increase in 
granulosa cell apoptosis.  This is in agreement with multiple papers that suggest an 
anti-apoptotic role for miR-21 in cancer cell lines.  Here we show, for the first time, 
that miR-21 also inhibits apoptosis in a physiological situation.  It is well established 
that LH acts as a pro-survival factor in granulosa cells, and here we show that LH-
induced upregulation of miR-21 helps mediate the pro-survival effect.  Interestingly, 
an examination of known miR-21 targets that have been implicated in its anti-
apoptotic role in cancer cell lines indicates that none of these are miR-21 targets in 
granulosa cells.  It is important to note that the molecular networks that are present 
within each cell type can be highly variable, and thus can dramatically impact the 
effect of a single molecule on the cell.  Therefore, the recent identification of cell 
type-specific RNA-binding proteins that have the ability to counteract miRNA 
activity may explain this discrepancy.  Furthermore, the presence of multiple polyA 
signals within the 3’UTR of a mRNA transcript can cause 3’UTRs to be of varying 
lengths, and this can differ between cell types.  Therefore, miRNA sites can be lost if 
an earlier polyA site is used within the 3’UTR.   
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 We show here that miR-21 plays an antiapoptotic role in granulosa cells in 
periovulatory follicles, and it would be interesting to further this examination and 
investigate the role of miR-21 in granulosa cells of other follicles.  For example, 
atresia of antral follicles is initiated by granulosa cell death (as opposed to atresia of 
early follicles, which is initiated by oocyte death).  Furthermore, cleaved caspase 3 is 
required for follicular atresia (Matikainen et al., 2001).  Therefore, it would be 
interesting to examine the role of miR-21 in atretic follicles.  For example, it may be 
that atretic follicles have decreased expression of miR-21, resulting in an increase in 
cleaved caspase 3 levels and thus leading to granulosa cell death and subsequent 
follicle atresia.   
 From a clinical standpoint, granulosa cells from polycystic ovarian syndrome 
(PCOS) patients have decreased granulosa cell apoptosis and decreased cleaved 
caspase 3 levels (Das et al., 2008).  In addition, anti-apoptotic factors are upregulated 
in PCOS granulosa cells (Das et al., 2008).  Since we have shown here that miR-21 is 
an anti-apopototic factor, it would be interesting to examine the expression of miR-21 
in these PCOS granulosa cells.   
 
4.  MicroRNA-21 promotes global translation in granulosa cells.   
 To identify miR-21 targets that are responsible for the anti-apoptotic action of 
miR-21 in granulosa cells, we used a proteomic approach  to identify proteins that are 
changed upon miR-21 knockdown.  Serendipitously, we found a change in the 
activity of elongation factor 2 (EF2), a regulator of translation elongation.  
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MicroRNA-21 knockdown resulted in an increase in phosphorylation of EF2, or a 
decrease in activity.  This change corresponded to a decrease in global translation of 
the cell.  Therefore, miR-21 indirectly promotes global translation within granulosa 
cells.  The change in phosphorylated EF2 levels was confirmed in vivo, as total EF2 
levels increased following LH while phosphorylated EF2 levels decreased.   
 Following LH stimulation, granulosa cells undergo massive hypertrophy as 
they increase mitochondria and endoplasmic reticulum in preparation for a rise in 
progesterone synthesis.  These changes are mediated by an increase in global protein 
synthesis within the cell, and here we show a role for miR-21 in mediating this 
increase.  Therefore, it would be expected that the loss of miR-21 could cause a loss 
in proper luteal growth and function, and we are currently exploring this possibility 
by knocking down miR-21 function in vivo and examining corpus luteum structure 
and steroidogenic ability.    
 
5. MicroRNA-21 activates the Akt/mTOR pathway.   
 The Akt/mTOR pathway is a major cell signaling pathway in the cell.  Here 
we show that miR-21 knockdown causes a decrease in Akt/mTOR signaling pathway.  
Interestingly, the effect of miR-21 on this pathway could explain both the apoptosis 
role of miR-21 as well as the translation role of miR-21.  Ongoing studies are 
examining further upstream modulators of these pathways in order to identify the 
direct miR-21 target responsible for these changes.  The Akt/mTOR pathway is 
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activated by a number of other cell signaling pathways, many of which have a well 
described increase in activity following LH.   
 
Collectively, these studies demonstrate that LH induces a number of molecular 
changes, both transcriptional and post-transcriptional, within the granulosa cell to 
induce ovulation and luteinization.  We provide evidence that miR-21 plays an 
important and necessary role to ovarian function.  This is the first study to examine 
the role of a specific miRNA to granulosa cell function, and the first to examine the 
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